id	sid	tid	token	lemma	pos
iajs-3485	1	1	125	125	NUM
iajs-3485	1	2	©	©	PROPN
iajs-3485	1	3	2022	2022	NUM
iajs-3485	1	4	the	the	DET
iajs-3485	1	5	author(s	author(s	NOUN
iajs-3485	1	6	)	)	PUNCT
iajs-3485	1	7	.	.	PUNCT
iajs-3485	2	1	published	publish	VERB
iajs-3485	2	2	by	by	ADP
iajs-3485	2	3	college	college	NOUN
iajs-3485	2	4	of	of	ADP
iajs-3485	2	5	education	education	NOUN
iajs-3485	2	6	for	for	ADP
iajs-3485	2	7	pure	pure	ADJ
iajs-3485	2	8	science	science	NOUN
iajs-3485	2	9	(	(	PUNCT
iajs-3485	2	10	ibn	ibn	PROPN
iajs-3485	2	11	al	al	PROPN
iajs-3485	2	12	-	-	PUNCT
iajs-3485	2	13	haitham	haitham	PROPN
iajs-3485	2	14	)	)	PUNCT
iajs-3485	2	15	,	,	PUNCT
iajs-3485	2	16	university	university	NOUN
iajs-3485	2	17	of	of	ADP
iajs-3485	2	18	baghdad	baghdad	PROPN
iajs-3485	2	19	.	.	PUNCT
iajs-3485	3	1	this	this	PRON
iajs-3485	3	2	is	be	AUX
iajs-3485	3	3	an	an	DET
iajs-3485	3	4	open	open	ADJ
iajs-3485	3	5	-	-	PUNCT
iajs-3485	3	6	access	access	NOUN
iajs-3485	3	7	article	article	NOUN
iajs-3485	3	8	distributed	distribute	VERB
iajs-3485	3	9	under	under	ADP
iajs-3485	3	10	the	the	DET
iajs-3485	3	11	terms	term	NOUN
iajs-3485	3	12	of	of	ADP
iajs-3485	3	13	the	the	DET
iajs-3485	3	14	creative	creative	ADJ
iajs-3485	3	15	commons	common	NOUN
iajs-3485	3	16	attribution	attribution	NOUN
iajs-3485	3	17	4.0	4.0	NUM
iajs-3485	3	18	international	international	ADJ
iajs-3485	3	19	license	license	NOUN
iajs-3485	3	20	ammi	ammi	NOUN
iajs-3485	3	21	majus	maju	VERB
iajs-3485	3	22	seed	seed	NOUN
iajs-3485	3	23	extract	extract	VERB
iajs-3485	3	24	cardioprotective	cardioprotective	ADJ
iajs-3485	3	25	effect	effect	NOUN
iajs-3485	3	26	against	against	ADP
iajs-3485	3	27	doxorubicin	doxorubicin	PROPN
iajs-3485	3	28	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	3	29	in	in	ADP
iajs-3485	3	30	mice	mouse	NOUN
iajs-3485	3	31	israa	israa	PROPN
iajs-3485	3	32	aj	aj	PROPN
iajs-3485	3	33	.	.	PUNCT
iajs-3485	3	34	jasim1	jasim1	PROPN
iajs-3485	3	35	and	and	CCONJ
iajs-3485	3	36	shihab	shihab	PROPN
iajs-3485	3	37	h	h	PROPN
iajs-3485	4	1	mutlag2	mutlag2	PROPN
iajs-3485	4	2	*	*	PUNCT
iajs-3485	5	1	1,2department	1,2department	NUM
iajs-3485	5	2	of	of	ADP
iajs-3485	5	3	pharmacology	pharmacology	NOUN
iajs-3485	5	4	&	&	CCONJ
iajs-3485	5	5	toxicology	toxicology	NOUN
iajs-3485	5	6	,	,	PUNCT
iajs-3485	5	7	college	college	NOUN
iajs-3485	5	8	of	of	ADP
iajs-3485	5	9	pharmacy	pharmacy	NOUN
iajs-3485	5	10	,	,	PUNCT
iajs-3485	5	11	university	university	NOUN
iajs-3485	5	12	of	of	ADP
iajs-3485	5	13	baghdad	baghdad	PROPN
iajs-3485	5	14	,	,	PUNCT
iajs-3485	5	15	baghdad	baghdad	PROPN
iajs-3485	5	16	,	,	PUNCT
iajs-3485	5	17	iraq	iraq	PROPN
iajs-3485	5	18	.	.	PUNCT
iajs-3485	6	1	*	*	PUNCT
iajs-3485	6	2	corresponding	correspond	VERB
iajs-3485	6	3	author	author	NOUN
iajs-3485	6	4	.	.	PUNCT
iajs-3485	7	1	received:14	received:14	X
iajs-3485	7	2	may	may	AUX
iajs-3485	7	3	2023	2023	NUM
iajs-3485	7	4	accepted	accept	VERB
iajs-3485	7	5	:	:	PUNCT
iajs-3485	7	6	19	19	NUM
iajs-3485	7	7	june	june	PROPN
iajs-3485	7	8	2023	2023	NUM
iajs-3485	7	9	published	publish	VERB
iajs-3485	7	10	:	:	PUNCT
iajs-3485	7	11	20	20	NUM
iajs-3485	7	12	july	july	PROPN
iajs-3485	7	13	2024	2024	NUM
iajs-3485	7	14	doi.org/10.30526/37.3.3485	doi.org/10.30526/37.3.3485	NOUN
iajs-3485	7	15	abstract	abstract	ADJ
iajs-3485	7	16	one	one	NUM
iajs-3485	7	17	of	of	ADP
iajs-3485	7	18	the	the	DET
iajs-3485	7	19	most	most	ADV
iajs-3485	7	20	efficient	efficient	ADJ
iajs-3485	7	21	anthracycline	anthracycline	NOUN
iajs-3485	7	22	anti	anti	ADJ
iajs-3485	7	23	-	-	ADJ
iajs-3485	7	24	cancer	cancer	ADJ
iajs-3485	7	25	medications	medication	NOUN
iajs-3485	7	26	,	,	PUNCT
iajs-3485	7	27	doxorubicin	doxorubicin	PROPN
iajs-3485	7	28	,	,	PUNCT
iajs-3485	7	29	is	be	AUX
iajs-3485	7	30	used	use	VERB
iajs-3485	7	31	to	to	PART
iajs-3485	7	32	treat	treat	VERB
iajs-3485	7	33	lymphoid	lymphoid	ADJ
iajs-3485	7	34	malignancies	malignancy	NOUN
iajs-3485	7	35	.	.	PUNCT
iajs-3485	8	1	intercalation	intercalation	NOUN
iajs-3485	8	2	with	with	ADP
iajs-3485	8	3	deoxyribonucleic	deoxyribonucleic	ADJ
iajs-3485	8	4	acid	acid	NOUN
iajs-3485	8	5	is	be	AUX
iajs-3485	8	6	a	a	DET
iajs-3485	8	7	key	key	ADJ
iajs-3485	8	8	component	component	NOUN
iajs-3485	8	9	of	of	ADP
iajs-3485	8	10	its	its	PRON
iajs-3485	8	11	primary	primary	ADJ
iajs-3485	8	12	chemotherapeutic	chemotherapeutic	ADJ
iajs-3485	8	13	mode	mode	NOUN
iajs-3485	8	14	of	of	ADP
iajs-3485	8	15	action	action	NOUN
iajs-3485	8	16	,	,	PUNCT
iajs-3485	8	17	which	which	PRON
iajs-3485	8	18	can	can	AUX
iajs-3485	8	19	ultimately	ultimately	ADV
iajs-3485	8	20	lead	lead	VERB
iajs-3485	8	21	to	to	ADP
iajs-3485	8	22	heart	heart	NOUN
iajs-3485	8	23	failure	failure	NOUN
iajs-3485	8	24	.	.	PUNCT
iajs-3485	9	1	therefore	therefore	ADV
iajs-3485	9	2	,	,	PUNCT
iajs-3485	9	3	the	the	DET
iajs-3485	9	4	objective	objective	NOUN
iajs-3485	9	5	of	of	ADP
iajs-3485	9	6	this	this	DET
iajs-3485	9	7	study	study	NOUN
iajs-3485	9	8	was	be	AUX
iajs-3485	9	9	to	to	PART
iajs-3485	9	10	determine	determine	VERB
iajs-3485	9	11	whether	whether	SCONJ
iajs-3485	9	12	the	the	DET
iajs-3485	9	13	ethanolic	ethanolic	ADJ
iajs-3485	9	14	extract	extract	NOUN
iajs-3485	9	15	of	of	ADP
iajs-3485	9	16	ammi	ammi	PROPN
iajs-3485	9	17	majus	maju	NOUN
iajs-3485	9	18	had	have	VERB
iajs-3485	9	19	any	any	DET
iajs-3485	9	20	cardioprotective	cardioprotective	ADJ
iajs-3485	9	21	effects	effect	NOUN
iajs-3485	9	22	against	against	ADP
iajs-3485	9	23	doxorubicin	doxorubicin	PROPN
iajs-3485	9	24	toxicity	toxicity	NOUN
iajs-3485	9	25	in	in	ADP
iajs-3485	9	26	mice	mouse	NOUN
iajs-3485	9	27	.	.	PUNCT
iajs-3485	10	1	48	48	NUM
iajs-3485	10	2	mature	mature	ADJ
iajs-3485	10	3	albino	albino	NOUN
iajs-3485	10	4	male	male	ADJ
iajs-3485	10	5	mice	mouse	NOUN
iajs-3485	10	6	were	be	AUX
iajs-3485	10	7	separated	separate	VERB
iajs-3485	10	8	into	into	ADP
iajs-3485	10	9	six	six	NUM
iajs-3485	10	10	groups	group	NOUN
iajs-3485	10	11	and	and	CCONJ
iajs-3485	10	12	distributed	distribute	VERB
iajs-3485	10	13	as	as	SCONJ
iajs-3485	10	14	follows	follow	VERB
iajs-3485	10	15	:	:	PUNCT
iajs-3485	10	16	for	for	ADP
iajs-3485	10	17	14	14	NUM
iajs-3485	10	18	days	day	NOUN
iajs-3485	10	19	,	,	PUNCT
iajs-3485	10	20	group	group	NOUN
iajs-3485	10	21	i	i	NOUN
iajs-3485	10	22	:	:	PUNCT
iajs-3485	10	23	"	"	PUNCT
iajs-3485	10	24	negative	negative	ADJ
iajs-3485	10	25	control	control	NOUN
iajs-3485	10	26	"	"	PUNCT
iajs-3485	10	27	received	receive	VERB
iajs-3485	10	28	distilled	distilled	ADJ
iajs-3485	10	29	water	water	NOUN
iajs-3485	10	30	;	;	PUNCT
iajs-3485	10	31	group	group	PROPN
iajs-3485	10	32	ii	ii	PROPN
iajs-3485	10	33	:	:	PUNCT
iajs-3485	10	34	mice	mouse	NOUN
iajs-3485	10	35	received	receive	VERB
iajs-3485	10	36	a	a	DET
iajs-3485	10	37	single	single	ADJ
iajs-3485	10	38	oral	oral	ADJ
iajs-3485	10	39	daily	daily	ADJ
iajs-3485	10	40	dose	dose	NOUN
iajs-3485	10	41	of	of	ADP
iajs-3485	10	42	64	64	NUM
iajs-3485	10	43	mg	mg	NUM
iajs-3485	10	44	/	/	SYM
iajs-3485	10	45	kg	kg	PROPN
iajs-3485	10	46	of	of	ADP
iajs-3485	10	47	ammi	ammi	PROPN
iajs-3485	10	48	majus	majus	ADJ
iajs-3485	10	49	seeds	seed	NOUN
iajs-3485	10	50	extract	extract	NOUN
iajs-3485	10	51	;	;	PUNCT
iajs-3485	10	52	group	group	NOUN
iajs-3485	10	53	iii	iii	PROPN
iajs-3485	10	54	:	:	PUNCT
iajs-3485	10	55	mice	mouse	NOUN
iajs-3485	10	56	received	receive	VERB
iajs-3485	10	57	a	a	DET
iajs-3485	10	58	single	single	ADJ
iajs-3485	10	59	oral	oral	ADJ
iajs-3485	10	60	daily	daily	ADJ
iajs-3485	10	61	dose	dose	NOUN
iajs-3485	10	62	of	of	ADP
iajs-3485	10	63	128	128	NUM
iajs-3485	10	64	mg	mg	PROPN
iajs-3485	10	65	/	/	SYM
iajs-3485	10	66	kg	kg	PROPN
iajs-3485	10	67	of	of	ADP
iajs-3485	10	68	ammi	ammi	PROPN
iajs-3485	10	69	majus	majus	ADJ
iajs-3485	10	70	seeds	seed	NOUN
iajs-3485	10	71	extract	extract	NOUN
iajs-3485	10	72	;	;	PUNCT
iajs-3485	10	73	and	and	CCONJ
iajs-3485	10	74	group	group	NOUN
iajs-3485	10	75	iv	iv	NUM
iajs-3485	10	76	:	:	PUNCT
iajs-3485	10	77	"	"	PUNCT
iajs-3485	10	78	positive	positive	ADJ
iajs-3485	10	79	control	control	NOUN
iajs-3485	10	80	"	"	PUNCT
iajs-3485	10	81	received	receive	VERB
iajs-3485	10	82	a	a	DET
iajs-3485	10	83	single	single	ADJ
iajs-3485	10	84	dose	dose	NOUN
iajs-3485	10	85	of	of	ADP
iajs-3485	10	86	2	2	NUM
iajs-3485	10	87	ml	ml	NOUN
iajs-3485	10	88	/	/	SYM
iajs-3485	10	89	kg	kg	PROPN
iajs-3485	10	90	of	of	ADP
iajs-3485	10	91	distilled	distil	VERB
iajs-3485	10	92	water	water	NOUN
iajs-3485	10	93	.	.	PUNCT
iajs-3485	11	1	on	on	ADP
iajs-3485	11	2	day	day	NOUN
iajs-3485	11	3	fifteen	fifteen	NUM
iajs-3485	11	4	,	,	PUNCT
iajs-3485	11	5	the	the	DET
iajs-3485	11	6	mice	mouse	NOUN
iajs-3485	11	7	got	get	VERB
iajs-3485	11	8	an	an	DET
iajs-3485	11	9	intraperitoneal	intraperitoneal	ADJ
iajs-3485	11	10	dose	dose	NOUN
iajs-3485	11	11	of	of	ADP
iajs-3485	11	12	15	15	NUM
iajs-3485	11	13	mg	mg	PROPN
iajs-3485	11	14	/	/	SYM
iajs-3485	11	15	kg	kg	PROPN
iajs-3485	11	16	of	of	ADP
iajs-3485	11	17	doxorubicin	doxorubicin	PROPN
iajs-3485	11	18	;	;	PUNCT
iajs-3485	11	19	they	they	PRON
iajs-3485	11	20	were	be	AUX
iajs-3485	11	21	sacrificed	sacrifice	VERB
iajs-3485	11	22	using	use	VERB
iajs-3485	11	23	anesthetic	anesthetic	ADJ
iajs-3485	11	24	ether	ether	NOUN
iajs-3485	11	25	24	24	NUM
iajs-3485	11	26	hours	hour	NOUN
iajs-3485	11	27	later	later	ADV
iajs-3485	11	28	.	.	PUNCT
iajs-3485	12	1	group	group	NOUN
iajs-3485	12	2	v	v	PROPN
iajs-3485	12	3	was	be	AUX
iajs-3485	12	4	given	give	VERB
iajs-3485	12	5	a	a	DET
iajs-3485	12	6	single	single	ADJ
iajs-3485	12	7	dose	dose	NOUN
iajs-3485	12	8	of	of	ADP
iajs-3485	12	9	15	15	NUM
iajs-3485	12	10	mg	mg	PROPN
iajs-3485	12	11	/	/	SYM
iajs-3485	12	12	kg	kg	NOUN
iajs-3485	12	13	of	of	ADP
iajs-3485	12	14	doxorubicin	doxorubicin	PROPN
iajs-3485	12	15	on	on	ADP
iajs-3485	12	16	day	day	NOUN
iajs-3485	12	17	15	15	NUM
iajs-3485	12	18	after	after	ADP
iajs-3485	12	19	receiving	receive	VERB
iajs-3485	12	20	64	64	NUM
iajs-3485	12	21	mg	mg	NUM
iajs-3485	12	22	/	/	SYM
iajs-3485	12	23	kg	kg	PROPN
iajs-3485	12	24	/	/	SYM
iajs-3485	12	25	day	day	NOUN
iajs-3485	12	26	of	of	ADP
iajs-3485	12	27	ammi	ammi	PROPN
iajs-3485	12	28	majus	maju	NOUN
iajs-3485	12	29	.	.	PUNCT
iajs-3485	13	1	finally	finally	ADV
iajs-3485	13	2	,	,	PUNCT
iajs-3485	13	3	group	group	NOUN
iajs-3485	13	4	vi	vi	NOUN
iajs-3485	13	5	mice	mouse	NOUN
iajs-3485	13	6	received	receive	VERB
iajs-3485	13	7	128	128	NUM
iajs-3485	13	8	mg	mg	NUM
iajs-3485	13	9	/	/	SYM
iajs-3485	13	10	kg	kg	PROPN
iajs-3485	13	11	of	of	ADP
iajs-3485	13	12	ammi	ammi	PROPN
iajs-3485	13	13	majus	maju	NOUN
iajs-3485	13	14	,	,	PUNCT
iajs-3485	13	15	and	and	CCONJ
iajs-3485	13	16	on	on	ADP
iajs-3485	13	17	day	day	NOUN
iajs-3485	13	18	15	15	NUM
iajs-3485	13	19	,	,	PUNCT
iajs-3485	13	20	they	they	PRON
iajs-3485	13	21	got	get	VERB
iajs-3485	13	22	a	a	DET
iajs-3485	13	23	single	single	ADJ
iajs-3485	13	24	dosage	dosage	NOUN
iajs-3485	13	25	of	of	ADP
iajs-3485	13	26	15	15	NUM
iajs-3485	13	27	mg	mg	NOUN
iajs-3485	13	28	/	/	SYM
iajs-3485	13	29	kg	kg	PROPN
iajs-3485	13	30	of	of	ADP
iajs-3485	13	31	doxorubicin	doxorubicin	PROPN
iajs-3485	13	32	.	.	PUNCT
iajs-3485	14	1	to	to	PART
iajs-3485	14	2	analyze	analyze	VERB
iajs-3485	14	3	malondialdehyde	malondialdehyde	PROPN
iajs-3485	14	4	,	,	PUNCT
iajs-3485	14	5	creatine	creatine	PROPN
iajs-3485	14	6	kinase	kinase	PROPN
iajs-3485	14	7	-	-	PUNCT
iajs-3485	14	8	myoglobin	myoglobin	PROPN
iajs-3485	14	9	binding	binding	NOUN
iajs-3485	14	10	,	,	PUNCT
iajs-3485	14	11	and	and	CCONJ
iajs-3485	14	12	creatine	creatine	NOUN
iajs-3485	14	13	phosphokinase	phosphokinase	NOUN
iajs-3485	14	14	as	as	ADP
iajs-3485	14	15	indicators	indicator	NOUN
iajs-3485	14	16	of	of	ADP
iajs-3485	14	17	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	14	18	,	,	PUNCT
iajs-3485	14	19	the	the	DET
iajs-3485	14	20	blood	blood	NOUN
iajs-3485	14	21	was	be	AUX
iajs-3485	14	22	drawn	draw	VERB
iajs-3485	14	23	from	from	ADP
iajs-3485	14	24	the	the	DET
iajs-3485	14	25	preorbital	preorbital	ADJ
iajs-3485	14	26	sac	sac	NOUN
iajs-3485	14	27	.	.	PUNCT
iajs-3485	15	1	data	datum	NOUN
iajs-3485	15	2	analysis	analysis	NOUN
iajs-3485	15	3	revealed	reveal	VERB
iajs-3485	15	4	that	that	SCONJ
iajs-3485	15	5	mice	mouse	NOUN
iajs-3485	15	6	pre	pre	VERB
iajs-3485	15	7	-	-	VERB
iajs-3485	15	8	treated	treat	VERB
iajs-3485	15	9	with	with	ADP
iajs-3485	15	10	different	different	ADJ
iajs-3485	15	11	doses	dose	NOUN
iajs-3485	15	12	of	of	ADP
iajs-3485	15	13	ammi	ammi	PROPN
iajs-3485	15	14	majus	majus	ADJ
iajs-3485	15	15	extract	extract	NOUN
iajs-3485	15	16	(	(	PUNCT
iajs-3485	15	17	64	64	NUM
iajs-3485	15	18	mg	mg	NOUN
iajs-3485	15	19	and	and	CCONJ
iajs-3485	15	20	128	128	NUM
iajs-3485	15	21	mg	mg	NUM
iajs-3485	15	22	/	/	SYM
iajs-3485	15	23	kg	kg	NOUN
iajs-3485	15	24	)	)	PUNCT
iajs-3485	15	25	significantly	significantly	ADV
iajs-3485	15	26	reduced	reduce	VERB
iajs-3485	15	27	the	the	DET
iajs-3485	15	28	heart	heart	NOUN
iajs-3485	15	29	damage	damage	NOUN
iajs-3485	15	30	as	as	ADP
iajs-3485	15	31	compared	compare	VERB
iajs-3485	15	32	to	to	ADP
iajs-3485	15	33	animals	animal	NOUN
iajs-3485	15	34	intoxicated	intoxicate	VERB
iajs-3485	15	35	by	by	ADP
iajs-3485	15	36	doxorubicin	doxorubicin	PROPN
iajs-3485	15	37	,	,	PUNCT
iajs-3485	15	38	as	as	SCONJ
iajs-3485	15	39	evidenced	evidence	VERB
iajs-3485	15	40	by	by	ADP
iajs-3485	15	41	an	an	DET
iajs-3485	15	42	increase	increase	NOUN
iajs-3485	15	43	in	in	ADP
iajs-3485	15	44	malondialdehyde	malondialdehyde	NOUN
iajs-3485	15	45	,	,	PUNCT
iajs-3485	15	46	creatine	creatine	PROPN
iajs-3485	15	47	kinase	kinase	PROPN
iajs-3485	15	48	-	-	PUNCT
iajs-3485	15	49	myoglobin	myoglobin	PROPN
iajs-3485	15	50	,	,	PUNCT
iajs-3485	15	51	and	and	CCONJ
iajs-3485	15	52	creatine	creatine	NOUN
iajs-3485	15	53	phosphokinase	phosphokinase	NOUN
iajs-3485	15	54	in	in	ADP
iajs-3485	15	55	the	the	DET
iajs-3485	15	56	doxorubicin	doxorubicin	PROPN
iajs-3485	15	57	group	group	NOUN
iajs-3485	15	58	.	.	PUNCT
iajs-3485	16	1	so	so	ADV
iajs-3485	16	2	the	the	DET
iajs-3485	16	3	alcoholic	alcoholic	ADJ
iajs-3485	16	4	extract	extract	NOUN
iajs-3485	16	5	of	of	ADP
iajs-3485	16	6	ammi	ammi	PROPN
iajs-3485	16	7	majus	majus	ADJ
iajs-3485	16	8	seeds	seed	NOUN
iajs-3485	16	9	reduced	reduce	VERB
iajs-3485	16	10	the	the	DET
iajs-3485	16	11	heart	heart	NOUN
iajs-3485	16	12	injury	injury	NOUN
iajs-3485	16	13	in	in	ADP
iajs-3485	16	14	pretreated	pretreated	ADJ
iajs-3485	16	15	mice	mouse	NOUN
iajs-3485	16	16	,	,	PUNCT
iajs-3485	16	17	because	because	SCONJ
iajs-3485	16	18	of	of	ADP
iajs-3485	16	19	its	its	PRON
iajs-3485	16	20	active	active	ADJ
iajs-3485	16	21	constituent	constituent	NOUN
iajs-3485	16	22	,	,	PUNCT
iajs-3485	16	23	which	which	PRON
iajs-3485	16	24	has	have	VERB
iajs-3485	16	25	anti	anti	ADJ
iajs-3485	16	26	-	-	ADJ
iajs-3485	16	27	inflammatory	inflammatory	ADJ
iajs-3485	16	28	action	action	NOUN
iajs-3485	16	29	and	and	CCONJ
iajs-3485	16	30	antioxidant	antioxidant	ADJ
iajs-3485	16	31	properties	property	NOUN
iajs-3485	16	32	.	.	PUNCT
iajs-3485	17	1	keywords	keyword	NOUN
iajs-3485	17	2	:	:	PUNCT
iajs-3485	17	3	ammi	ammi	PROPN
iajs-3485	17	4	majus	maju	VERB
iajs-3485	17	5	doxorubicin	doxorubicin	PROPN
iajs-3485	17	6	,	,	PUNCT
iajs-3485	17	7	malondialdehyde	malondialdehyde	PROPN
iajs-3485	17	8	,	,	PUNCT
iajs-3485	17	9	creatine	creatine	NOUN
iajs-3485	17	10	phosphokinase	phosphokinase	NOUN
iajs-3485	17	11	,	,	PUNCT
iajs-3485	17	12	creatine	creatine	PROPN
iajs-3485	17	13	kinasemyoglobin	kinasemyoglobin	PROPN
iajs-3485	17	14	binding	binding	PROPN
iajs-3485	17	15	.	.	PUNCT
iajs-3485	18	1	1	1	X
iajs-3485	18	2	.	.	X
iajs-3485	18	3	introduction	introduction	NOUN
iajs-3485	18	4	doxorubicin	doxorubicin	PROPN
iajs-3485	18	5	(	(	PUNCT
iajs-3485	18	6	dox	dox	NOUN
iajs-3485	18	7	)	)	PUNCT
iajs-3485	18	8	is	be	AUX
iajs-3485	18	9	a	a	DET
iajs-3485	18	10	member	member	NOUN
iajs-3485	18	11	of	of	ADP
iajs-3485	18	12	the	the	DET
iajs-3485	18	13	highly	highly	ADV
iajs-3485	18	14	efficacious	efficacious	ADJ
iajs-3485	18	15	anti	anti	ADJ
iajs-3485	18	16	-	-	ADJ
iajs-3485	18	17	cancer	cancer	ADJ
iajs-3485	18	18	medication	medication	NOUN
iajs-3485	18	19	class	class	NOUN
iajs-3485	18	20	of	of	ADP
iajs-3485	18	21	anthracyclines	anthracycline	NOUN
iajs-3485	18	22	.	.	PUNCT
iajs-3485	19	1	it	it	PRON
iajs-3485	19	2	can	can	AUX
iajs-3485	19	3	be	be	AUX
iajs-3485	19	4	used	use	VERB
iajs-3485	19	5	alone	alone	ADJ
iajs-3485	19	6	or	or	CCONJ
iajs-3485	19	7	in	in	ADP
iajs-3485	19	8	conjunction	conjunction	NOUN
iajs-3485	19	9	with	with	ADP
iajs-3485	19	10	other	other	ADJ
iajs-3485	19	11	chemotherapy	chemotherapy	NOUN
iajs-3485	19	12	-	-	PUNCT
iajs-3485	19	13	based	base	VERB
iajs-3485	19	14	treatments	treatment	NOUN
iajs-3485	19	15	to	to	PART
iajs-3485	19	16	treat	treat	VERB
iajs-3485	19	17	a	a	DET
iajs-3485	19	18	variety	variety	NOUN
iajs-3485	19	19	of	of	ADP
iajs-3485	19	20	adult	adult	NOUN
iajs-3485	19	21	and	and	CCONJ
iajs-3485	19	22	pediatric	pediatric	ADJ
iajs-3485	19	23	malignancies	malignancy	NOUN
iajs-3485	19	24	,	,	PUNCT
iajs-3485	19	25	including	include	VERB
iajs-3485	19	26	hodgkin	hodgkin	PROPN
iajs-3485	19	27	's	's	PART
iajs-3485	19	28	and	and	CCONJ
iajs-3485	19	29	non	non	ADJ
iajs-3485	19	30	-	-	ADJ
iajs-3485	19	31	hodgkin	hodgkin	NOUN
iajs-3485	19	32	's	's	PART
iajs-3485	19	33	lymphomas	lymphoma	NOUN
iajs-3485	19	34	,	,	PUNCT
iajs-3485	19	35	neuroblastomas	neuroblastoma	NOUN
iajs-3485	19	36	,	,	PUNCT
iajs-3485	19	37	soft	soft	ADJ
iajs-3485	19	38	tissue	tissue	NOUN
iajs-3485	19	39	sarcomas	sarcoma	NOUN
iajs-3485	19	40	,	,	PUNCT
iajs-3485	19	41	and	and	CCONJ
iajs-3485	19	42	solid	solid	ADJ
iajs-3485	19	43	tumors	tumor	NOUN
iajs-3485	19	44	like	like	ADP
iajs-3485	19	45	breast	breast	NOUN
iajs-3485	19	46	cancer	cancer	NOUN
iajs-3485	19	47	[	[	X
iajs-3485	19	48	1	1	NUM
iajs-3485	19	49	]	]	PUNCT
iajs-3485	19	50	.	.	PUNCT
iajs-3485	20	1	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3485	20	2	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3485	20	3	https://orcid.org/0009-0006-4817-2954	https://orcid.org/0009-0006-4817-2954	PROPN
iajs-3485	20	4	mailto:israa.alm3amry89@gmail.com	mailto:israa.alm3amry89@gmail.com	X
iajs-3485	21	1	https://orcid.org/0000-0002-5361-8221	https://orcid.org/0000-0002-5361-8221	VERB
iajs-3485	21	2	mailto:shihabhattab@copharm.uobaghdad.edu.iq	mailto:shihabhattab@copharm.uobaghdad.edu.iq	NOUN
iajs-3485	21	3	ihjpas	ihjpa	NOUN
iajs-3485	21	4	.	.	PUNCT
iajs-3485	22	1	2024	2024	NUM
iajs-3485	22	2	,	,	PUNCT
iajs-3485	22	3	37	37	NUM
iajs-3485	22	4	(	(	PUNCT
iajs-3485	22	5	3	3	NUM
iajs-3485	22	6	)	)	PUNCT
iajs-3485	22	7	126	126	NUM
iajs-3485	22	8	the	the	DET
iajs-3485	22	9	mechanism	mechanism	NOUN
iajs-3485	22	10	of	of	ADP
iajs-3485	22	11	its	its	PRON
iajs-3485	22	12	cytotoxicity	cytotoxicity	NOUN
iajs-3485	22	13	may	may	AUX
iajs-3485	22	14	entail	entail	VERB
iajs-3485	22	15	the	the	DET
iajs-3485	22	16	particular	particular	ADJ
iajs-3485	22	17	intercalation	intercalation	NOUN
iajs-3485	22	18	of	of	ADP
iajs-3485	22	19	the	the	DET
iajs-3485	22	20	planar	planar	ADJ
iajs-3485	22	21	anthracycline	anthracycline	NOUN
iajs-3485	22	22	nucleus	nucleus	PROPN
iajs-3485	22	23	with	with	ADP
iajs-3485	22	24	the	the	DET
iajs-3485	22	25	dna	dna	PROPN
iajs-3485	22	26	double	double	ADJ
iajs-3485	22	27	helix	helix	NOUN
iajs-3485	22	28	,	,	PUNCT
iajs-3485	22	29	which	which	PRON
iajs-3485	22	30	might	might	AUX
iajs-3485	22	31	hinder	hinder	VERB
iajs-3485	22	32	further	further	ADJ
iajs-3485	22	33	dna	dna	NOUN
iajs-3485	22	34	replication	replication	NOUN
iajs-3485	22	35	[	[	X
iajs-3485	22	36	2	2	NUM
iajs-3485	22	37	]	]	PUNCT
iajs-3485	22	38	and	and	CCONJ
iajs-3485	22	39	,	,	PUNCT
iajs-3485	22	40	as	as	ADP
iajs-3485	22	41	a	a	DET
iajs-3485	22	42	result	result	NOUN
iajs-3485	22	43	,	,	PUNCT
iajs-3485	22	44	cause	cause	VERB
iajs-3485	22	45	cellular	cellular	ADJ
iajs-3485	22	46	survival	survival	NOUN
iajs-3485	22	47	-	-	PUNCT
iajs-3485	22	48	critical	critical	ADJ
iajs-3485	22	49	macromolecule	macromolecule	NOUN
iajs-3485	22	50	synthesis	synthesis	NOUN
iajs-3485	22	51	to	to	PART
iajs-3485	22	52	be	be	AUX
iajs-3485	22	53	inhibited	inhibit	VERB
iajs-3485	22	54	and	and	CCONJ
iajs-3485	22	55	to	to	PART
iajs-3485	22	56	cause	cause	VERB
iajs-3485	22	57	dna	dna	ADJ
iajs-3485	22	58	damage	damage	NOUN
iajs-3485	22	59	[	[	X
iajs-3485	22	60	3	3	NUM
iajs-3485	22	61	]	]	PUNCT
iajs-3485	22	62	.	.	PUNCT
iajs-3485	23	1	the	the	DET
iajs-3485	23	2	reduction	reduction	NOUN
iajs-3485	23	3	of	of	ADP
iajs-3485	23	4	doxorubicin	doxorubicin	PROPN
iajs-3485	23	5	to	to	ADP
iajs-3485	23	6	an	an	DET
iajs-3485	23	7	unstable	unstable	ADJ
iajs-3485	23	8	metabolite	metabolite	NOUN
iajs-3485	23	9	(	(	PUNCT
iajs-3485	23	10	semiquinone	semiquinone	NOUN
iajs-3485	23	11	)	)	PUNCT
iajs-3485	23	12	,	,	PUNCT
iajs-3485	23	13	which	which	PRON
iajs-3485	23	14	is	be	AUX
iajs-3485	23	15	then	then	ADV
iajs-3485	23	16	converted	convert	VERB
iajs-3485	23	17	back	back	ADV
iajs-3485	23	18	to	to	ADP
iajs-3485	23	19	doxorubicin	doxorubicin	PROPN
iajs-3485	23	20	in	in	ADP
iajs-3485	23	21	a	a	DET
iajs-3485	23	22	process	process	NOUN
iajs-3485	23	23	that	that	PRON
iajs-3485	23	24	releases	release	VERB
iajs-3485	23	25	reactive	reactive	ADJ
iajs-3485	23	26	oxygen	oxygen	NOUN
iajs-3485	23	27	species	specie	NOUN
iajs-3485	23	28	,	,	PUNCT
iajs-3485	23	29	may	may	AUX
iajs-3485	23	30	also	also	ADV
iajs-3485	23	31	be	be	AUX
iajs-3485	23	32	another	another	DET
iajs-3485	23	33	way	way	NOUN
iajs-3485	23	34	that	that	PRON
iajs-3485	23	35	doxorubicin	doxorubicin	PROPN
iajs-3485	23	36	affects	affect	VERB
iajs-3485	23	37	cancer	cancer	NOUN
iajs-3485	23	38	cells	cell	NOUN
iajs-3485	23	39	.	.	PUNCT
iajs-3485	24	1	this	this	DET
iajs-3485	24	2	process	process	NOUN
iajs-3485	24	3	results	result	VERB
iajs-3485	24	4	in	in	ADP
iajs-3485	24	5	the	the	DET
iajs-3485	24	6	production	production	NOUN
iajs-3485	24	7	of	of	ADP
iajs-3485	24	8	free	free	ADJ
iajs-3485	24	9	radicals	radical	NOUN
iajs-3485	24	10	,	,	PUNCT
iajs-3485	24	11	which	which	PRON
iajs-3485	24	12	in	in	ADP
iajs-3485	24	13	turn	turn	NOUN
iajs-3485	24	14	cause	cause	VERB
iajs-3485	24	15	damage	damage	NOUN
iajs-3485	24	16	to	to	ADP
iajs-3485	24	17	cellular	cellular	ADJ
iajs-3485	24	18	membranes	membrane	NOUN
iajs-3485	24	19	,	,	PUNCT
iajs-3485	24	20	dna	dna	NOUN
iajs-3485	24	21	,	,	PUNCT
iajs-3485	24	22	and	and	CCONJ
iajs-3485	24	23	proteins	protein	NOUN
iajs-3485	24	24	.	.	PUNCT
iajs-3485	25	1	reactive	reactive	ADJ
iajs-3485	25	2	oxygen	oxygen	NOUN
iajs-3485	25	3	species	specie	NOUN
iajs-3485	25	4	(	(	PUNCT
iajs-3485	25	5	ros	ros	PROPN
iajs-3485	25	6	)	)	PUNCT
iajs-3485	25	7	trigger	trigger	NOUN
iajs-3485	25	8	the	the	DET
iajs-3485	25	9	apoptotic	apoptotic	ADJ
iajs-3485	25	10	pathways	pathway	NOUN
iajs-3485	25	11	that	that	PRON
iajs-3485	25	12	lead	lead	VERB
iajs-3485	25	13	to	to	ADP
iajs-3485	25	14	cell	cell	NOUN
iajs-3485	25	15	death	death	NOUN
iajs-3485	25	16	,	,	PUNCT
iajs-3485	25	17	dna	dna	NOUN
iajs-3485	25	18	damage	damage	NOUN
iajs-3485	25	19	,	,	PUNCT
iajs-3485	25	20	oxidative	oxidative	ADJ
iajs-3485	25	21	stress	stress	NOUN
iajs-3485	25	22	,	,	PUNCT
iajs-3485	25	23	lipid	lipid	NOUN
iajs-3485	25	24	peroxidation	peroxidation	NOUN
iajs-3485	25	25	,	,	PUNCT
iajs-3485	25	26	and	and	CCONJ
iajs-3485	25	27	membrane	membrane	NOUN
iajs-3485	25	28	damage	damage	NOUN
iajs-3485	25	29	[	[	X
iajs-3485	25	30	4	4	NUM
iajs-3485	25	31	]	]	PUNCT
iajs-3485	25	32	.	.	PUNCT
iajs-3485	26	1	furthermore	furthermore	ADV
iajs-3485	26	2	,	,	PUNCT
iajs-3485	26	3	topoisomerase	topoisomerase	PROPN
iajs-3485	26	4	-	-	PUNCT
iajs-3485	26	5	ii	ii	NOUN
iajs-3485	26	6	is	be	AUX
iajs-3485	26	7	negatively	negatively	ADV
iajs-3485	26	8	impacted	impact	VERB
iajs-3485	26	9	by	by	ADP
iajs-3485	26	10	dox	dox	NOUN
iajs-3485	26	11	when	when	SCONJ
iajs-3485	26	12	it	it	PRON
iajs-3485	26	13	enters	enter	VERB
iajs-3485	26	14	the	the	DET
iajs-3485	26	15	nucleus	nucleus	NOUN
iajs-3485	26	16	,	,	PUNCT
iajs-3485	26	17	which	which	PRON
iajs-3485	26	18	also	also	ADV
iajs-3485	26	19	causes	cause	VERB
iajs-3485	26	20	dna	dna	ADJ
iajs-3485	26	21	damage	damage	NOUN
iajs-3485	26	22	and	and	CCONJ
iajs-3485	26	23	cell	cell	NOUN
iajs-3485	26	24	death	death	NOUN
iajs-3485	27	1	[	[	X
iajs-3485	27	2	5].unfortunately	5].unfortunately	ADV
iajs-3485	27	3	,	,	PUNCT
iajs-3485	27	4	toxicities	toxicity	NOUN
iajs-3485	27	5	like	like	ADP
iajs-3485	27	6	hematopoietic	hematopoietic	ADJ
iajs-3485	27	7	suppression	suppression	NOUN
iajs-3485	27	8	,	,	PUNCT
iajs-3485	27	9	myelosuppression	myelosuppression	NOUN
iajs-3485	27	10	,	,	PUNCT
iajs-3485	27	11	mucositis	mucositis	NOUN
iajs-3485	27	12	,	,	PUNCT
iajs-3485	27	13	nausea	nausea	NOUN
iajs-3485	27	14	,	,	PUNCT
iajs-3485	27	15	vomiting	vomiting	NOUN
iajs-3485	27	16	,	,	PUNCT
iajs-3485	27	17	extravasation	extravasation	NOUN
iajs-3485	27	18	,	,	PUNCT
iajs-3485	27	19	alopecia	alopecia	NOUN
iajs-3485	27	20	,	,	PUNCT
iajs-3485	27	21	and	and	CCONJ
iajs-3485	27	22	cardiovascular	cardiovascular	ADJ
iajs-3485	27	23	adverse	adverse	ADJ
iajs-3485	27	24	effects	effect	NOUN
iajs-3485	27	25	like	like	ADP
iajs-3485	27	26	heart	heart	NOUN
iajs-3485	27	27	failure	failure	NOUN
iajs-3485	27	28	,	,	PUNCT
iajs-3485	27	29	tachycardia	tachycardia	NOUN
iajs-3485	27	30	,	,	PUNCT
iajs-3485	27	31	hypotension	hypotension	NOUN
iajs-3485	27	32	,	,	PUNCT
iajs-3485	27	33	and	and	CCONJ
iajs-3485	27	34	arrhythmias	arrhythmia	NOUN
iajs-3485	27	35	hampered	hamper	VERB
iajs-3485	27	36	its	its	PRON
iajs-3485	27	37	successful	successful	ADJ
iajs-3485	27	38	usage	usage	NOUN
iajs-3485	27	39	.	.	PUNCT
iajs-3485	28	1	however	however	ADV
iajs-3485	28	2	,	,	PUNCT
iajs-3485	28	3	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	28	4	is	be	AUX
iajs-3485	28	5	the	the	DET
iajs-3485	28	6	most	most	ADV
iajs-3485	28	7	concerning	concern	VERB
iajs-3485	28	8	side	side	NOUN
iajs-3485	28	9	effect	effect	NOUN
iajs-3485	29	1	[	[	X
iajs-3485	29	2	6].a	6].a	NOUN
iajs-3485	29	3	.	.	PUNCT
iajs-3485	29	4	majus	maju	NOUN
iajs-3485	29	5	(	(	PUNCT
iajs-3485	29	6	family	family	NOUN
iajs-3485	29	7	umbelliferae	umbelliferae	NOUN
iajs-3485	29	8	)	)	PUNCT
iajs-3485	29	9	is	be	AUX
iajs-3485	29	10	a	a	DET
iajs-3485	29	11	traditional	traditional	ADJ
iajs-3485	29	12	medicinal	medicinal	ADJ
iajs-3485	29	13	herb	herb	NOUN
iajs-3485	29	14	whose	whose	DET
iajs-3485	29	15	seeds	seed	NOUN
iajs-3485	29	16	are	be	AUX
iajs-3485	29	17	known	know	VERB
iajs-3485	29	18	as	as	ADP
iajs-3485	29	19	"	"	PUNCT
iajs-3485	29	20	khella	khella	NOUN
iajs-3485	29	21	shaitani	shaitani	PROPN
iajs-3485	29	22	"	"	PUNCT
iajs-3485	29	23	,	,	PUNCT
iajs-3485	29	24	this	this	DET
iajs-3485	29	25	herb	herb	NOUN
iajs-3485	29	26	’s	’s	PART
iajs-3485	29	27	seeds	seed	NOUN
iajs-3485	29	28	and	and	CCONJ
iajs-3485	29	29	roots	root	NOUN
iajs-3485	29	30	have	have	AUX
iajs-3485	29	31	long	long	ADV
iajs-3485	29	32	been	be	AUX
iajs-3485	29	33	used	use	VERB
iajs-3485	29	34	to	to	PART
iajs-3485	29	35	treat	treat	VERB
iajs-3485	29	36	inflammatory	inflammatory	ADJ
iajs-3485	29	37	disorders	disorder	NOUN
iajs-3485	29	38	such	such	ADJ
iajs-3485	29	39	as	as	ADP
iajs-3485	29	40	rheumatoid	rheumatoid	NOUN
iajs-3485	29	41	arthritis	arthritis	NOUN
iajs-3485	29	42	,	,	PUNCT
iajs-3485	29	43	as	as	ADP
iajs-3485	29	44	analgesics	analgesic	NOUN
iajs-3485	29	45	in	in	ADP
iajs-3485	29	46	the	the	DET
iajs-3485	29	47	treatment	treatment	NOUN
iajs-3485	29	48	of	of	ADP
iajs-3485	29	49	headaches	headache	NOUN
iajs-3485	29	50	,	,	PUNCT
iajs-3485	29	51	diaphoretics	diaphoretic	NOUN
iajs-3485	29	52	,	,	PUNCT
iajs-3485	29	53	and	and	CCONJ
iajs-3485	29	54	many	many	ADJ
iajs-3485	29	55	other	other	ADJ
iajs-3485	29	56	diseases	disease	NOUN
iajs-3485	29	57	[	[	X
iajs-3485	29	58	7	7	NUM
iajs-3485	29	59	]	]	PUNCT
iajs-3485	29	60	.	.	PUNCT
iajs-3485	30	1	many	many	ADJ
iajs-3485	30	2	pharmacological	pharmacological	ADJ
iajs-3485	30	3	studies	study	NOUN
iajs-3485	30	4	on	on	ADP
iajs-3485	30	5	a.	a.	NOUN
iajs-3485	30	6	majus	maju	NOUN
iajs-3485	30	7	have	have	AUX
iajs-3485	30	8	been	be	AUX
iajs-3485	30	9	conducted	conduct	VERB
iajs-3485	30	10	,	,	PUNCT
iajs-3485	30	11	and	and	CCONJ
iajs-3485	30	12	various	various	ADJ
iajs-3485	30	13	therapeutic	therapeutic	ADJ
iajs-3485	30	14	effects	effect	NOUN
iajs-3485	30	15	have	have	AUX
iajs-3485	30	16	been	be	AUX
iajs-3485	30	17	reported	report	VERB
iajs-3485	30	18	.	.	PUNCT
iajs-3485	31	1	due	due	ADP
iajs-3485	31	2	to	to	ADP
iajs-3485	31	3	the	the	DET
iajs-3485	31	4	enormous	enormous	ADJ
iajs-3485	31	5	pharmacological	pharmacological	ADJ
iajs-3485	31	6	effects	effect	NOUN
iajs-3485	31	7	of	of	ADP
iajs-3485	31	8	coumarins	coumarin	NOUN
iajs-3485	31	9	,	,	PUNCT
iajs-3485	31	10	much	much	ADJ
iajs-3485	31	11	research	research	NOUN
iajs-3485	31	12	has	have	AUX
iajs-3485	31	13	been	be	AUX
iajs-3485	31	14	conducted	conduct	VERB
iajs-3485	31	15	on	on	ADP
iajs-3485	31	16	them	they	PRON
iajs-3485	31	17	in	in	ADP
iajs-3485	31	18	recent	recent	ADJ
iajs-3485	31	19	years	year	NOUN
iajs-3485	31	20	.	.	PUNCT
iajs-3485	32	1	its	its	PRON
iajs-3485	32	2	chemical	chemical	ADJ
iajs-3485	32	3	constituents	constituent	NOUN
iajs-3485	32	4	among	among	ADP
iajs-3485	32	5	other	other	ADJ
iajs-3485	32	6	substances	substance	NOUN
iajs-3485	32	7	,	,	PUNCT
iajs-3485	32	8	contained	contain	VERB
iajs-3485	32	9	amorphous	amorphous	ADJ
iajs-3485	32	10	glucosides	glucoside	NOUN
iajs-3485	32	11	,	,	PUNCT
iajs-3485	32	12	tannins	tannin	NOUN
iajs-3485	32	13	,	,	PUNCT
iajs-3485	32	14	oleoresins	oleoresin	NOUN
iajs-3485	32	15	,	,	PUNCT
iajs-3485	32	16	acrid	acrid	ADJ
iajs-3485	32	17	oils	oil	NOUN
iajs-3485	32	18	,	,	PUNCT
iajs-3485	32	19	fixed	fix	VERB
iajs-3485	32	20	oils	oil	NOUN
iajs-3485	32	21	,	,	PUNCT
iajs-3485	32	22	proteins	protein	NOUN
iajs-3485	32	23	,	,	PUNCT
iajs-3485	32	24	and	and	CCONJ
iajs-3485	32	25	cellulose	cellulose	NOUN
iajs-3485	32	26	.	.	PUNCT
iajs-3485	33	1	xanthotoxins	xanthotoxins	PROPN
iajs-3485	33	2	,	,	PUNCT
iajs-3485	33	3	imperatorin	imperatorin	PROPN
iajs-3485	33	4	,	,	PUNCT
iajs-3485	33	5	bergaptens	bergapten	NOUN
iajs-3485	33	6	,	,	PUNCT
iajs-3485	33	7	marmesin	marmesin	NOUN
iajs-3485	33	8	,	,	PUNCT
iajs-3485	33	9	isoimperatorin	isoimperatorin	NOUN
iajs-3485	33	10	,	,	PUNCT
iajs-3485	33	11	heraclenin	heraclenin	ADJ
iajs-3485	33	12	,	,	PUNCT
iajs-3485	33	13	and	and	CCONJ
iajs-3485	33	14	isomepimpinellin	isomepimpinellin	NOUN
iajs-3485	33	15	are	be	AUX
iajs-3485	33	16	the	the	PRON
iajs-3485	33	17	[	[	X
iajs-3485	33	18	8	8	NUM
iajs-3485	33	19	,	,	PUNCT
iajs-3485	33	20	9	9	NUM
iajs-3485	33	21	]	]	X
iajs-3485	33	22	major	major	ADJ
iajs-3485	33	23	constituents	constituent	NOUN
iajs-3485	33	24	of	of	ADP
iajs-3485	33	25	furanocoumarins	furanocoumarin	NOUN
iajs-3485	33	26	.	.	PUNCT
iajs-3485	34	1	nonfurocoumarin	nonfurocoumarin	ADJ
iajs-3485	34	2	,	,	PUNCT
iajs-3485	34	3	umbelliprenin	umbelliprenin	INTJ
iajs-3485	34	4	,	,	PUNCT
iajs-3485	34	5	quercetin	quercetin	NOUN
iajs-3485	34	6	glycosides	glycoside	NOUN
iajs-3485	34	7	,	,	PUNCT
iajs-3485	34	8	luteolin	luteolin	PROPN
iajs-3485	34	9	,	,	PUNCT
iajs-3485	34	10	kaempferol	kaempferol	NOUN
iajs-3485	34	11	,	,	PUNCT
iajs-3485	34	12	oleic	oleic	ADV
iajs-3485	34	13	acid	acid	PROPN
iajs-3485	34	14	methyl	methyl	NOUN
iajs-3485	34	15	ester	ester	NOUN
iajs-3485	34	16	,	,	PUNCT
iajs-3485	34	17	palmitic	palmitic	ADJ
iajs-3485	34	18	acid	acid	NOUN
iajs-3485	34	19	,	,	PUNCT
iajs-3485	34	20	and	and	CCONJ
iajs-3485	34	21	additionally	additionally	ADV
iajs-3485	34	22	,	,	PUNCT
iajs-3485	34	23	linolenic	linolenic	NOUN
iajs-3485	34	24	acid	acid	NOUN
iajs-3485	34	25	were	be	AUX
iajs-3485	34	26	found	find	VERB
iajs-3485	34	27	[	[	X
iajs-3485	34	28	10–20	10–20	NUM
iajs-3485	34	29	]	]	PUNCT
iajs-3485	34	30	.	.	PUNCT
iajs-3485	35	1	it	it	PRON
iajs-3485	35	2	has	have	VERB
iajs-3485	35	3	many	many	ADJ
iajs-3485	35	4	pharmacological	pharmacological	ADJ
iajs-3485	35	5	properties	property	NOUN
iajs-3485	35	6	,	,	PUNCT
iajs-3485	35	7	like	like	ADP
iajs-3485	35	8	antioxidants	antioxidant	NOUN
iajs-3485	35	9	.	.	PUNCT
iajs-3485	36	1	an	an	DET
iajs-3485	36	2	experimental	experimental	ADJ
iajs-3485	36	3	investigation	investigation	NOUN
iajs-3485	36	4	showed	show	VERB
iajs-3485	36	5	that	that	SCONJ
iajs-3485	36	6	crude	crude	ADJ
iajs-3485	36	7	extract	extract	NOUN
iajs-3485	36	8	had	have	VERB
iajs-3485	36	9	antioxidant	antioxidant	ADJ
iajs-3485	36	10	activity	activity	NOUN
iajs-3485	36	11	as	as	SCONJ
iajs-3485	36	12	measured	measure	VERB
iajs-3485	36	13	by	by	ADP
iajs-3485	36	14	free	free	ADJ
iajs-3485	36	15	radical	radical	ADJ
iajs-3485	36	16	scavenging	scavenging	NOUN
iajs-3485	36	17	by	by	ADP
iajs-3485	36	18	dpph	dpph	PROPN
iajs-3485	36	19	[	[	X
iajs-3485	36	20	21	21	NUM
iajs-3485	36	21	,	,	PUNCT
iajs-3485	36	22	22	22	NUM
iajs-3485	36	23	]	]	PUNCT
iajs-3485	36	24	.	.	PUNCT
iajs-3485	37	1	gram	gram	NOUN
iajs-3485	37	2	-	-	PUNCT
iajs-3485	37	3	positive	positive	ADJ
iajs-3485	37	4	bacteria	bacteria	NOUN
iajs-3485	37	5	like	like	ADP
iajs-3485	37	6	staphylococcus	staphylococcus	NOUN
iajs-3485	37	7	aureus	aureus	PROPN
iajs-3485	37	8	(	(	PUNCT
iajs-3485	37	9	s.	s.	PROPN
iajs-3485	37	10	aureus	aureus	PROPN
iajs-3485	37	11	)	)	PUNCT
iajs-3485	37	12	and	and	CCONJ
iajs-3485	37	13	gram	gram	NOUN
iajs-3485	37	14	-	-	PUNCT
iajs-3485	37	15	negative	negative	ADJ
iajs-3485	37	16	bacteria	bacteria	NOUN
iajs-3485	37	17	like	like	ADP
iajs-3485	37	18	escherichia	escherichia	NOUN
iajs-3485	37	19	coli	coli	NOUN
iajs-3485	37	20	(	(	PUNCT
iajs-3485	37	21	e.	e.	NOUN
iajs-3485	37	22	coli	coli	PROPN
iajs-3485	37	23	)	)	PUNCT
iajs-3485	37	24	,	,	PUNCT
iajs-3485	37	25	haemophilus	haemophilus	ADP
iajs-3485	37	26	influenzae	influenzae	X
iajs-3485	37	27	(	(	PUNCT
iajs-3485	37	28	h.	h.	PROPN
iajs-3485	37	29	influenzae	influenzae	PROPN
iajs-3485	37	30	)	)	PUNCT
iajs-3485	37	31	,	,	PUNCT
iajs-3485	37	32	and	and	CCONJ
iajs-3485	37	33	proteus	proteus	PROPN
iajs-3485	37	34	spp	spp	NOUN
iajs-3485	37	35	.	.	PUNCT
iajs-3485	38	1	(	(	PUNCT
iajs-3485	38	2	proteus	proteus	PROPN
iajs-3485	38	3	spp	spp	NOUN
iajs-3485	38	4	.	.	PUNCT
iajs-3485	38	5	)	)	PUNCT
iajs-3485	38	6	are	be	AUX
iajs-3485	38	7	all	all	ADV
iajs-3485	38	8	susceptible	susceptible	ADJ
iajs-3485	38	9	to	to	ADP
iajs-3485	38	10	the	the	DET
iajs-3485	38	11	antibacterial	antibacterial	ADJ
iajs-3485	38	12	effects	effect	NOUN
iajs-3485	38	13	of	of	ADP
iajs-3485	38	14	crude	crude	ADJ
iajs-3485	38	15	extracts	extract	NOUN
iajs-3485	38	16	of	of	ADP
iajs-3485	38	17	a.	a.	NOUN
iajs-3485	38	18	majus	maju	NOUN
iajs-3485	38	19	[	[	X
iajs-3485	38	20	10	10	NUM
iajs-3485	38	21	,	,	PUNCT
iajs-3485	38	22	23	23	NUM
iajs-3485	38	23	]	]	PUNCT
iajs-3485	38	24	.	.	PUNCT
iajs-3485	39	1	therefore	therefore	ADV
iajs-3485	39	2	,	,	PUNCT
iajs-3485	39	3	in	in	ADP
iajs-3485	39	4	addition	addition	NOUN
iajs-3485	39	5	to	to	ADP
iajs-3485	39	6	its	its	PRON
iajs-3485	39	7	widespread	widespread	ADJ
iajs-3485	39	8	usage	usage	NOUN
iajs-3485	39	9	to	to	PART
iajs-3485	39	10	control	control	VERB
iajs-3485	39	11	menstruation	menstruation	NOUN
iajs-3485	39	12	and	and	CCONJ
iajs-3485	39	13	as	as	ADP
iajs-3485	39	14	a	a	DET
iajs-3485	39	15	diuretic	diuretic	NOUN
iajs-3485	39	16	,	,	PUNCT
iajs-3485	39	17	the	the	DET
iajs-3485	39	18	effect	effect	NOUN
iajs-3485	39	19	of	of	ADP
iajs-3485	39	20	all	all	DET
iajs-3485	39	21	crude	crude	ADJ
iajs-3485	39	22	extracts	extract	NOUN
iajs-3485	39	23	of	of	ADP
iajs-3485	39	24	a.	a.	NOUN
iajs-3485	39	25	majus	maju	NOUN
iajs-3485	39	26	calls	call	VERB
iajs-3485	39	27	for	for	SCONJ
iajs-3485	39	28	research	research	NOUN
iajs-3485	39	29	to	to	PART
iajs-3485	39	30	identify	identify	VERB
iajs-3485	39	31	possible	possible	ADJ
iajs-3485	39	32	anticancer	anticancer	NOUN
iajs-3485	39	33	agents	agent	NOUN
iajs-3485	39	34	[	[	X
iajs-3485	39	35	19	19	NUM
iajs-3485	39	36	,	,	PUNCT
iajs-3485	39	37	24	24	NUM
iajs-3485	39	38	,	,	PUNCT
iajs-3485	39	39	25	25	NUM
iajs-3485	39	40	]	]	PUNCT
iajs-3485	39	41	.	.	PUNCT
iajs-3485	40	1	antihyperlipidemic	antihyperlipidemic	ADJ
iajs-3485	40	2	a.	a.	NOUN
iajs-3485	40	3	majus	maju	VERB
iajs-3485	40	4	seed	seed	NOUN
iajs-3485	40	5	extract	extract	NOUN
iajs-3485	40	6	dramatically	dramatically	ADV
iajs-3485	40	7	elevates	elevate	VERB
iajs-3485	40	8	high	high	ADJ
iajs-3485	40	9	-	-	PUNCT
iajs-3485	40	10	density	density	NOUN
iajs-3485	40	11	lipoprotein	lipoprotein	ADJ
iajs-3485	40	12	levels	level	NOUN
iajs-3485	40	13	while	while	SCONJ
iajs-3485	40	14	considerably	considerably	ADV
iajs-3485	40	15	lowering	lower	VERB
iajs-3485	40	16	triglyceride	triglyceride	ADP
iajs-3485	40	17	,	,	PUNCT
iajs-3485	40	18	cholesterol	cholesterol	NOUN
iajs-3485	40	19	,	,	PUNCT
iajs-3485	40	20	and	and	CCONJ
iajs-3485	40	21	low	low	ADJ
iajs-3485	40	22	-	-	PUNCT
iajs-3485	40	23	density	density	NOUN
iajs-3485	40	24	lipoprotein	lipoprotein	ADJ
iajs-3485	40	25	levels	level	NOUN
iajs-3485	40	26	[	[	X
iajs-3485	40	27	26	26	NUM
iajs-3485	40	28	]	]	PUNCT
iajs-3485	40	29	.	.	PUNCT
iajs-3485	41	1	the	the	DET
iajs-3485	41	2	aim	aim	NOUN
iajs-3485	41	3	of	of	ADP
iajs-3485	41	4	the	the	DET
iajs-3485	41	5	study	study	NOUN
iajs-3485	41	6	was	be	AUX
iajs-3485	41	7	to	to	PART
iajs-3485	41	8	determine	determine	VERB
iajs-3485	41	9	the	the	DET
iajs-3485	41	10	possible	possible	ADJ
iajs-3485	41	11	cardioprotective	cardioprotective	ADJ
iajs-3485	41	12	effect	effect	NOUN
iajs-3485	41	13	of	of	ADP
iajs-3485	41	14	a.	a.	NOUN
iajs-3485	41	15	majus	maju	VERB
iajs-3485	41	16	seed	seed	NOUN
iajs-3485	41	17	extract	extract	NOUN
iajs-3485	41	18	on	on	ADP
iajs-3485	41	19	doxorubicin	doxorubicin	PROPN
iajs-3485	41	20	cardiotoxicity	cardiotoxicity	PROPN
iajs-3485	41	21	.	.	PUNCT
iajs-3485	42	1	2	2	X
iajs-3485	42	2	.	.	X
iajs-3485	42	3	materials	material	NOUN
iajs-3485	42	4	and	and	CCONJ
iajs-3485	42	5	methods	method	NOUN
iajs-3485	42	6	2.1	2.1	NUM
iajs-3485	42	7	.	.	PUNCT
iajs-3485	43	1	plant	plant	NOUN
iajs-3485	43	2	material	material	NOUN
iajs-3485	43	3	in	in	ADP
iajs-3485	43	4	the	the	DET
iajs-3485	43	5	iraqi	iraqi	ADJ
iajs-3485	43	6	region	region	NOUN
iajs-3485	43	7	of	of	ADP
iajs-3485	43	8	baghdad	baghdad	PROPN
iajs-3485	43	9	,	,	PUNCT
iajs-3485	43	10	a	a	DET
iajs-3485	43	11	local	local	ADJ
iajs-3485	43	12	herbal	herbal	ADJ
iajs-3485	43	13	market	market	NOUN
iajs-3485	43	14	sold	sell	VERB
iajs-3485	43	15	1	1	NUM
iajs-3485	43	16	kilogram	kilogram	NOUN
iajs-3485	43	17	of	of	ADP
iajs-3485	43	18	dried	dry	VERB
iajs-3485	43	19	a.	a.	NOUN
iajs-3485	43	20	majus	maju	NOUN
iajs-3485	43	21	seeds	seed	NOUN
iajs-3485	43	22	.	.	PUNCT
iajs-3485	44	1	the	the	DET
iajs-3485	44	2	plant	plant	NOUN
iajs-3485	44	3	was	be	AUX
iajs-3485	44	4	authenticated	authenticate	VERB
iajs-3485	44	5	by	by	ADP
iajs-3485	44	6	assistant	assistant	PROPN
iajs-3485	44	7	professor	professor	PROPN
iajs-3485	44	8	dr	dr	PROPN
iajs-3485	44	9	.	.	PROPN
iajs-3485	44	10	ibrahim	ibrahim	PROPN
iajs-3485	44	11	salih	salih	PROPN
iajs-3485	44	12	,	,	PUNCT
iajs-3485	44	13	a	a	DET
iajs-3485	44	14	botanist	botanist	NOUN
iajs-3485	44	15	at	at	ADP
iajs-3485	44	16	the	the	DET
iajs-3485	44	17	department	department	NOUN
iajs-3485	44	18	of	of	ADP
iajs-3485	44	19	pharmacognosy	pharmacognosy	NOUN
iajs-3485	44	20	,	,	PUNCT
iajs-3485	44	21	college	college	NOUN
iajs-3485	44	22	of	of	ADP
iajs-3485	44	23	pharmacy	pharmacy	NOUN
iajs-3485	44	24	,	,	PUNCT
iajs-3485	44	25	university	university	NOUN
iajs-3485	44	26	of	of	ADP
iajs-3485	44	27	al	al	PROPN
iajs-3485	44	28	-	-	PUNCT
iajs-3485	44	29	mustansira	mustansira	PROPN
iajs-3485	44	30	,	,	PUNCT
iajs-3485	44	31	and	and	CCONJ
iajs-3485	44	32	baghdad	baghdad	PROPN
iajs-3485	44	33	,	,	PUNCT
iajs-3485	44	34	iraq	iraq	PROPN
iajs-3485	44	35	.	.	PUNCT
iajs-3485	45	1	1	1	NUM
iajs-3485	45	2	kg	kg	NOUN
iajs-3485	45	3	of	of	ADP
iajs-3485	45	4	dried	dry	VERB
iajs-3485	45	5	a.	a.	NOUN
iajs-3485	45	6	majus	maju	NOUN
iajs-3485	45	7	seeds	seed	NOUN
iajs-3485	45	8	are	be	AUX
iajs-3485	45	9	crushed	crush	VERB
iajs-3485	45	10	and	and	CCONJ
iajs-3485	45	11	ground	grind	VERB
iajs-3485	45	12	by	by	ADP
iajs-3485	45	13	a	a	DET
iajs-3485	45	14	mortar	mortar	NOUN
iajs-3485	45	15	before	before	ADP
iajs-3485	45	16	being	be	AUX
iajs-3485	45	17	continuously	continuously	ADV
iajs-3485	45	18	extracted	extract	VERB
iajs-3485	45	19	(	(	PUNCT
iajs-3485	45	20	soxhlet	soxhlet	PROPN
iajs-3485	45	21	)	)	PUNCT
iajs-3485	45	22	with	with	ADP
iajs-3485	45	23	1500	1500	NUM
iajs-3485	45	24	ml	ml	NOUN
iajs-3485	45	25	of	of	ADP
iajs-3485	45	26	n	n	X
iajs-3485	45	27	-	-	PUNCT
iajs-3485	45	28	hexane	hexane	NOUN
iajs-3485	45	29	until	until	SCONJ
iajs-3485	45	30	the	the	DET
iajs-3485	45	31	yellowish	yellowish	NOUN
iajs-3485	45	32	tint	tint	NOUN
iajs-3485	45	33	has	have	AUX
iajs-3485	45	34	vanished	vanish	VERB
iajs-3485	45	35	.	.	PUNCT
iajs-3485	46	1	the	the	DET
iajs-3485	46	2	oil	oil	NOUN
iajs-3485	46	3	-	-	PUNCT
iajs-3485	46	4	free	free	ADJ
iajs-3485	46	5	residue	residue	NOUN
iajs-3485	46	6	,	,	PUNCT
iajs-3485	46	7	which	which	PRON
iajs-3485	46	8	represents	represent	VERB
iajs-3485	46	9	the	the	DET
iajs-3485	46	10	defatted	defatted	ADJ
iajs-3485	46	11	a.	a.	NOUN
iajs-3485	46	12	majus	maju	NOUN
iajs-3485	46	13	seeds	seed	NOUN
iajs-3485	46	14	,	,	PUNCT
iajs-3485	46	15	is	be	AUX
iajs-3485	46	16	extracted	extract	VERB
iajs-3485	46	17	with	with	ADP
iajs-3485	46	18	2	2	NUM
iajs-3485	46	19	liters	liter	NOUN
iajs-3485	46	20	of	of	ADP
iajs-3485	46	21	80	80	NUM
iajs-3485	46	22	%	%	NOUN
iajs-3485	46	23	ethanol	ethanol	NOUN
iajs-3485	46	24	using	use	VERB
iajs-3485	46	25	the	the	DET
iajs-3485	46	26	reflux	reflux	NOUN
iajs-3485	46	27	method	method	NOUN
iajs-3485	46	28	for	for	ADP
iajs-3485	46	29	6	6	NUM
iajs-3485	46	30	hours	hour	NOUN
iajs-3485	46	31	at	at	ADP
iajs-3485	46	32	40	40	NUM
iajs-3485	46	33	°	°	NOUN
iajs-3485	46	34	c	c	NOUN
iajs-3485	46	35	.	.	PUNCT
iajs-3485	47	1	after	after	ADP
iajs-3485	47	2	allowing	allow	VERB
iajs-3485	47	3	the	the	DET
iajs-3485	47	4	mixture	mixture	NOUN
iajs-3485	47	5	to	to	PART
iajs-3485	47	6	cool	cool	ADJ
iajs-3485	47	7	,	,	PUNCT
iajs-3485	47	8	filter	filter	NOUN
iajs-3485	47	9	paper	paper	NOUN
iajs-3485	47	10	is	be	AUX
iajs-3485	47	11	used	use	VERB
iajs-3485	47	12	to	to	PART
iajs-3485	47	13	ihjpas	ihjpas	PROPN
iajs-3485	47	14	.	.	PUNCT
iajs-3485	48	1	2024	2024	NUM
iajs-3485	48	2	,	,	PUNCT
iajs-3485	48	3	37	37	NUM
iajs-3485	48	4	(	(	PUNCT
iajs-3485	48	5	3	3	NUM
iajs-3485	48	6	)	)	PUNCT
iajs-3485	48	7	127	127	NUM
iajs-3485	48	8	remove	remove	VERB
iajs-3485	48	9	the	the	DET
iajs-3485	48	10	impurities	impurity	NOUN
iajs-3485	48	11	.	.	PUNCT
iajs-3485	49	1	an	an	DET
iajs-3485	49	2	extract	extract	NOUN
iajs-3485	49	3	devoid	devoid	ADJ
iajs-3485	49	4	of	of	ADP
iajs-3485	49	5	ethanol	ethanol	NOUN
iajs-3485	49	6	and	and	CCONJ
iajs-3485	49	7	containing	contain	VERB
iajs-3485	49	8	the	the	DET
iajs-3485	49	9	active	active	ADJ
iajs-3485	49	10	component	component	NOUN
iajs-3485	49	11	found	find	VERB
iajs-3485	49	12	in	in	ADP
iajs-3485	49	13	a.	a.	NOUN
iajs-3485	49	14	majus	maju	NOUN
iajs-3485	49	15	seeds	seed	NOUN
iajs-3485	49	16	is	be	AUX
iajs-3485	49	17	produced	produce	VERB
iajs-3485	49	18	by	by	ADP
iajs-3485	49	19	rotating	rotate	VERB
iajs-3485	49	20	vacuum	vacuum	NOUN
iajs-3485	49	21	evaporation	evaporation	NOUN
iajs-3485	49	22	of	of	ADP
iajs-3485	49	23	the	the	DET
iajs-3485	49	24	filtrate	filtrate	NOUN
iajs-3485	49	25	at	at	ADP
iajs-3485	49	26	a	a	DET
iajs-3485	49	27	temperature	temperature	NOUN
iajs-3485	49	28	of	of	ADP
iajs-3485	49	29	40	40	NUM
iajs-3485	49	30	°	°	NOUN
iajs-3485	49	31	c	c	NOUN
iajs-3485	49	32	[	[	X
iajs-3485	49	33	27	27	NUM
iajs-3485	49	34	]	]	PUNCT
iajs-3485	49	35	.	.	PUNCT
iajs-3485	50	1	2.2	2.2	NUM
iajs-3485	50	2	.	.	PUNCT
iajs-3485	50	3	experimental	experimental	ADJ
iajs-3485	50	4	model	model	NOUN
iajs-3485	50	5	the	the	DET
iajs-3485	50	6	present	present	ADJ
iajs-3485	50	7	study	study	NOUN
iajs-3485	50	8	was	be	AUX
iajs-3485	50	9	carried	carry	VERB
iajs-3485	50	10	out	out	ADP
iajs-3485	50	11	on	on	ADP
iajs-3485	50	12	48	48	NUM
iajs-3485	50	13	albino	albino	NOUN
iajs-3485	50	14	male	male	ADJ
iajs-3485	50	15	mice	mouse	NOUN
iajs-3485	50	16	weighing	weigh	VERB
iajs-3485	50	17	25–30	25–30	NUM
iajs-3485	50	18	g	g	NOUN
iajs-3485	50	19	and	and	CCONJ
iajs-3485	50	20	aged	aged	ADJ
iajs-3485	50	21	8–10	8–10	NOUN
iajs-3485	50	22	weeks	week	NOUN
iajs-3485	50	23	,	,	PUNCT
iajs-3485	50	24	obtained	obtain	VERB
iajs-3485	50	25	from	from	ADP
iajs-3485	50	26	the	the	DET
iajs-3485	50	27	animal	animal	NOUN
iajs-3485	50	28	house	house	NOUN
iajs-3485	50	29	of	of	ADP
iajs-3485	50	30	the	the	DET
iajs-3485	50	31	college	college	PROPN
iajs-3485	50	32	of	of	ADP
iajs-3485	50	33	pharmacy	pharmacy	NOUN
iajs-3485	50	34	,	,	PUNCT
iajs-3485	50	35	university	university	NOUN
iajs-3485	50	36	of	of	ADP
iajs-3485	50	37	baghdad	baghdad	PROPN
iajs-3485	50	38	,	,	PUNCT
iajs-3485	50	39	iraq	iraq	PROPN
iajs-3485	50	40	.	.	PUNCT
iajs-3485	51	1	the	the	DET
iajs-3485	51	2	mice	mouse	NOUN
iajs-3485	51	3	were	be	AUX
iajs-3485	51	4	kept	keep	VERB
iajs-3485	51	5	in	in	ADP
iajs-3485	51	6	plastic	plastic	ADJ
iajs-3485	51	7	cages	cage	NOUN
iajs-3485	51	8	(	(	PUNCT
iajs-3485	51	9	20	20	NUM
iajs-3485	51	10	*	*	SYM
iajs-3485	51	11	30	30	NUM
iajs-3485	51	12	cm	cm	NOUN
iajs-3485	51	13	)	)	PUNCT
iajs-3485	51	14	with	with	ADP
iajs-3485	51	15	eight	eight	NUM
iajs-3485	51	16	mice	mouse	NOUN
iajs-3485	51	17	per	per	ADP
iajs-3485	51	18	cage	cage	NOUN
iajs-3485	51	19	.	.	PUNCT
iajs-3485	52	1	they	they	PRON
iajs-3485	52	2	were	be	AUX
iajs-3485	52	3	kept	keep	VERB
iajs-3485	52	4	under	under	ADP
iajs-3485	52	5	conventional	conventional	ADJ
iajs-3485	52	6	laboratory	laboratory	NOUN
iajs-3485	52	7	conditions	condition	NOUN
iajs-3485	52	8	,	,	PUNCT
iajs-3485	52	9	which	which	PRON
iajs-3485	52	10	included	include	VERB
iajs-3485	52	11	a	a	DET
iajs-3485	52	12	temperature	temperature	NOUN
iajs-3485	52	13	range	range	NOUN
iajs-3485	52	14	of	of	ADP
iajs-3485	52	15	22–24	22–24	NUM
iajs-3485	52	16	°	°	ADP
iajs-3485	52	17	c	c	NOUN
iajs-3485	52	18	and	and	CCONJ
iajs-3485	52	19	a	a	DET
iajs-3485	52	20	12	12	NUM
iajs-3485	52	21	-	-	PUNCT
iajs-3485	52	22	hour	hour	NOUN
iajs-3485	52	23	light	light	ADJ
iajs-3485	52	24	/	/	SYM
iajs-3485	52	25	dark	dark	ADJ
iajs-3485	52	26	cycle	cycle	NOUN
iajs-3485	52	27	,	,	PUNCT
iajs-3485	52	28	and	and	CCONJ
iajs-3485	52	29	they	they	PRON
iajs-3485	52	30	were	be	AUX
iajs-3485	52	31	offered	offer	VERB
iajs-3485	52	32	free	free	ADJ
iajs-3485	52	33	food	food	NOUN
iajs-3485	52	34	access	access	NOUN
iajs-3485	52	35	(	(	PUNCT
iajs-3485	52	36	commercial	commercial	ADJ
iajs-3485	52	37	mouse	mouse	NOUN
iajs-3485	52	38	pellets	pellet	NOUN
iajs-3485	52	39	)	)	PUNCT
iajs-3485	52	40	and	and	CCONJ
iajs-3485	52	41	water	water	NOUN
iajs-3485	52	42	.	.	PUNCT
iajs-3485	53	1	the	the	DET
iajs-3485	53	2	experimental	experimental	ADJ
iajs-3485	53	3	group	group	NOUN
iajs-3485	53	4	kept	keep	VERB
iajs-3485	53	5	acclimated	acclimate	VERB
iajs-3485	53	6	for	for	ADP
iajs-3485	53	7	5	5	NUM
iajs-3485	53	8	days	day	NOUN
iajs-3485	53	9	before	before	ADP
iajs-3485	53	10	starting	start	VERB
iajs-3485	53	11	the	the	DET
iajs-3485	53	12	experiment	experiment	NOUN
iajs-3485	53	13	.	.	PUNCT
iajs-3485	54	1	2.3	2.3	NUM
iajs-3485	54	2	.	.	PUNCT
iajs-3485	55	1	methodology	methodology	NOUN
iajs-3485	55	2	mice	mouse	NOUN
iajs-3485	55	3	were	be	AUX
iajs-3485	55	4	divided	divide	VERB
iajs-3485	55	5	into	into	ADP
iajs-3485	55	6	six	six	NUM
iajs-3485	55	7	equal	equal	ADJ
iajs-3485	55	8	groups	group	NOUN
iajs-3485	55	9	as	as	SCONJ
iajs-3485	55	10	follows	follow	VERB
iajs-3485	55	11	to	to	PART
iajs-3485	55	12	examine	examine	VERB
iajs-3485	55	13	the	the	DET
iajs-3485	55	14	potential	potential	ADJ
iajs-3485	55	15	preventive	preventive	ADJ
iajs-3485	55	16	impact	impact	NOUN
iajs-3485	55	17	of	of	ADP
iajs-3485	55	18	various	various	ADJ
iajs-3485	55	19	dosages	dosage	NOUN
iajs-3485	55	20	of	of	ADP
iajs-3485	55	21	a.	a.	NOUN
iajs-3485	55	22	majus	maju	NOUN
iajs-3485	55	23	extract	extract	VERB
iajs-3485	55	24	against	against	ADP
iajs-3485	55	25	dox	dox	NOUN
iajs-3485	55	26	-	-	PUNCT
iajs-3485	55	27	induced	induce	VERB
iajs-3485	55	28	heart	heart	NOUN
iajs-3485	55	29	damage	damage	NOUN
iajs-3485	55	30	:	:	PUNCT
iajs-3485	55	31	group	group	NOUN
iajs-3485	55	32	i	i	PRON
iajs-3485	55	33	:	:	PUNCT
iajs-3485	55	34	8	8	NUM
iajs-3485	55	35	mice	mouse	NOUN
iajs-3485	55	36	given	give	VERB
iajs-3485	55	37	for	for	ADP
iajs-3485	55	38	14	14	NUM
iajs-3485	55	39	days	day	NOUN
iajs-3485	55	40	with	with	ADP
iajs-3485	55	41	a	a	DET
iajs-3485	55	42	single	single	ADJ
iajs-3485	55	43	oral	oral	ADJ
iajs-3485	55	44	dose	dose	NOUN
iajs-3485	55	45	of	of	ADP
iajs-3485	55	46	2	2	NUM
iajs-3485	55	47	ml	ml	NOUN
iajs-3485	55	48	/	/	SYM
iajs-3485	55	49	kg	kg	PROPN
iajs-3485	55	50	/	/	SYM
iajs-3485	55	51	day	day	NOUN
iajs-3485	55	52	d.w	d.w	NOUN
iajs-3485	55	53	.	.	PUNCT
iajs-3485	56	1	the	the	DET
iajs-3485	56	2	group	group	NOUN
iajs-3485	56	3	acted	act	VERB
iajs-3485	56	4	as	as	ADP
iajs-3485	56	5	the	the	DET
iajs-3485	56	6	negative	negative	ADJ
iajs-3485	56	7	control	control	NOUN
iajs-3485	56	8	.	.	PUNCT
iajs-3485	57	1	group	group	NOUN
iajs-3485	57	2	ii—8	ii—8	PROPN
iajs-3485	57	3	mice	mouse	NOUN
iajs-3485	57	4	were	be	AUX
iajs-3485	57	5	provided	provide	VERB
iajs-3485	57	6	with	with	ADP
iajs-3485	57	7	a	a	DET
iajs-3485	57	8	single	single	ADJ
iajs-3485	57	9	oral	oral	ADJ
iajs-3485	57	10	dose	dose	NOUN
iajs-3485	57	11	of	of	ADP
iajs-3485	57	12	64	64	NUM
iajs-3485	57	13	mg	mg	NUM
iajs-3485	57	14	/	/	SYM
iajs-3485	57	15	kg	kg	NOUN
iajs-3485	57	16	of	of	ADP
iajs-3485	57	17	the	the	DET
iajs-3485	57	18	extract	extract	NOUN
iajs-3485	57	19	from	from	ADP
iajs-3485	57	20	a.	a.	NOUN
iajs-3485	57	21	majus	maju	NOUN
iajs-3485	57	22	seeds	seed	NOUN
iajs-3485	57	23	every	every	DET
iajs-3485	57	24	day	day	NOUN
iajs-3485	57	25	for	for	ADP
iajs-3485	57	26	14	14	NUM
iajs-3485	57	27	days	day	NOUN
iajs-3485	57	28	.	.	PUNCT
iajs-3485	58	1	group	group	NOUN
iajs-3485	58	2	iii	iii	PROPN
iajs-3485	58	3	consists	consist	VERB
iajs-3485	58	4	of	of	ADP
iajs-3485	58	5	8	8	NUM
iajs-3485	58	6	mice	mouse	NOUN
iajs-3485	58	7	that	that	PRON
iajs-3485	58	8	were	be	AUX
iajs-3485	58	9	given	give	VERB
iajs-3485	58	10	a	a	DET
iajs-3485	58	11	single	single	ADJ
iajs-3485	58	12	oral	oral	ADJ
iajs-3485	58	13	dose	dose	NOUN
iajs-3485	58	14	of	of	ADP
iajs-3485	58	15	128	128	NUM
iajs-3485	58	16	mg	mg	PROPN
iajs-3485	58	17	/	/	SYM
iajs-3485	58	18	kg	kg	PROPN
iajs-3485	58	19	of	of	ADP
iajs-3485	58	20	a.	a.	NOUN
iajs-3485	58	21	majus	maju	VERB
iajs-3485	58	22	seed	seed	NOUN
iajs-3485	58	23	extract	extract	NOUN
iajs-3485	58	24	daily	daily	ADV
iajs-3485	58	25	for	for	ADP
iajs-3485	58	26	14	14	NUM
iajs-3485	58	27	days	day	NOUN
iajs-3485	58	28	.	.	PUNCT
iajs-3485	59	1	group	group	NOUN
iajs-3485	59	2	iv	iv	NUM
iajs-3485	59	3	:	:	PUNCT
iajs-3485	59	4	8	8	NUM
iajs-3485	59	5	mice	mouse	NOUN
iajs-3485	59	6	were	be	AUX
iajs-3485	59	7	given	give	VERB
iajs-3485	59	8	a	a	DET
iajs-3485	59	9	single	single	ADJ
iajs-3485	59	10	oral	oral	ADJ
iajs-3485	59	11	dose	dose	NOUN
iajs-3485	59	12	of	of	ADP
iajs-3485	59	13	2	2	NUM
iajs-3485	59	14	ml	ml	NOUN
iajs-3485	59	15	/	/	SYM
iajs-3485	59	16	kg	kg	PROPN
iajs-3485	59	17	/	/	SYM
iajs-3485	59	18	day	day	NOUN
iajs-3485	59	19	d.w	d.w	NOUN
iajs-3485	59	20	.	.	PUNCT
iajs-3485	60	1	for	for	ADP
iajs-3485	60	2	14	14	NUM
iajs-3485	60	3	days	day	NOUN
iajs-3485	60	4	.	.	PUNCT
iajs-3485	61	1	the	the	DET
iajs-3485	61	2	animal	animal	NOUN
iajs-3485	61	3	was	be	AUX
iajs-3485	61	4	given	give	VERB
iajs-3485	61	5	a	a	DET
iajs-3485	61	6	single	single	ADJ
iajs-3485	61	7	intraperitoneal	intraperitoneal	ADJ
iajs-3485	61	8	injection	injection	NOUN
iajs-3485	61	9	of	of	ADP
iajs-3485	61	10	15	15	NUM
iajs-3485	61	11	mg	mg	NOUN
iajs-3485	61	12	of	of	ADP
iajs-3485	61	13	dox	dox	NOUN
iajs-3485	61	14	on	on	ADP
iajs-3485	61	15	day	day	NOUN
iajs-3485	61	16	15	15	NUM
iajs-3485	61	17	to	to	PART
iajs-3485	61	18	cause	cause	VERB
iajs-3485	61	19	a	a	DET
iajs-3485	61	20	heart	heart	NOUN
iajs-3485	61	21	injury	injury	NOUN
iajs-3485	61	22	.	.	PUNCT
iajs-3485	62	1	the	the	DET
iajs-3485	62	2	group	group	NOUN
iajs-3485	62	3	acted	act	VERB
iajs-3485	62	4	as	as	ADP
iajs-3485	62	5	a	a	DET
iajs-3485	62	6	positive	positive	ADJ
iajs-3485	62	7	control	control	NOUN
iajs-3485	62	8	.	.	PUNCT
iajs-3485	63	1	group	group	NOUN
iajs-3485	63	2	v-8	v-8	NOUN
iajs-3485	63	3	mice	mouse	NOUN
iajs-3485	63	4	were	be	AUX
iajs-3485	63	5	treated	treat	VERB
iajs-3485	63	6	with	with	ADP
iajs-3485	63	7	a	a	DET
iajs-3485	63	8	single	single	ADJ
iajs-3485	63	9	oral	oral	ADJ
iajs-3485	63	10	dose	dose	NOUN
iajs-3485	63	11	of	of	ADP
iajs-3485	63	12	64	64	NUM
iajs-3485	63	13	mg	mg	PROPN
iajs-3485	63	14	/	/	SYM
iajs-3485	63	15	kg	kg	PROPN
iajs-3485	63	16	/	/	SYM
iajs-3485	63	17	day	day	NOUN
iajs-3485	63	18	of	of	ADP
iajs-3485	63	19	seed	seed	NOUN
iajs-3485	63	20	a.	a.	NOUN
iajs-3485	63	21	majus	maju	NOUN
iajs-3485	63	22	extract	extract	VERB
iajs-3485	63	23	for	for	ADP
iajs-3485	63	24	14	14	NUM
iajs-3485	63	25	days	day	NOUN
iajs-3485	63	26	,	,	PUNCT
iajs-3485	63	27	and	and	CCONJ
iajs-3485	63	28	then	then	ADV
iajs-3485	63	29	on	on	ADP
iajs-3485	63	30	the	the	DET
iajs-3485	63	31	15th	15th	ADJ
iajs-3485	63	32	day	day	NOUN
iajs-3485	63	33	,	,	PUNCT
iajs-3485	63	34	the	the	DET
iajs-3485	63	35	mice	mouse	NOUN
iajs-3485	63	36	were	be	AUX
iajs-3485	63	37	given	give	VERB
iajs-3485	63	38	a	a	DET
iajs-3485	63	39	15	15	NUM
iajs-3485	63	40	mg	mg	PROPN
iajs-3485	63	41	/	/	SYM
iajs-3485	63	42	dox	dox	NOUN
iajs-3485	63	43	ip	ip	PROPN
iajs-3485	63	44	dose	dose	PROPN
iajs-3485	63	45	,	,	PUNCT
iajs-3485	63	46	24	24	NUM
iajs-3485	63	47	hours	hour	NOUN
iajs-3485	63	48	after	after	ADP
iajs-3485	63	49	dox	dox	ADJ
iajs-3485	63	50	injection	injection	NOUN
iajs-3485	63	51	.	.	PUNCT
iajs-3485	64	1	the	the	DET
iajs-3485	64	2	animals	animal	NOUN
iajs-3485	64	3	were	be	AUX
iajs-3485	64	4	sacrificed	sacrifice	VERB
iajs-3485	64	5	using	use	VERB
iajs-3485	64	6	anesthetic	anesthetic	ADJ
iajs-3485	64	7	ether	ether	NOUN
iajs-3485	64	8	.	.	PUNCT
iajs-3485	65	1	group	group	NOUN
iajs-3485	65	2	vi-8	vi-8	DET
iajs-3485	65	3	mice	mouse	NOUN
iajs-3485	65	4	received	receive	VERB
iajs-3485	65	5	a	a	DET
iajs-3485	65	6	single	single	ADJ
iajs-3485	65	7	oral	oral	ADJ
iajs-3485	65	8	daily	daily	ADJ
iajs-3485	65	9	dose	dose	NOUN
iajs-3485	65	10	of	of	ADP
iajs-3485	65	11	128	128	NUM
iajs-3485	65	12	mg	mg	PROPN
iajs-3485	65	13	/	/	SYM
iajs-3485	65	14	kg	kg	PROPN
iajs-3485	65	15	/	/	SYM
iajs-3485	65	16	day	day	NOUN
iajs-3485	65	17	of	of	ADP
iajs-3485	65	18	the	the	DET
iajs-3485	65	19	extract	extract	NOUN
iajs-3485	65	20	from	from	ADP
iajs-3485	65	21	a.	a.	NOUN
iajs-3485	65	22	majus	maju	VERB
iajs-3485	65	23	seeds	seed	NOUN
iajs-3485	65	24	beginning	begin	VERB
iajs-3485	65	25	14	14	NUM
iajs-3485	65	26	days	day	NOUN
iajs-3485	65	27	before	before	ADP
iajs-3485	65	28	receiving	receive	VERB
iajs-3485	65	29	15	15	NUM
iajs-3485	65	30	mg	mg	PROPN
iajs-3485	65	31	/	/	SYM
iajs-3485	65	32	dox	dox	NOUN
iajs-3485	65	33	at	at	ADP
iajs-3485	65	34	the	the	DET
iajs-3485	65	35	15	15	NUM
iajs-3485	65	36	-	-	PUNCT
iajs-3485	65	37	day	day	NOUN
iajs-3485	65	38	mark	mark	NOUN
iajs-3485	65	39	.	.	PUNCT
iajs-3485	66	1	24	24	NUM
iajs-3485	66	2	hours	hour	NOUN
iajs-3485	66	3	after	after	ADP
iajs-3485	66	4	dox	dox	ADJ
iajs-3485	66	5	injection	injection	NOUN
iajs-3485	66	6	,	,	PUNCT
iajs-3485	66	7	the	the	DET
iajs-3485	66	8	animals	animal	NOUN
iajs-3485	66	9	were	be	AUX
iajs-3485	66	10	sacrificed	sacrifice	VERB
iajs-3485	66	11	using	use	VERB
iajs-3485	66	12	anesthetic	anesthetic	ADJ
iajs-3485	66	13	ether	ether	NOUN
iajs-3485	66	14	.	.	PUNCT
iajs-3485	67	1	blood	blood	NOUN
iajs-3485	67	2	was	be	AUX
iajs-3485	67	3	collected	collect	VERB
iajs-3485	67	4	after	after	ADP
iajs-3485	67	5	24	24	NUM
iajs-3485	67	6	hours	hour	NOUN
iajs-3485	67	7	of	of	ADP
iajs-3485	67	8	the	the	DET
iajs-3485	67	9	last	last	ADJ
iajs-3485	67	10	dose	dose	NOUN
iajs-3485	67	11	of	of	ADP
iajs-3485	67	12	distil	distil	PROPN
iajs-3485	67	13	water	water	NOUN
iajs-3485	67	14	in	in	ADP
iajs-3485	67	15	group	group	NOUN
iajs-3485	67	16	i	i	PRON
iajs-3485	67	17	,	,	PUNCT
iajs-3485	67	18	after	after	ADP
iajs-3485	67	19	24	24	NUM
iajs-3485	67	20	hours	hour	NOUN
iajs-3485	67	21	of	of	ADP
iajs-3485	67	22	the	the	DET
iajs-3485	67	23	last	last	ADJ
iajs-3485	67	24	dose	dose	NOUN
iajs-3485	67	25	of	of	ADP
iajs-3485	67	26	a.	a.	NOUN
iajs-3485	67	27	majus	maju	NOUN
iajs-3485	67	28	in	in	ADP
iajs-3485	67	29	groups	group	NOUN
iajs-3485	67	30	ii	ii	PROPN
iajs-3485	67	31	and	and	CCONJ
iajs-3485	67	32	iii	iii	NOUN
iajs-3485	67	33	,	,	PUNCT
iajs-3485	67	34	and	and	CCONJ
iajs-3485	67	35	after	after	ADP
iajs-3485	67	36	24	24	NUM
iajs-3485	67	37	hours	hour	NOUN
iajs-3485	67	38	of	of	ADP
iajs-3485	67	39	the	the	DET
iajs-3485	67	40	doxorubicin	doxorubicin	PROPN
iajs-3485	67	41	dose	dose	VERB
iajs-3485	67	42	in	in	ADP
iajs-3485	67	43	groups	group	NOUN
iajs-3485	67	44	iv	iv	ADP
iajs-3485	67	45	,	,	PUNCT
iajs-3485	67	46	v	v	NOUN
iajs-3485	67	47	,	,	PUNCT
iajs-3485	67	48	and	and	CCONJ
iajs-3485	67	49	vi	vi	X
iajs-3485	67	50	by	by	ADP
iajs-3485	67	51	a	a	DET
iajs-3485	67	52	heparinized	heparinize	VERB
iajs-3485	67	53	microcapillary	microcapillary	ADJ
iajs-3485	67	54	tube	tube	NOUN
iajs-3485	67	55	through	through	ADP
iajs-3485	67	56	the	the	DET
iajs-3485	67	57	retroorbital	retroorbital	PROPN
iajs-3485	67	58	sac	sac	NOUN
iajs-3485	67	59	.	.	PUNCT
iajs-3485	68	1	the	the	DET
iajs-3485	68	2	drained	drain	VERB
iajs-3485	68	3	blood	blood	NOUN
iajs-3485	68	4	(	(	PUNCT
iajs-3485	68	5	1	1	NUM
iajs-3485	68	6	–	–	SYM
iajs-3485	68	7	1.5	1.5	NUM
iajs-3485	68	8	ml	ml	NOUN
iajs-3485	68	9	)	)	PUNCT
iajs-3485	68	10	was	be	AUX
iajs-3485	68	11	collected	collect	VERB
iajs-3485	68	12	in	in	ADP
iajs-3485	68	13	the	the	DET
iajs-3485	68	14	eppendorf	eppendorf	ADJ
iajs-3485	68	15	tube	tube	NOUN
iajs-3485	68	16	for	for	ADP
iajs-3485	68	17	20	20	NUM
iajs-3485	68	18	minutes	minute	NOUN
iajs-3485	68	19	until	until	SCONJ
iajs-3485	68	20	blood	blood	NOUN
iajs-3485	68	21	coagulation	coagulation	NOUN
iajs-3485	68	22	occurred	occur	VERB
iajs-3485	68	23	.	.	PUNCT
iajs-3485	69	1	serum	serum	NOUN
iajs-3485	69	2	was	be	AUX
iajs-3485	69	3	collected	collect	VERB
iajs-3485	69	4	after	after	ADP
iajs-3485	69	5	centrifugation	centrifugation	NOUN
iajs-3485	69	6	in	in	ADP
iajs-3485	69	7	a	a	DET
iajs-3485	69	8	cold	cold	ADJ
iajs-3485	69	9	centrifuge	centrifuge	NOUN
iajs-3485	69	10	at	at	ADP
iajs-3485	69	11	3000	3000	NUM
iajs-3485	69	12	rpm	rpm	NOUN
iajs-3485	69	13	for	for	ADP
iajs-3485	69	14	20	20	NUM
iajs-3485	69	15	minutes	minute	NOUN
iajs-3485	69	16	at	at	ADP
iajs-3485	69	17	4	4	NUM
iajs-3485	69	18	°	°	ADP
iajs-3485	69	19	c	c	NOUN
iajs-3485	69	20	and	and	CCONJ
iajs-3485	69	21	kept	keep	VERB
iajs-3485	69	22	frozen	freeze	VERB
iajs-3485	69	23	for	for	ADP
iajs-3485	69	24	analysis	analysis	NOUN
iajs-3485	69	25	.	.	PUNCT
iajs-3485	70	1	2.4	2.4	NUM
iajs-3485	70	2	.	.	PUNCT
iajs-3485	71	1	histopathological	histopathological	ADJ
iajs-3485	71	2	examination	examination	NOUN
iajs-3485	71	3	of	of	ADP
iajs-3485	71	4	heart	heart	NOUN
iajs-3485	71	5	tissue	tissue	NOUN
iajs-3485	71	6	:	:	PUNCT
iajs-3485	71	7	the	the	DET
iajs-3485	71	8	hearts	heart	NOUN
iajs-3485	71	9	of	of	ADP
iajs-3485	71	10	each	each	DET
iajs-3485	71	11	mouse	mouse	NOUN
iajs-3485	71	12	were	be	AUX
iajs-3485	71	13	carefully	carefully	ADV
iajs-3485	71	14	removed	remove	VERB
iajs-3485	71	15	,	,	PUNCT
iajs-3485	71	16	washed	wash	VERB
iajs-3485	71	17	in	in	ADP
iajs-3485	71	18	pbs	pbs	PROPN
iajs-3485	71	19	solution	solution	NOUN
iajs-3485	71	20	(	(	PUNCT
iajs-3485	71	21	ph	ph	NOUN
iajs-3485	71	22	7.4	7.4	NUM
iajs-3485	71	23	)	)	PUNCT
iajs-3485	71	24	,	,	PUNCT
iajs-3485	71	25	and	and	CCONJ
iajs-3485	71	26	then	then	ADV
iajs-3485	71	27	taken	take	VERB
iajs-3485	71	28	and	and	CCONJ
iajs-3485	71	29	firmed	firm	VERB
iajs-3485	71	30	with	with	ADP
iajs-3485	71	31	10	10	NUM
iajs-3485	71	32	%	%	NOUN
iajs-3485	71	33	formaldehyde	formaldehyde	NOUN
iajs-3485	71	34	solution	solution	NOUN
iajs-3485	71	35	for	for	ADP
iajs-3485	71	36	histological	histological	ADJ
iajs-3485	71	37	investigation	investigation	NOUN
iajs-3485	71	38	after	after	SCONJ
iajs-3485	71	39	each	each	DET
iajs-3485	71	40	mouse	mouse	NOUN
iajs-3485	71	41	was	be	AUX
iajs-3485	71	42	put	put	VERB
iajs-3485	71	43	down	down	ADP
iajs-3485	71	44	by	by	ADP
iajs-3485	71	45	the	the	DET
iajs-3485	71	46	anesthetic	anesthetic	ADJ
iajs-3485	71	47	diethyl	diethyl	NOUN
iajs-3485	71	48	ether	ether	NOUN
iajs-3485	71	49	and	and	CCONJ
iajs-3485	71	50	by	by	ADP
iajs-3485	71	51	cervical	cervical	ADJ
iajs-3485	71	52	dislocation	dislocation	NOUN
iajs-3485	71	53	,	,	PUNCT
iajs-3485	71	54	where	where	SCONJ
iajs-3485	71	55	the	the	DET
iajs-3485	71	56	heart	heart	NOUN
iajs-3485	71	57	tissues	tissue	NOUN
iajs-3485	71	58	were	be	AUX
iajs-3485	71	59	prepared	prepare	VERB
iajs-3485	71	60	for	for	ADP
iajs-3485	71	61	histological	histological	ADJ
iajs-3485	71	62	analysis	analysis	NOUN
iajs-3485	71	63	by	by	ADP
iajs-3485	71	64	the	the	DET
iajs-3485	71	65	histopathologist	histopathologist	PROPN
iajs-3485	71	66	dr	dr	PROPN
iajs-3485	71	67	.	.	PROPN
iajs-3485	71	68	salem	salem	PROPN
iajs-3485	71	69	rasheed	rasheed	PROPN
iajs-3485	71	70	al	al	PROPN
iajs-3485	71	71	-	-	PUNCT
iajs-3485	71	72	obaidi	obaidi	PROPN
iajs-3485	71	73	according	accord	VERB
iajs-3485	71	74	to	to	ADP
iajs-3485	71	75	the	the	DET
iajs-3485	71	76	method	method	NOUN
iajs-3485	71	77	of	of	ADP
iajs-3485	71	78	junqueira	junqueira	PROPN
iajs-3485	71	79	lc	lc	PROPN
iajs-3485	71	80	et	et	PROPN
iajs-3485	71	81	al	al	PROPN
iajs-3485	71	82	.	.	PROPN
iajs-3485	72	1	(	(	PUNCT
iajs-3485	72	2	1995	1995	NUM
iajs-3485	72	3	)	)	PUNCT
iajs-3485	73	1	using	use	VERB
iajs-3485	73	2	the	the	DET
iajs-3485	73	3	paraffin	paraffin	NOUN
iajs-3485	73	4	sections	section	NOUN
iajs-3485	73	5	technique	technique	NOUN
iajs-3485	74	1	[	[	X
iajs-3485	74	2	28	28	NUM
iajs-3485	74	3	]	]	PUNCT
iajs-3485	74	4	.	.	PUNCT
iajs-3485	75	1	the	the	DET
iajs-3485	75	2	fixative	fixative	ADJ
iajs-3485	75	3	tissue	tissue	NOUN
iajs-3485	75	4	was	be	AUX
iajs-3485	75	5	dried	dry	VERB
iajs-3485	75	6	,	,	PUNCT
iajs-3485	75	7	then	then	ADV
iajs-3485	75	8	cleaned	clean	VERB
iajs-3485	75	9	with	with	ADP
iajs-3485	75	10	xylene	xylene	NOUN
iajs-3485	75	11	to	to	PART
iajs-3485	75	12	remove	remove	VERB
iajs-3485	75	13	alcohol	alcohol	NOUN
iajs-3485	75	14	and	and	CCONJ
iajs-3485	75	15	give	give	VERB
iajs-3485	75	16	the	the	DET
iajs-3485	75	17	heart	heart	NOUN
iajs-3485	75	18	tissue	tissue	NOUN
iajs-3485	75	19	some	some	DET
iajs-3485	75	20	transparency	transparency	NOUN
iajs-3485	75	21	.	.	PUNCT
iajs-3485	76	1	the	the	DET
iajs-3485	76	2	tissues	tissue	NOUN
iajs-3485	76	3	were	be	AUX
iajs-3485	76	4	then	then	ADV
iajs-3485	76	5	saturated	saturate	VERB
iajs-3485	76	6	with	with	ADP
iajs-3485	76	7	paraffin	paraffin	NOUN
iajs-3485	76	8	wax	wax	NOUN
iajs-3485	76	9	,	,	PUNCT
iajs-3485	76	10	heated	heated	ADJ
iajs-3485	76	11	,	,	PUNCT
iajs-3485	76	12	and	and	CCONJ
iajs-3485	76	13	blocked	block	VERB
iajs-3485	76	14	by	by	ADP
iajs-3485	76	15	adding	add	VERB
iajs-3485	76	16	embedded	embed	VERB
iajs-3485	76	17	models	model	NOUN
iajs-3485	76	18	.	.	PUNCT
iajs-3485	77	1	the	the	DET
iajs-3485	77	2	tissues	tissue	NOUN
iajs-3485	77	3	were	be	AUX
iajs-3485	77	4	cut	cut	VERB
iajs-3485	77	5	by	by	ADP
iajs-3485	77	6	microtoning	microtone	VERB
iajs-3485	77	7	into	into	ADP
iajs-3485	77	8	5	5	NUM
iajs-3485	77	9	m	m	NOUN
iajs-3485	77	10	-	-	PUNCT
iajs-3485	77	11	thick	thick	ADJ
iajs-3485	77	12	sections	section	NOUN
iajs-3485	77	13	,	,	PUNCT
iajs-3485	77	14	washed	wash	VERB
iajs-3485	77	15	in	in	ADP
iajs-3485	77	16	a	a	DET
iajs-3485	77	17	water	water	NOUN
iajs-3485	77	18	bath	bath	NOUN
iajs-3485	77	19	,	,	PUNCT
iajs-3485	77	20	and	and	CCONJ
iajs-3485	77	21	left	leave	VERB
iajs-3485	77	22	in	in	ADP
iajs-3485	77	23	the	the	DET
iajs-3485	77	24	oven	oven	NOUN
iajs-3485	77	25	to	to	PART
iajs-3485	77	26	finish	finish	VERB
iajs-3485	77	27	the	the	DET
iajs-3485	77	28	dewaxing	dewaxing	NOUN
iajs-3485	77	29	process	process	NOUN
iajs-3485	77	30	.	.	PUNCT
iajs-3485	78	1	then	then	ADV
iajs-3485	78	2	it	it	PRON
iajs-3485	78	3	was	be	AUX
iajs-3485	78	4	stained	stain	VERB
iajs-3485	78	5	with	with	ADP
iajs-3485	78	6	hematoxylin	hematoxylin	NOUN
iajs-3485	78	7	and	and	CCONJ
iajs-3485	78	8	eosin	eosin	PROPN
iajs-3485	78	9	(	(	PUNCT
iajs-3485	78	10	h&e	h&e	PROPN
iajs-3485	78	11	)	)	PUNCT
iajs-3485	78	12	dye	dye	NOUN
iajs-3485	78	13	,	,	PUNCT
iajs-3485	78	14	and	and	CCONJ
iajs-3485	78	15	the	the	DET
iajs-3485	78	16	histopathologist	histopathologist	NOUN
iajs-3485	78	17	viewed	view	VERB
iajs-3485	78	18	it	it	PRON
iajs-3485	78	19	under	under	ADP
iajs-3485	78	20	a	a	DET
iajs-3485	78	21	light	light	ADJ
iajs-3485	78	22	microscope	microscope	NOUN
iajs-3485	78	23	.	.	PUNCT
iajs-3485	79	1	ihjpas	ihjpas	PROPN
iajs-3485	79	2	.	.	PUNCT
iajs-3485	80	1	2024	2024	NUM
iajs-3485	80	2	,	,	PUNCT
iajs-3485	80	3	37	37	NUM
iajs-3485	80	4	(	(	PUNCT
iajs-3485	80	5	3	3	NUM
iajs-3485	80	6	)	)	PUNCT
iajs-3485	80	7	128	128	NUM
iajs-3485	81	1	3.results	3.results	NUM
iajs-3485	81	2	3.1.effects	3.1.effects	NUM
iajs-3485	81	3	of	of	ADP
iajs-3485	81	4	the	the	DET
iajs-3485	81	5	various	various	ADJ
iajs-3485	81	6	treatments	treatment	NOUN
iajs-3485	81	7	on	on	ADP
iajs-3485	81	8	heart	heart	NOUN
iajs-3485	81	9	tissue	tissue	NOUN
iajs-3485	81	10	homogenate	homogenate	NOUN
iajs-3485	81	11	malondialdehyde	malondialdehyde	NOUN
iajs-3485	81	12	(	(	PUNCT
iajs-3485	81	13	mda	mda	PROPN
iajs-3485	81	14	)	)	PUNCT
iajs-3485	81	15	contents	content	NOUN
iajs-3485	81	16	:	:	PUNCT
iajs-3485	81	17	table	table	NOUN
iajs-3485	81	18	1	1	NUM
iajs-3485	81	19	showed	show	VERB
iajs-3485	81	20	that	that	SCONJ
iajs-3485	81	21	male	male	ADJ
iajs-3485	81	22	mice	mouse	NOUN
iajs-3485	81	23	ip	ip	VERB
iajs-3485	81	24	injected	inject	VERB
iajs-3485	81	25	with	with	ADP
iajs-3485	81	26	15	15	NUM
iajs-3485	81	27	mg	mg	NOUN
iajs-3485	81	28	/	/	SYM
iajs-3485	81	29	kg	kg	PROPN
iajs-3485	81	30	doxorubicin	doxorubicin	PROPN
iajs-3485	81	31	hydrochloride	hydrochloride	NOUN
iajs-3485	81	32	(	(	PUNCT
iajs-3485	81	33	group	group	NOUN
iajs-3485	81	34	iv	iv	NUM
iajs-3485	81	35	)	)	PUNCT
iajs-3485	81	36	showed	show	VERB
iajs-3485	81	37	a	a	DET
iajs-3485	81	38	significant	significant	ADJ
iajs-3485	81	39	increase	increase	NOUN
iajs-3485	81	40	(	(	PUNCT
iajs-3485	81	41	p	p	X
iajs-3485	81	42	<	<	X
iajs-3485	81	43	0.05	0.05	NUM
iajs-3485	81	44	)	)	PUNCT
iajs-3485	81	45	in	in	ADP
iajs-3485	81	46	heart	heart	NOUN
iajs-3485	81	47	tissue	tissue	NOUN
iajs-3485	81	48	homogenate	homogenate	NOUN
iajs-3485	81	49	of	of	ADP
iajs-3485	81	50	mda	mda	PROPN
iajs-3485	81	51	compared	compare	VERB
iajs-3485	81	52	to	to	ADP
iajs-3485	81	53	the	the	DET
iajs-3485	81	54	corresponding	corresponding	ADJ
iajs-3485	81	55	activity	activity	NOUN
iajs-3485	81	56	in	in	ADP
iajs-3485	81	57	negative	negative	ADJ
iajs-3485	81	58	control	control	NOUN
iajs-3485	81	59	animals	animal	NOUN
iajs-3485	81	60	(	(	PUNCT
iajs-3485	81	61	group	group	NOUN
iajs-3485	81	62	i	i	PROPN
iajs-3485	81	63	)	)	PUNCT
iajs-3485	81	64	,	,	PUNCT
iajs-3485	81	65	with	with	ADP
iajs-3485	81	66	the	the	DET
iajs-3485	81	67	serum	serum	NOUN
iajs-3485	81	68	activity	activity	NOUN
iajs-3485	81	69	of	of	ADP
iajs-3485	81	70	the	the	DET
iajs-3485	81	71	intended	intend	VERB
iajs-3485	81	72	isoenzyme	isoenzyme	NOUN
iajs-3485	81	73	being	be	AUX
iajs-3485	81	74	(	(	PUNCT
iajs-3485	81	75	3.05	3.05	NUM
iajs-3485	81	76	±	±	NUM
iajs-3485	81	77	0.96	0.96	NUM
iajs-3485	81	78	vs.	vs.	ADP
iajs-3485	81	79	1.29±	1.29±	NUM
iajs-3485	81	80	0.13	0.13	NUM
iajs-3485	81	81	)	)	PUNCT
iajs-3485	81	82	,	,	PUNCT
iajs-3485	81	83	respectively	respectively	ADV
iajs-3485	81	84	.	.	PUNCT
iajs-3485	82	1	moreover	moreover	ADV
iajs-3485	82	2	,	,	PUNCT
iajs-3485	82	3	table	table	NOUN
iajs-3485	82	4	1	1	NUM
iajs-3485	82	5	showed	show	VERB
iajs-3485	82	6	that	that	SCONJ
iajs-3485	82	7	pre	pre	NOUN
iajs-3485	82	8	-	-	NOUN
iajs-3485	82	9	treatment	treatment	NOUN
iajs-3485	82	10	of	of	ADP
iajs-3485	82	11	mice	mouse	NOUN
iajs-3485	82	12	with	with	ADP
iajs-3485	82	13	either	either	PRON
iajs-3485	82	14	64	64	NUM
iajs-3485	82	15	mg	mg	NOUN
iajs-3485	82	16	(	(	PUNCT
iajs-3485	82	17	group	group	NOUN
iajs-3485	82	18	v	v	NOUN
iajs-3485	82	19	)	)	PUNCT
iajs-3485	82	20	or	or	CCONJ
iajs-3485	82	21	128mg	128mg	ADJ
iajs-3485	82	22	/	/	SYM
iajs-3485	82	23	mice	mouse	NOUN
iajs-3485	82	24	(	(	PUNCT
iajs-3485	82	25	group	group	NOUN
iajs-3485	82	26	vi	vi	PROPN
iajs-3485	82	27	)	)	PUNCT
iajs-3485	82	28	of	of	ADP
iajs-3485	82	29	a.	a.	NOUN
iajs-3485	82	30	majus	maju	NOUN
iajs-3485	82	31	extract	extract	VERB
iajs-3485	82	32	for	for	ADP
iajs-3485	82	33	14	14	NUM
iajs-3485	82	34	days	day	NOUN
iajs-3485	82	35	before	before	SCONJ
iajs-3485	82	36	doxorubicin	doxorubicin	PROPN
iajs-3485	82	37	had	have	VERB
iajs-3485	82	38	a	a	DET
iajs-3485	82	39	significant	significant	ADJ
iajs-3485	82	40	reduction	reduction	NOUN
iajs-3485	82	41	(	(	PUNCT
iajs-3485	82	42	p<0.05	p<0.05	NOUN
iajs-3485	82	43	)	)	PUNCT
iajs-3485	82	44	in	in	ADP
iajs-3485	82	45	the	the	DET
iajs-3485	82	46	heart	heart	NOUN
iajs-3485	82	47	tissue	tissue	NOUN
iajs-3485	82	48	homogenate	homogenate	NOUN
iajs-3485	82	49	mda	mda	NOUN
iajs-3485	82	50	activity	activity	NOUN
iajs-3485	82	51	in	in	ADP
iajs-3485	82	52	mice	mouse	NOUN
iajs-3485	82	53	as	as	SCONJ
iajs-3485	82	54	compared	compare	VERB
iajs-3485	82	55	with	with	ADP
iajs-3485	82	56	the	the	DET
iajs-3485	82	57	corresponding	corresponding	ADJ
iajs-3485	82	58	activity	activity	NOUN
iajs-3485	82	59	level	level	NOUN
iajs-3485	82	60	in	in	ADP
iajs-3485	82	61	positive	positive	ADJ
iajs-3485	82	62	control	control	NOUN
iajs-3485	82	63	animals	animal	NOUN
iajs-3485	82	64	(	(	PUNCT
iajs-3485	82	65	group	group	NOUN
iajs-3485	82	66	iv	iv	NUM
iajs-3485	82	67	)	)	PUNCT
iajs-3485	82	68	.	.	PUNCT
iajs-3485	83	1	the	the	DET
iajs-3485	83	2	mean±sem	mean±sem	PROPN
iajs-3485	83	3	of	of	ADP
iajs-3485	83	4	serum	serum	PROPN
iajs-3485	83	5	mda	mda	PROPN
iajs-3485	83	6	activities	activity	NOUN
iajs-3485	83	7	were	be	AUX
iajs-3485	83	8	(	(	PUNCT
iajs-3485	83	9	0.89	0.89	NUM
iajs-3485	83	10	±	±	NUM
iajs-3485	83	11	0.14	0.14	NUM
iajs-3485	83	12	,	,	PUNCT
iajs-3485	83	13	0.94±0.12	0.94±0.12	NUM
iajs-3485	83	14	vs.	vs.	ADP
iajs-3485	83	15	3.05	3.05	NUM
iajs-3485	83	16	±	±	NUM
iajs-3485	83	17	0.96	0.96	NUM
iajs-3485	83	18	)	)	PUNCT
iajs-3485	83	19	,	,	PUNCT
iajs-3485	83	20	respectively	respectively	ADV
iajs-3485	83	21	.	.	PUNCT
iajs-3485	84	1	also	also	ADV
iajs-3485	84	2	,	,	PUNCT
iajs-3485	84	3	there	there	PRON
iajs-3485	84	4	were	be	VERB
iajs-3485	84	5	non	non	ADJ
iajs-3485	84	6	-	-	ADJ
iajs-3485	84	7	significant	significant	ADJ
iajs-3485	84	8	differences	difference	NOUN
iajs-3485	84	9	in	in	ADP
iajs-3485	84	10	the	the	DET
iajs-3485	84	11	heart	heart	NOUN
iajs-3485	84	12	tissue	tissue	NOUN
iajs-3485	84	13	homogenate	homogenate	NOUN
iajs-3485	84	14	of	of	ADP
iajs-3485	84	15	mda	mda	PROPN
iajs-3485	84	16	groups	group	NOUN
iajs-3485	84	17	of	of	ADP
iajs-3485	84	18	pretreated	pretreate	VERB
iajs-3485	84	19	mice	mouse	NOUN
iajs-3485	84	20	with	with	ADP
iajs-3485	84	21	64	64	NUM
iajs-3485	84	22	mg	mg	NOUN
iajs-3485	84	23	/	/	SYM
iajs-3485	84	24	kg	kg	PROPN
iajs-3485	84	25	(	(	PUNCT
iajs-3485	84	26	group	group	NOUN
iajs-3485	84	27	v	v	NOUN
iajs-3485	84	28	)	)	PUNCT
iajs-3485	84	29	and	and	CCONJ
iajs-3485	84	30	128	128	NUM
iajs-3485	84	31	mg	mg	NUM
iajs-3485	84	32	/	/	SYM
iajs-3485	84	33	kg	kg	PROPN
iajs-3485	84	34	(	(	PUNCT
iajs-3485	84	35	group	group	NOUN
iajs-3485	84	36	vi	vi	PROPN
iajs-3485	84	37	)	)	PUNCT
iajs-3485	84	38	of	of	ADP
iajs-3485	84	39	a.	a.	NOUN
iajs-3485	84	40	majus	maju	NOUN
iajs-3485	84	41	compared	compare	VERB
iajs-3485	84	42	to	to	ADP
iajs-3485	84	43	the	the	DET
iajs-3485	84	44	negative	negative	ADJ
iajs-3485	84	45	control	control	NOUN
iajs-3485	84	46	mice	mouse	NOUN
iajs-3485	84	47	group	group	NOUN
iajs-3485	84	48	(	(	PUNCT
iajs-3485	84	49	group	group	NOUN
iajs-3485	84	50	i	i	PROPN
iajs-3485	84	51	)	)	PUNCT
iajs-3485	84	52	.	.	PUNCT
iajs-3485	85	1	mean±sem	mean±sem	PROPN
iajs-3485	85	2	of	of	ADP
iajs-3485	85	3	the	the	DET
iajs-3485	85	4	serum	serum	NOUN
iajs-3485	85	5	activities	activity	NOUN
iajs-3485	85	6	of	of	ADP
iajs-3485	85	7	mda	mda	PROPN
iajs-3485	85	8	were	be	AUX
iajs-3485	85	9	,	,	PUNCT
iajs-3485	85	10	respectively	respectively	ADV
iajs-3485	85	11	,	,	PUNCT
iajs-3485	85	12	(	(	PUNCT
iajs-3485	85	13	0.89±0.14	0.89±0.14	PROPN
iajs-3485	85	14	,	,	PUNCT
iajs-3485	85	15	0.94±0.12	0.94±0.12	NUM
iajs-3485	85	16	vs.	vs.	ADP
iajs-3485	85	17	1.29±0.13).also	1.29±0.13).also	NUM
iajs-3485	85	18	,	,	PUNCT
iajs-3485	85	19	table	table	NOUN
iajs-3485	85	20	1	1	NUM
iajs-3485	85	21	shows	show	VERB
iajs-3485	85	22	that	that	SCONJ
iajs-3485	85	23	there	there	PRON
iajs-3485	85	24	is	be	VERB
iajs-3485	85	25	a	a	DET
iajs-3485	85	26	non	non	ADJ
iajs-3485	85	27	-	-	ADJ
iajs-3485	85	28	significant	significant	ADJ
iajs-3485	85	29	difference	difference	NOUN
iajs-3485	85	30	in	in	ADP
iajs-3485	85	31	the	the	DET
iajs-3485	85	32	homogenate	homogenate	NOUN
iajs-3485	85	33	heart	heart	NOUN
iajs-3485	85	34	tissue	tissue	NOUN
iajs-3485	85	35	mda	mda	NOUN
iajs-3485	85	36	activity	activity	NOUN
iajs-3485	85	37	between	between	ADP
iajs-3485	85	38	the	the	DET
iajs-3485	85	39	pretreated	pretreate	VERB
iajs-3485	85	40	mice	mouse	NOUN
iajs-3485	85	41	with	with	ADP
iajs-3485	85	42	64	64	NUM
iajs-3485	85	43	mg	mg	NOUN
iajs-3485	85	44	/	/	SYM
iajs-3485	85	45	kg	kg	PROPN
iajs-3485	85	46	(	(	PUNCT
iajs-3485	85	47	group	group	NOUN
iajs-3485	85	48	v	v	NOUN
iajs-3485	85	49	)	)	PUNCT
iajs-3485	85	50	and	and	CCONJ
iajs-3485	85	51	128	128	NUM
iajs-3485	85	52	mg	mg	NUM
iajs-3485	85	53	/	/	SYM
iajs-3485	85	54	kg	kg	PROPN
iajs-3485	85	55	(	(	PUNCT
iajs-3485	85	56	group	group	NOUN
iajs-3485	85	57	vi	vi	PROPN
iajs-3485	85	58	)	)	PUNCT
iajs-3485	85	59	of	of	ADP
iajs-3485	85	60	ammi	ammi	PROPN
iajs-3485	85	61	majus	majus	PROPN
iajs-3485	85	62	.	.	PUNCT
iajs-3485	86	1	table	table	NOUN
iajs-3485	86	2	1	1	NUM
iajs-3485	86	3	:	:	PUNCT
iajs-3485	86	4	effects	effect	NOUN
iajs-3485	86	5	of	of	ADP
iajs-3485	86	6	treatment	treatment	NOUN
iajs-3485	86	7	with	with	ADP
iajs-3485	86	8	different	different	ADJ
iajs-3485	86	9	doses	dose	NOUN
iajs-3485	86	10	of	of	ADP
iajs-3485	86	11	ammi	ammi	PROPN
iajs-3485	86	12	majus	maju	NOUN
iajs-3485	86	13	extract	extract	VERB
iajs-3485	86	14	prior	prior	ADV
iajs-3485	86	15	to	to	ADP
iajs-3485	86	16	dox	dox	NOUN
iajs-3485	86	17	on	on	ADP
iajs-3485	86	18	the	the	DET
iajs-3485	86	19	heart	heart	NOUN
iajs-3485	86	20	contents	content	NOUN
iajs-3485	86	21	of	of	ADP
iajs-3485	86	22	mda	mda	PROPN
iajs-3485	86	23	compared	compare	VERB
iajs-3485	86	24	to	to	ADP
iajs-3485	86	25	doxtreated	doxtreate	VERB
iajs-3485	86	26	and	and	CCONJ
iajs-3485	86	27	control	control	NOUN
iajs-3485	86	28	groups	group	NOUN
iajs-3485	86	29	groups	group	NOUN
iajs-3485	86	30	no	no	ADV
iajs-3485	86	31	.	.	PUNCT
iajs-3485	87	1	treatments	treatment	NOUN
iajs-3485	87	2	mda	mda	PROPN
iajs-3485	87	3	(	(	PUNCT
iajs-3485	87	4	mmole	mmole	PROPN
iajs-3485	87	5	/	/	SYM
iajs-3485	87	6	l	l	NOUN
iajs-3485	87	7	)	)	PUNCT
iajs-3485	87	8	group	group	NOUN
iajs-3485	87	9	i	i	PRON
iajs-3485	87	10	8	8	NUM
iajs-3485	87	11	dw	dw	PROPN
iajs-3485	87	12	1.29±0.13b	1.29±0.13b	NUM
iajs-3485	87	13	group	group	NOUN
iajs-3485	87	14	ii	ii	PROPN
iajs-3485	87	15	8	8	NUM
iajs-3485	87	16	64	64	NUM
iajs-3485	87	17	mg	mg	PROPN
iajs-3485	87	18	/	/	SYM
iajs-3485	87	19	kg	kg	PROPN
iajs-3485	87	20	ammi	ammi	PROPN
iajs-3485	87	21	majus	majus	PROPN
iajs-3485	87	22	0.96±0.04b	0.96±0.04b	PROPN
iajs-3485	87	23	group	group	PROPN
iajs-3485	87	24	iii	iii	PROPN
iajs-3485	87	25	8	8	NUM
iajs-3485	87	26	128	128	NUM
iajs-3485	87	27	mg	mg	NUM
iajs-3485	87	28	/	/	SYM
iajs-3485	87	29	kg	kg	PROPN
iajs-3485	87	30	ammi	ammi	PROPN
iajs-3485	87	31	majus	maju	NOUN
iajs-3485	87	32	1.09±0.07b	1.09±0.07b	PROPN
iajs-3485	87	33	group	group	NOUN
iajs-3485	87	34	iv	iv	NUM
iajs-3485	87	35	8	8	NUM
iajs-3485	87	36	14	14	NUM
iajs-3485	87	37	days	day	NOUN
iajs-3485	87	38	dw	dw	NOUN
iajs-3485	87	39	prior	prior	ADV
iajs-3485	87	40	to	to	ADP
iajs-3485	87	41	a	a	DET
iajs-3485	87	42	single	single	ADJ
iajs-3485	87	43	dose	dose	NOUN
iajs-3485	87	44	of	of	ADP
iajs-3485	87	45	doxorubicin	doxorubicin	PROPN
iajs-3485	87	46	3.05±0.96a	3.05±0.96a	NUM
iajs-3485	87	47	group	group	NOUN
iajs-3485	87	48	v	v	ADP
iajs-3485	87	49	8	8	NUM
iajs-3485	87	50	64mg	64mg	ADJ
iajs-3485	87	51	/	/	SYM
iajs-3485	87	52	kg	kg	PROPN
iajs-3485	87	53	ammi	ammi	PROPN
iajs-3485	87	54	majus	maju	NOUN
iajs-3485	87	55	prior	prior	ADV
iajs-3485	87	56	to	to	ADP
iajs-3485	87	57	a	a	DET
iajs-3485	87	58	single	single	ADJ
iajs-3485	87	59	dose	dose	NOUN
iajs-3485	87	60	of	of	ADP
iajs-3485	87	61	doxorubicin	doxorubicin	PROPN
iajs-3485	87	62	0.89±0.14b	0.89±0.14b	NUM
iajs-3485	87	63	group	group	NOUN
iajs-3485	87	64	vi	vi	PROPN
iajs-3485	87	65	8	8	NUM
iajs-3485	87	66	128/	128/	NUM
iajs-3485	87	67	ammi	ammi	PROPN
iajs-3485	87	68	majus	maju	NOUN
iajs-3485	87	69	prior	prior	ADV
iajs-3485	87	70	to	to	ADP
iajs-3485	87	71	a	a	DET
iajs-3485	87	72	single	single	ADJ
iajs-3485	87	73	dose	dose	NOUN
iajs-3485	87	74	of	of	ADP
iajs-3485	87	75	doxorubicin	doxorubicin	PROPN
iajs-3485	87	76	0.94±0.12b	0.94±0.12b	VERB
iajs-3485	87	77	each	each	DET
iajs-3485	87	78	value	value	NOUN
iajs-3485	87	79	represents	represent	VERB
iajs-3485	87	80	the	the	DET
iajs-3485	87	81	mean	mean	ADJ
iajs-3485	87	82	±	±	NOUN
iajs-3485	87	83	standard	standard	NOUN
iajs-3485	87	84	error	error	NOUN
iajs-3485	87	85	of	of	ADP
iajs-3485	87	86	means	mean	NOUN
iajs-3485	87	87	(	(	PUNCT
iajs-3485	87	88	sem	sem	NOUN
iajs-3485	87	89	)	)	PUNCT
iajs-3485	87	90	.	.	PUNCT
iajs-3485	88	1	(	(	PUNCT
iajs-3485	88	2	a	a	X
iajs-3485	88	3	,	,	PUNCT
iajs-3485	88	4	b)=	b)=	VERB
iajs-3485	88	5	different	different	ADJ
iajs-3485	88	6	superscripts	superscript	NOUN
iajs-3485	88	7	indicate	indicate	VERB
iajs-3485	88	8	significant	significant	ADJ
iajs-3485	88	9	differences	difference	NOUN
iajs-3485	88	10	between	between	ADP
iajs-3485	88	11	designed	design	VERB
iajs-3485	88	12	groups	group	NOUN
iajs-3485	88	13	(	(	PUNCT
iajs-3485	88	14	p<0.05	p<0.05	NOUN
iajs-3485	88	15	)	)	PUNCT
iajs-3485	88	16	using	use	VERB
iajs-3485	88	17	an	an	DET
iajs-3485	88	18	unpaired	unpaired	ADJ
iajs-3485	88	19	student	student	NOUN
iajs-3485	88	20	t	t	NOUN
iajs-3485	88	21	-	-	PUNCT
iajs-3485	88	22	test	test	NOUN
iajs-3485	88	23	.	.	PUNCT
iajs-3485	89	1	apositive	apositive	ADJ
iajs-3485	89	2	control	control	PROPN
iajs-3485	89	3	group	group	NOUN
iajs-3485	89	4	(	(	PUNCT
iajs-3485	89	5	doxorubicin	doxorubicin	PROPN
iajs-3485	89	6	-	-	PUNCT
iajs-3485	89	7	treated	treat	VERB
iajs-3485	89	8	animals	animal	NOUN
iajs-3485	89	9	)	)	PUNCT
iajs-3485	89	10	and	and	CCONJ
iajs-3485	89	11	b	b	X
iajs-3485	89	12	-	-	PUNCT
iajs-3485	89	13	other	other	ADJ
iajs-3485	89	14	groups.values	groups.value	NOUN
iajs-3485	89	15	with	with	ADP
iajs-3485	89	16	the	the	DET
iajs-3485	89	17	same	same	ADJ
iajs-3485	89	18	letter	letter	NOUN
iajs-3485	89	19	superscript	superscript	PROPN
iajs-3485	89	20	(	(	PUNCT
iajs-3485	89	21	b	b	NOUN
iajs-3485	89	22	)	)	PUNCT
iajs-3485	89	23	are	be	AUX
iajs-3485	89	24	non	non	ADJ
iajs-3485	89	25	-	-	ADJ
iajs-3485	89	26	significantly	significantly	ADV
iajs-3485	89	27	different	different	ADJ
iajs-3485	89	28	(	(	PUNCT
iajs-3485	89	29	p>0.05	p>0.05	NOUN
iajs-3485	89	30	)	)	PUNCT
iajs-3485	89	31	among	among	ADP
iajs-3485	89	32	(	(	PUNCT
iajs-3485	89	33	i	i	PROPN
iajs-3485	89	34	,	,	PUNCT
iajs-3485	89	35	ii	ii	PROPN
iajs-3485	89	36	,	,	PUNCT
iajs-3485	89	37	iii	iii	PROPN
iajs-3485	89	38	,	,	PUNCT
iajs-3485	89	39	v	v	NOUN
iajs-3485	89	40	and	and	CCONJ
iajs-3485	89	41	vi	vi	NOUN
iajs-3485	89	42	)	)	PUNCT
iajs-3485	89	43	groups	group	NOUN
iajs-3485	89	44	using	use	VERB
iajs-3485	89	45	anova	anova	PROPN
iajs-3485	89	46	and	and	CCONJ
iajs-3485	89	47	lsd	lsd	NOUN
iajs-3485	89	48	analyses	analysis	NOUN
iajs-3485	89	49	.	.	PUNCT
iajs-3485	90	1	3.2	3.2	NUM
iajs-3485	90	2	.	.	PUNCT
iajs-3485	90	3	effect	effect	NOUN
iajs-3485	90	4	of	of	ADP
iajs-3485	90	5	various	various	ADJ
iajs-3485	90	6	treatments	treatment	NOUN
iajs-3485	90	7	on	on	ADP
iajs-3485	90	8	serum	serum	NOUN
iajs-3485	90	9	creatine	creatine	PROPN
iajs-3485	90	10	phosphokinase	phosphokinase	NOUN
iajs-3485	90	11	levels	level	NOUN
iajs-3485	90	12	in	in	ADP
iajs-3485	90	13	the	the	DET
iajs-3485	90	14	experimental	experimental	ADJ
iajs-3485	90	15	male	male	ADJ
iajs-3485	90	16	mice	mouse	NOUN
iajs-3485	90	17	:	:	PUNCT
iajs-3485	90	18	table	table	NOUN
iajs-3485	90	19	2	2	NUM
iajs-3485	90	20	showed	show	VERB
iajs-3485	90	21	that	that	SCONJ
iajs-3485	90	22	there	there	PRON
iajs-3485	90	23	was	be	VERB
iajs-3485	90	24	a	a	DET
iajs-3485	90	25	significant	significant	ADJ
iajs-3485	90	26	elevation	elevation	NOUN
iajs-3485	90	27	(	(	PUNCT
iajs-3485	90	28	p<0.05	p<0.05	NOUN
iajs-3485	90	29	)	)	PUNCT
iajs-3485	90	30	in	in	ADP
iajs-3485	90	31	the	the	DET
iajs-3485	90	32	serum	serum	NOUN
iajs-3485	90	33	activity	activity	NOUN
iajs-3485	90	34	of	of	ADP
iajs-3485	90	35	the	the	DET
iajs-3485	90	36	creatine	creatine	NOUN
iajs-3485	90	37	phosphokinase	phosphokinase	NOUN
iajs-3485	90	38	(	(	PUNCT
iajs-3485	90	39	cpk	cpk	NOUN
iajs-3485	90	40	)	)	PUNCT
iajs-3485	90	41	enzyme	enzyme	NOUN
iajs-3485	90	42	in	in	ADP
iajs-3485	90	43	the	the	DET
iajs-3485	90	44	group	group	NOUN
iajs-3485	90	45	of	of	ADP
iajs-3485	90	46	mice	mouse	NOUN
iajs-3485	90	47	ip	ip	VERB
iajs-3485	90	48	treated	treat	VERB
iajs-3485	90	49	with	with	ADP
iajs-3485	90	50	a	a	DET
iajs-3485	90	51	single	single	ADJ
iajs-3485	90	52	dose	dose	NOUN
iajs-3485	90	53	of	of	ADP
iajs-3485	90	54	dox	dox	NOUN
iajs-3485	90	55	(	(	PUNCT
iajs-3485	90	56	group	group	NOUN
iajs-3485	90	57	iv	iv	NUM
iajs-3485	90	58	)	)	PUNCT
iajs-3485	90	59	as	as	SCONJ
iajs-3485	90	60	compared	compare	VERB
iajs-3485	90	61	to	to	ADP
iajs-3485	90	62	the	the	DET
iajs-3485	90	63	negative	negative	ADJ
iajs-3485	90	64	control	control	NOUN
iajs-3485	90	65	(	(	PUNCT
iajs-3485	90	66	group	group	NOUN
iajs-3485	90	67	i	i	PROPN
iajs-3485	90	68	)	)	PUNCT
iajs-3485	90	69	.	.	PUNCT
iajs-3485	91	1	pretreated	pretreate	VERB
iajs-3485	91	2	mice	mouse	NOUN
iajs-3485	91	3	with	with	ADP
iajs-3485	91	4	either	either	DET
iajs-3485	91	5	64	64	NUM
iajs-3485	91	6	mg	mg	NUM
iajs-3485	91	7	/	/	SYM
iajs-3485	91	8	kg	kg	PROPN
iajs-3485	91	9	(	(	PUNCT
iajs-3485	91	10	group	group	NOUN
iajs-3485	91	11	v	v	NOUN
iajs-3485	91	12	)	)	PUNCT
iajs-3485	91	13	or	or	CCONJ
iajs-3485	91	14	128	128	NUM
iajs-3485	91	15	mg	mg	NUM
iajs-3485	91	16	/	/	SYM
iajs-3485	91	17	kg	kg	PROPN
iajs-3485	91	18	(	(	PUNCT
iajs-3485	91	19	group	group	NOUN
iajs-3485	91	20	vi	vi	PROPN
iajs-3485	91	21	)	)	PUNCT
iajs-3485	91	22	of	of	ADP
iajs-3485	91	23	a.	a.	NOUN
iajs-3485	91	24	majus	maju	NOUN
iajs-3485	91	25	showed	show	VERB
iajs-3485	91	26	a	a	DET
iajs-3485	91	27	significant	significant	ADJ
iajs-3485	91	28	reduction	reduction	NOUN
iajs-3485	91	29	(	(	PUNCT
iajs-3485	91	30	p<0.05)in	p<0.05)in	ADJ
iajs-3485	91	31	serum	serum	NOUN
iajs-3485	91	32	levels	level	NOUN
iajs-3485	91	33	of	of	ADP
iajs-3485	91	34	cpk	cpk	PROPN
iajs-3485	91	35	as	as	SCONJ
iajs-3485	91	36	compared	compare	VERB
iajs-3485	91	37	to	to	ADP
iajs-3485	91	38	the	the	DET
iajs-3485	91	39	positive	positive	ADJ
iajs-3485	91	40	control	control	NOUN
iajs-3485	91	41	.	.	PUNCT
iajs-3485	92	1	moreover	moreover	ADV
iajs-3485	92	2	,	,	PUNCT
iajs-3485	92	3	there	there	PRON
iajs-3485	92	4	were	be	VERB
iajs-3485	92	5	no	no	DET
iajs-3485	92	6	significant	significant	ADJ
iajs-3485	92	7	differences	difference	NOUN
iajs-3485	92	8	between	between	ADP
iajs-3485	92	9	the	the	DET
iajs-3485	92	10	dosage	dosage	NOUN
iajs-3485	92	11	rates	rate	NOUN
iajs-3485	92	12	used	use	VERB
iajs-3485	92	13	for	for	ADP
iajs-3485	92	14	a.	a.	NOUN
iajs-3485	92	15	majus	maju	NOUN
iajs-3485	92	16	.	.	PUNCT
iajs-3485	93	1	furthermore	furthermore	ADV
iajs-3485	93	2	,	,	PUNCT
iajs-3485	93	3	pre	pre	ADJ
iajs-3485	93	4	-	-	ADJ
iajs-3485	93	5	treated	treat	VERB
iajs-3485	93	6	mice	mouse	NOUN
iajs-3485	93	7	with	with	ADP
iajs-3485	93	8	64	64	NUM
iajs-3485	93	9	mg	mg	NOUN
iajs-3485	93	10	/	/	SYM
iajs-3485	93	11	kg	kg	PROPN
iajs-3485	93	12	and	and	CCONJ
iajs-3485	93	13	128	128	NUM
iajs-3485	93	14	mg	mg	NUM
iajs-3485	93	15	/	/	SYM
iajs-3485	93	16	kg	kg	PROPN
iajs-3485	93	17	of	of	ADP
iajs-3485	93	18	a.	a.	NOUN
iajs-3485	93	19	majus	maju	NOUN
iajs-3485	93	20	for	for	ADP
iajs-3485	93	21	14	14	NUM
iajs-3485	93	22	days	day	NOUN
iajs-3485	93	23	before	before	ADP
iajs-3485	93	24	doxorubicin	doxorubicin	PROPN
iajs-3485	93	25	(	(	PUNCT
iajs-3485	93	26	groups	group	NOUN
iajs-3485	93	27	v	v	ADP
iajs-3485	93	28	and	and	CCONJ
iajs-3485	93	29	vi	vi	PRON
iajs-3485	93	30	)	)	PUNCT
iajs-3485	93	31	showed	show	VERB
iajs-3485	93	32	a	a	DET
iajs-3485	93	33	non	non	ADJ
iajs-3485	93	34	-	-	ADJ
iajs-3485	93	35	significant	significant	ADJ
iajs-3485	93	36	reduction	reduction	NOUN
iajs-3485	93	37	(	(	PUNCT
iajs-3485	93	38	p>0.05	p>0.05	NOUN
iajs-3485	93	39	)	)	PUNCT
iajs-3485	93	40	in	in	ADP
iajs-3485	93	41	serum	serum	NOUN
iajs-3485	93	42	levels	level	NOUN
iajs-3485	93	43	of	of	ADP
iajs-3485	93	44	cpk	cpk	PROPN
iajs-3485	93	45	as	as	SCONJ
iajs-3485	93	46	compared	compare	VERB
iajs-3485	93	47	with	with	ADP
iajs-3485	93	48	the	the	DET
iajs-3485	93	49	negative	negative	ADJ
iajs-3485	93	50	control	control	NOUN
iajs-3485	93	51	(	(	PUNCT
iajs-3485	93	52	group	group	NOUN
iajs-3485	93	53	iv	iv	NUM
iajs-3485	93	54	)	)	PUNCT
iajs-3485	93	55	.	.	PUNCT
iajs-3485	94	1	mean±sem	mean±sem	PROPN
iajs-3485	94	2	of	of	ADP
iajs-3485	94	3	the	the	DET
iajs-3485	94	4	serum	serum	NOUN
iajs-3485	94	5	activities	activity	NOUN
iajs-3485	94	6	of	of	ADP
iajs-3485	94	7	cpk	cpk	PROPN
iajs-3485	94	8	enzyme	enzyme	NOUN
iajs-3485	94	9	levels	level	NOUN
iajs-3485	94	10	were	be	AUX
iajs-3485	94	11	(	(	PUNCT
iajs-3485	94	12	157.85±8.49	157.85±8.49	NUM
iajs-3485	94	13	and	and	CCONJ
iajs-3485	94	14	153.42±2.86	153.42±2.86	NUM
iajs-3485	94	15	vs.	vs.	ADP
iajs-3485	94	16	128.57±6.24	128.57±6.24	NUM
iajs-3485	94	17	)	)	PUNCT
iajs-3485	94	18	,	,	PUNCT
iajs-3485	94	19	respectively	respectively	ADV
iajs-3485	94	20	.	.	PUNCT
iajs-3485	95	1	ihjpas	ihjpas	PROPN
iajs-3485	95	2	.	.	PUNCT
iajs-3485	96	1	2024	2024	NUM
iajs-3485	96	2	,	,	PUNCT
iajs-3485	96	3	37	37	NUM
iajs-3485	96	4	(	(	PUNCT
iajs-3485	96	5	3	3	NUM
iajs-3485	96	6	)	)	PUNCT
iajs-3485	96	7	129	129	NUM
iajs-3485	96	8	table	table	NOUN
iajs-3485	96	9	2	2	NUM
iajs-3485	96	10	effects	effect	NOUN
iajs-3485	96	11	of	of	ADP
iajs-3485	96	12	treatment	treatment	NOUN
iajs-3485	96	13	of	of	ADP
iajs-3485	96	14	mice	mouse	NOUN
iajs-3485	96	15	with	with	ADP
iajs-3485	96	16	different	different	ADJ
iajs-3485	96	17	doses	dose	NOUN
iajs-3485	96	18	of	of	ADP
iajs-3485	96	19	a	a	DET
iajs-3485	96	20	majus	majus	ADJ
iajs-3485	96	21	extract	extract	NOUN
iajs-3485	96	22	on	on	ADP
iajs-3485	96	23	the	the	DET
iajs-3485	96	24	serum	serum	NOUN
iajs-3485	96	25	activities	activity	NOUN
iajs-3485	96	26	of	of	ADP
iajs-3485	96	27	cpk	cpk	PROPN
iajs-3485	96	28	prior	prior	ADV
iajs-3485	96	29	to	to	ADP
iajs-3485	96	30	dox	dox	NOUN
iajs-3485	96	31	;	;	PUNCT
iajs-3485	96	32	compared	compare	VERB
iajs-3485	96	33	to	to	ADP
iajs-3485	96	34	dox	dox	NOUN
iajs-3485	96	35	treated	treat	VERB
iajs-3485	96	36	and	and	CCONJ
iajs-3485	96	37	control	control	NOUN
iajs-3485	96	38	groups	group	NOUN
iajs-3485	96	39	:	:	PUNCT
iajs-3485	96	40	cpk	cpk	PROPN
iajs-3485	96	41	,	,	PUNCT
iajs-3485	96	42	(	(	PUNCT
iajs-3485	96	43	iu	iu	PROPN
iajs-3485	96	44	/	/	SYM
iajs-3485	96	45	l	l	NOUN
iajs-3485	96	46	)	)	PUNCT
iajs-3485	96	47	mean	mean	VERB
iajs-3485	96	48	±	±	NUM
iajs-3485	96	49	sem	sem	NOUN
iajs-3485	96	50	treatment	treatment	NOUN
iajs-3485	96	51	groups	group	NOUN
iajs-3485	96	52	128.57±6.24c	128.57±6.24c	NUM
iajs-3485	96	53	dw	dw	PROPN
iajs-3485	96	54	group	group	NOUN
iajs-3485	96	55	i	i	PRON
iajs-3485	96	56	109.85±4.61c	109.85±4.61c	NUM
iajs-3485	96	57	64	64	NUM
iajs-3485	96	58	mg	mg	NUM
iajs-3485	96	59	/	/	SYM
iajs-3485	96	60	kg	kg	NOUN
iajs-3485	96	61	a	a	DET
iajs-3485	96	62	majus	majus	ADJ
iajs-3485	96	63	group	group	NOUN
iajs-3485	96	64	ii	ii	PROPN
iajs-3485	96	65	117.57±	117.57±	NUM
iajs-3485	97	1	2.58c	2.58c	NUM
iajs-3485	97	2	128	128	NUM
iajs-3485	97	3	mg	mg	NUM
iajs-3485	97	4	/	/	SYM
iajs-3485	97	5	kg	kg	NOUN
iajs-3485	97	6	a	a	DET
iajs-3485	97	7	majus	majus	ADJ
iajs-3485	97	8	group	group	NOUN
iajs-3485	97	9	iii	iii	NUM
iajs-3485	97	10	216.42±10.20a	216.42±10.20a	NUM
iajs-3485	97	11	14	14	NUM
iajs-3485	97	12	days	day	NOUN
iajs-3485	97	13	dw	dw	NOUN
iajs-3485	97	14	prior	prior	ADV
iajs-3485	97	15	to	to	ADP
iajs-3485	97	16	a	a	DET
iajs-3485	97	17	single	single	ADJ
iajs-3485	97	18	dose	dose	NOUN
iajs-3485	97	19	of	of	ADP
iajs-3485	97	20	doxorubicin	doxorubicin	PROPN
iajs-3485	97	21	group	group	NOUN
iajs-3485	97	22	iv	iv	NUM
iajs-3485	97	23	157.85±2.86b	157.85±2.86b	NUM
iajs-3485	97	24	64mg	64mg	ADJ
iajs-3485	97	25	/	/	SYM
iajs-3485	97	26	kg	kg	NOUN
iajs-3485	97	27	a	a	DET
iajs-3485	97	28	majus	maju	NOUN
iajs-3485	97	29	prior	prior	ADV
iajs-3485	97	30	to	to	ADP
iajs-3485	97	31	a	a	DET
iajs-3485	97	32	single	single	ADJ
iajs-3485	97	33	dose	dose	NOUN
iajs-3485	97	34	of	of	ADP
iajs-3485	97	35	doxorubicin	doxorubicin	PROPN
iajs-3485	97	36	group	group	PROPN
iajs-3485	97	37	v	v	ADP
iajs-3485	97	38	153.42±8.49b	153.42±8.49b	NUM
iajs-3485	97	39	128/	128/	NUM
iajs-3485	97	40	a	a	DET
iajs-3485	97	41	majus	maju	NOUN
iajs-3485	97	42	prior	prior	ADV
iajs-3485	97	43	to	to	ADP
iajs-3485	97	44	a	a	DET
iajs-3485	97	45	single	single	ADJ
iajs-3485	97	46	dose	dose	NOUN
iajs-3485	97	47	of	of	ADP
iajs-3485	97	48	doxorubicin	doxorubicin	PROPN
iajs-3485	97	49	group	group	PROPN
iajs-3485	97	50	vi	vi	PROPN
iajs-3485	97	51	3.3	3.3	NUM
iajs-3485	97	52	.	.	PUNCT
iajs-3485	98	1	effects	effect	NOUN
iajs-3485	98	2	of	of	ADP
iajs-3485	98	3	various	various	ADJ
iajs-3485	98	4	treatments	treatment	NOUN
iajs-3485	98	5	on	on	ADP
iajs-3485	98	6	serum	serum	NOUN
iajs-3485	98	7	activities	activity	NOUN
iajs-3485	98	8	of	of	ADP
iajs-3485	98	9	creatine	creatine	PROPN
iajs-3485	98	10	kinase	kinase	PROPN
iajs-3485	98	11	-	-	PUNCT
iajs-3485	98	12	myoglobin	myoglobin	ADJ
iajs-3485	98	13	binding	binding	NOUN
iajs-3485	98	14	(	(	PUNCT
iajs-3485	98	15	ck	ck	NOUN
iajs-3485	98	16	-	-	PUNCT
iajs-3485	98	17	mb	mb	NOUN
iajs-3485	98	18	)	)	PUNCT
iajs-3485	98	19	enzyme	enzyme	NOUN
iajs-3485	98	20	.	.	PUNCT
iajs-3485	98	21	table	table	NOUN
iajs-3485	98	22	3	3	NUM
iajs-3485	98	23	demonstrated	demonstrate	VERB
iajs-3485	98	24	that	that	SCONJ
iajs-3485	98	25	the	the	DET
iajs-3485	98	26	blood	blood	NOUN
iajs-3485	98	27	activity	activity	NOUN
iajs-3485	98	28	of	of	ADP
iajs-3485	98	29	the	the	DET
iajs-3485	98	30	ck	ck	ADJ
iajs-3485	98	31	-	-	PUNCT
iajs-3485	98	32	mb	mb	ADJ
iajs-3485	98	33	enzyme	enzyme	NOUN
iajs-3485	98	34	was	be	AUX
iajs-3485	98	35	significantly	significantly	ADV
iajs-3485	98	36	elevated	elevate	VERB
iajs-3485	98	37	(	(	PUNCT
iajs-3485	98	38	9p<0.05	9p<0.05	NOUN
iajs-3485	98	39	)	)	PUNCT
iajs-3485	98	40	in	in	ADP
iajs-3485	98	41	the	the	DET
iajs-3485	98	42	group	group	NOUN
iajs-3485	98	43	of	of	ADP
iajs-3485	98	44	mice	mouse	NOUN
iajs-3485	98	45	ip	ip	VERB
iajs-3485	98	46	treated	treat	VERB
iajs-3485	98	47	with	with	ADP
iajs-3485	98	48	a	a	DET
iajs-3485	98	49	single	single	ADJ
iajs-3485	98	50	dose	dose	NOUN
iajs-3485	98	51	of	of	ADP
iajs-3485	98	52	dox	dox	NOUN
iajs-3485	98	53	(	(	PUNCT
iajs-3485	98	54	group	group	NOUN
iajs-3485	98	55	iv	iv	NUM
iajs-3485	98	56	)	)	PUNCT
iajs-3485	98	57	as	as	SCONJ
iajs-3485	98	58	compared	compare	VERB
iajs-3485	98	59	to	to	ADP
iajs-3485	98	60	the	the	DET
iajs-3485	98	61	negative	negative	ADJ
iajs-3485	98	62	control	control	NOUN
iajs-3485	98	63	(	(	PUNCT
iajs-3485	98	64	group	group	NOUN
iajs-3485	98	65	i	i	PROPN
iajs-3485	98	66	)	)	PUNCT
iajs-3485	98	67	.	.	PUNCT
iajs-3485	99	1	when	when	SCONJ
iajs-3485	99	2	compared	compare	VERB
iajs-3485	99	3	to	to	ADP
iajs-3485	99	4	the	the	DET
iajs-3485	99	5	positive	positive	ADJ
iajs-3485	99	6	control	control	NOUN
iajs-3485	99	7	,	,	PUNCT
iajs-3485	99	8	pretreated	pretreate	VERB
iajs-3485	99	9	mice	mouse	NOUN
iajs-3485	99	10	with	with	ADP
iajs-3485	99	11	either	either	PRON
iajs-3485	99	12	64	64	NUM
iajs-3485	99	13	mg	mg	NUM
iajs-3485	99	14	/	/	SYM
iajs-3485	99	15	kg	kg	PROPN
iajs-3485	99	16	or	or	CCONJ
iajs-3485	99	17	128	128	NUM
iajs-3485	99	18	mg	mg	NUM
iajs-3485	99	19	/	/	SYM
iajs-3485	99	20	kg	kg	PROPN
iajs-3485	99	21	of	of	ADP
iajs-3485	99	22	a.	a.	NOUN
iajs-3485	99	23	majus	maju	NOUN
iajs-3485	99	24	(	(	PUNCT
iajs-3485	99	25	groups	group	NOUN
iajs-3485	99	26	v	v	ADP
iajs-3485	99	27	and	and	CCONJ
iajs-3485	99	28	vi	vi	PRON
iajs-3485	99	29	)	)	PUNCT
iajs-3485	99	30	displayed	display	VERB
iajs-3485	99	31	a	a	DET
iajs-3485	99	32	substantial	substantial	ADJ
iajs-3485	99	33	decrease	decrease	NOUN
iajs-3485	99	34	(	(	PUNCT
iajs-3485	99	35	p<0.05	p<0.05	NOUN
iajs-3485	99	36	)	)	PUNCT
iajs-3485	99	37	in	in	ADP
iajs-3485	99	38	serum	serum	NOUN
iajs-3485	99	39	levels	level	NOUN
iajs-3485	99	40	of	of	ADP
iajs-3485	99	41	ck	ck	NOUN
iajs-3485	99	42	-	-	PUNCT
iajs-3485	99	43	mb	mb	NOUN
iajs-3485	99	44	.	.	PUNCT
iajs-3485	100	1	and	and	CCONJ
iajs-3485	100	2	there	there	PRON
iajs-3485	100	3	were	be	VERB
iajs-3485	100	4	no	no	DET
iajs-3485	100	5	discernible	discernible	ADJ
iajs-3485	100	6	differences	difference	NOUN
iajs-3485	100	7	between	between	ADP
iajs-3485	100	8	groups	group	NOUN
iajs-3485	100	9	given	give	VERB
iajs-3485	100	10	various	various	ADJ
iajs-3485	100	11	a	a	PRON
iajs-3485	100	12	-	-	PUNCT
iajs-3485	100	13	majus	majus	ADJ
iajs-3485	100	14	dosage	dosage	NOUN
iajs-3485	100	15	rates	rate	NOUN
iajs-3485	100	16	.	.	PUNCT
iajs-3485	101	1	furthermore	furthermore	ADV
iajs-3485	101	2	,	,	PUNCT
iajs-3485	101	3	pre	pre	ADJ
iajs-3485	101	4	-	-	ADJ
iajs-3485	101	5	treated	treat	VERB
iajs-3485	101	6	mice	mouse	NOUN
iajs-3485	101	7	with	with	ADP
iajs-3485	101	8	64	64	NUM
iajs-3485	101	9	and	and	CCONJ
iajs-3485	101	10	128	128	NUM
iajs-3485	101	11	mg	mg	NUM
iajs-3485	101	12	/	/	SYM
iajs-3485	101	13	kg	kg	PROPN
iajs-3485	101	14	.	.	PUNCT
iajs-3485	102	1	for	for	ADP
iajs-3485	102	2	14	14	NUM
iajs-3485	102	3	days	day	NOUN
iajs-3485	102	4	only	only	ADV
iajs-3485	102	5	(	(	PUNCT
iajs-3485	102	6	groups	group	NOUN
iajs-3485	102	7	ii	ii	PROPN
iajs-3485	102	8	and	and	CCONJ
iajs-3485	102	9	iii	iii	X
iajs-3485	102	10	)	)	PUNCT
iajs-3485	102	11	showed	show	VERB
iajs-3485	102	12	a	a	DET
iajs-3485	102	13	significant	significant	ADJ
iajs-3485	102	14	(	(	PUNCT
iajs-3485	102	15	p<0.05	p<0.05	NOUN
iajs-3485	102	16	)	)	PUNCT
iajs-3485	102	17	reduction	reduction	NOUN
iajs-3485	102	18	in	in	ADP
iajs-3485	102	19	serum	serum	NOUN
iajs-3485	102	20	levels	level	NOUN
iajs-3485	102	21	of	of	ADP
iajs-3485	102	22	ck	ck	NOUN
iajs-3485	102	23	-	-	PUNCT
iajs-3485	102	24	mb	mb	NOUN
iajs-3485	102	25	as	as	ADP
iajs-3485	102	26	compared	compare	VERB
iajs-3485	102	27	with	with	ADP
iajs-3485	102	28	the	the	DET
iajs-3485	102	29	positive	positive	ADJ
iajs-3485	102	30	control	control	NOUN
iajs-3485	102	31	(	(	PUNCT
iajs-3485	102	32	group	group	NOUN
iajs-3485	102	33	iv	iv	NUM
iajs-3485	102	34	)	)	PUNCT
iajs-3485	102	35	.	.	PUNCT
iajs-3485	103	1	additionally	additionally	ADV
iajs-3485	103	2	,	,	PUNCT
iajs-3485	103	3	table	table	NOUN
iajs-3485	103	4	(	(	PUNCT
iajs-3485	103	5	3	3	NUM
iajs-3485	103	6	)	)	PUNCT
iajs-3485	103	7	demonstrated	demonstrate	VERB
iajs-3485	103	8	a	a	DET
iajs-3485	103	9	significant	significant	ADJ
iajs-3485	103	10	decrease	decrease	NOUN
iajs-3485	103	11	(	(	PUNCT
iajs-3485	103	12	p<0.05	p<0.05	NOUN
iajs-3485	103	13	)	)	PUNCT
iajs-3485	103	14	in	in	ADP
iajs-3485	103	15	the	the	DET
iajs-3485	103	16	heart	heart	NOUN
iajs-3485	103	17	's	's	PART
iajs-3485	103	18	serum	serum	NOUN
iajs-3485	103	19	ck	ck	ADJ
iajs-3485	103	20	-	-	PUNCT
iajs-3485	103	21	mb	mb	ADJ
iajs-3485	103	22	activity	activity	NOUN
iajs-3485	103	23	in	in	ADP
iajs-3485	103	24	the	the	DET
iajs-3485	103	25	groups	group	NOUN
iajs-3485	103	26	that	that	PRON
iajs-3485	103	27	received	receive	VERB
iajs-3485	103	28	either	either	CCONJ
iajs-3485	103	29	64	64	NUM
iajs-3485	103	30	mg	mg	PROPN
iajs-3485	103	31	(	(	PUNCT
iajs-3485	103	32	group	group	NOUN
iajs-3485	103	33	ii	ii	PROPN
iajs-3485	103	34	)	)	PUNCT
iajs-3485	103	35	or	or	CCONJ
iajs-3485	103	36	128	128	NUM
iajs-3485	103	37	mg	mg	NUM
iajs-3485	103	38	/	/	SYM
iajs-3485	103	39	mice	mouse	NOUN
iajs-3485	103	40	(	(	PUNCT
iajs-3485	103	41	group	group	NOUN
iajs-3485	103	42	iii	iii	PROPN
iajs-3485	103	43	)	)	PUNCT
iajs-3485	103	44	of	of	ADP
iajs-3485	103	45	a	a	DET
iajs-3485	103	46	majus	maju	NOUN
iajs-3485	103	47	extract	extract	NOUN
iajs-3485	103	48	for	for	ADP
iajs-3485	103	49	14	14	NUM
iajs-3485	103	50	days	day	NOUN
iajs-3485	103	51	,	,	PUNCT
iajs-3485	103	52	as	as	ADV
iajs-3485	103	53	well	well	ADV
iajs-3485	103	54	as	as	ADP
iajs-3485	103	55	pretreated	pretreate	VERB
iajs-3485	103	56	groups	group	NOUN
iajs-3485	103	57	of	of	ADP
iajs-3485	103	58	mice	mouse	NOUN
iajs-3485	103	59	that	that	PRON
iajs-3485	103	60	received	receive	VERB
iajs-3485	103	61	64	64	NUM
iajs-3485	103	62	mg	mg	NOUN
iajs-3485	103	63	/	/	SYM
iajs-3485	103	64	kg	kg	PROPN
iajs-3485	103	65	(	(	PUNCT
iajs-3485	103	66	group	group	NOUN
iajs-3485	103	67	v	v	NOUN
iajs-3485	103	68	)	)	PUNCT
iajs-3485	103	69	or	or	CCONJ
iajs-3485	103	70	128	128	NUM
iajs-3485	103	71	mg	mg	NUM
iajs-3485	103	72	/	/	SYM
iajs-3485	103	73	kg	kg	PROPN
iajs-3485	103	74	(	(	PUNCT
iajs-3485	103	75	group	group	NOUN
iajs-3485	103	76	vi	vi	PROPN
iajs-3485	103	77	)	)	PUNCT
iajs-3485	103	78	of	of	ADP
iajs-3485	103	79	a.	a.	NOUN
iajs-3485	103	80	majus	maju	NOUN
iajs-3485	103	81	for	for	ADP
iajs-3485	103	82	14	14	NUM
iajs-3485	103	83	days	day	NOUN
iajs-3485	103	84	prior	prior	ADV
iajs-3485	103	85	to	to	ADP
iajs-3485	103	86	doxorubicin	doxorubicin	PROPN
iajs-3485	103	87	,	,	PUNCT
iajs-3485	103	88	when	when	SCONJ
iajs-3485	103	89	compared	compare	VERB
iajs-3485	103	90	to	to	ADP
iajs-3485	103	91	the	the	DET
iajs-3485	103	92	corresponding	corresponding	ADJ
iajs-3485	103	93	activity	activity	NOUN
iajs-3485	103	94	level	level	NOUN
iajs-3485	103	95	in	in	ADP
iajs-3485	103	96	positive	positive	ADJ
iajs-3485	103	97	,	,	PUNCT
iajs-3485	103	98	the	the	DET
iajs-3485	103	99	mean±sem	mean±sem	PROPN
iajs-3485	103	100	of	of	ADP
iajs-3485	103	101	serum	serum	NOUN
iajs-3485	103	102	ck	ck	PROPN
iajs-3485	103	103	-	-	PUNCT
iajs-3485	103	104	mb	mb	ADJ
iajs-3485	103	105	activities	activity	NOUN
iajs-3485	103	106	were	be	AUX
iajs-3485	103	107	(	(	PUNCT
iajs-3485	103	108	88.66±	88.66±	NUM
iajs-3485	103	109	1.42	1.42	NUM
iajs-3485	103	110	,	,	PUNCT
iajs-3485	103	111	88.33±1.30	88.33±1.30	NUM
iajs-3485	103	112	,	,	PUNCT
iajs-3485	103	113	122.00±1.31,120.16	122.00±1.31,120.16	NUM
iajs-3485	103	114	±1.19	±1.19	NOUN
iajs-3485	103	115	,	,	PUNCT
iajs-3485	103	116	vs164.16±7.12	vs164.16±7.12	NOUN
iajs-3485	103	117	.	.	PUNCT
iajs-3485	103	118	)	)	PUNCT
iajs-3485	103	119	,	,	PUNCT
iajs-3485	104	1	respectively	respectively	ADV
iajs-3485	104	2	.	.	PUNCT
iajs-3485	104	3	table	table	NOUN
iajs-3485	104	4	3	3	NUM
iajs-3485	104	5	:	:	PUNCT
iajs-3485	104	6	effects	effect	NOUN
iajs-3485	104	7	of	of	ADP
iajs-3485	104	8	treatment	treatment	NOUN
iajs-3485	104	9	of	of	ADP
iajs-3485	104	10	mice	mouse	NOUN
iajs-3485	104	11	with	with	ADP
iajs-3485	104	12	different	different	ADJ
iajs-3485	104	13	doses	dose	NOUN
iajs-3485	104	14	of	of	ADP
iajs-3485	104	15	a	a	DET
iajs-3485	104	16	majus	majus	ADJ
iajs-3485	104	17	extract	extract	NOUN
iajs-3485	104	18	on	on	ADP
iajs-3485	104	19	the	the	DET
iajs-3485	104	20	serum	serum	NOUN
iajs-3485	104	21	activities	activity	NOUN
iajs-3485	104	22	of	of	ADP
iajs-3485	104	23	ck	ck	NOUN
iajs-3485	104	24	-	-	PUNCT
iajs-3485	104	25	mb	mb	NOUN
iajs-3485	104	26	prior	prior	ADV
iajs-3485	104	27	to	to	ADP
iajs-3485	104	28	dox	dox	NOUN
iajs-3485	104	29	;	;	PUNCT
iajs-3485	104	30	compared	compare	VERB
iajs-3485	104	31	to	to	ADP
iajs-3485	104	32	dox	dox	NOUN
iajs-3485	104	33	-	-	PUNCT
iajs-3485	104	34	treated	treat	VERB
iajs-3485	104	35	and	and	CCONJ
iajs-3485	104	36	control	control	NOUN
iajs-3485	104	37	groups	group	NOUN
iajs-3485	104	38	:	:	PUNCT
iajs-3485	104	39	ck	ck	ADJ
iajs-3485	104	40	-	-	PUNCT
iajs-3485	104	41	mb	mb	NOUN
iajs-3485	104	42	,	,	PUNCT
iajs-3485	104	43	(	(	PUNCT
iajs-3485	104	44	iu	iu	PROPN
iajs-3485	104	45	/	/	SYM
iajs-3485	104	46	l	l	NOUN
iajs-3485	104	47	)	)	PUNCT
iajs-3485	104	48	mean	mean	VERB
iajs-3485	104	49	±	±	NUM
iajs-3485	104	50	sem	sem	NOUN
iajs-3485	104	51	treatment	treatment	NOUN
iajs-3485	104	52	groups	group	NOUN
iajs-3485	104	53	93.50±1.40c	93.50±1.40c	NUM
iajs-3485	104	54	dw	dw	NOUN
iajs-3485	104	55	group	group	NOUN
iajs-3485	104	56	i	i	PRON
iajs-3485	104	57	88.66±1.42c	88.66±1.42c	NUM
iajs-3485	104	58	64	64	NUM
iajs-3485	104	59	mg	mg	NUM
iajs-3485	104	60	/	/	SYM
iajs-3485	104	61	kg	kg	NOUN
iajs-3485	104	62	a	a	DET
iajs-3485	104	63	majus	majus	ADJ
iajs-3485	104	64	group	group	NOUN
iajs-3485	104	65	ii	ii	PROPN
iajs-3485	104	66	88.33±	88.33±	NUM
iajs-3485	104	67	1.30c	1.30c	NUM
iajs-3485	104	68	128	128	NUM
iajs-3485	104	69	mg	mg	NUM
iajs-3485	104	70	/	/	SYM
iajs-3485	104	71	kg	kg	NOUN
iajs-3485	104	72	a	a	DET
iajs-3485	104	73	majus	majus	ADJ
iajs-3485	104	74	group	group	NOUN
iajs-3485	104	75	iii	iii	PROPN
iajs-3485	105	1	164.16±7.12a	164.16±7.12a	NUM
iajs-3485	105	2	14	14	NUM
iajs-3485	105	3	days	day	NOUN
iajs-3485	105	4	dw	dw	NOUN
iajs-3485	105	5	prior	prior	ADV
iajs-3485	105	6	to	to	ADP
iajs-3485	105	7	a	a	DET
iajs-3485	105	8	single	single	ADJ
iajs-3485	105	9	dose	dose	NOUN
iajs-3485	105	10	of	of	ADP
iajs-3485	105	11	doxorubicin	doxorubicin	PROPN
iajs-3485	105	12	group	group	PROPN
iajs-3485	105	13	iv	iv	NUM
iajs-3485	105	14	122.00±1.31b	122.00±1.31b	NUM
iajs-3485	105	15	64mg	64mg	ADJ
iajs-3485	105	16	/	/	SYM
iajs-3485	105	17	kg	kg	NOUN
iajs-3485	105	18	a	a	DET
iajs-3485	105	19	majus	maju	NOUN
iajs-3485	105	20	prior	prior	ADV
iajs-3485	105	21	to	to	ADP
iajs-3485	105	22	a	a	DET
iajs-3485	105	23	single	single	ADJ
iajs-3485	105	24	dose	dose	NOUN
iajs-3485	105	25	of	of	ADP
iajs-3485	105	26	doxorubicin	doxorubicin	PROPN
iajs-3485	105	27	group	group	PROPN
iajs-3485	105	28	v	v	ADP
iajs-3485	105	29	120.16±1.19b	120.16±1.19b	NUM
iajs-3485	105	30	128/	128/	NUM
iajs-3485	105	31	a	a	DET
iajs-3485	105	32	majus	maju	NOUN
iajs-3485	105	33	prior	prior	ADV
iajs-3485	105	34	to	to	ADP
iajs-3485	105	35	a	a	DET
iajs-3485	105	36	single	single	ADJ
iajs-3485	105	37	dose	dose	NOUN
iajs-3485	105	38	of	of	ADP
iajs-3485	105	39	doxorubicin	doxorubicin	PROPN
iajs-3485	105	40	group	group	PROPN
iajs-3485	105	41	vi	vi	PROPN
iajs-3485	105	42	a	a	PROPN
iajs-3485	105	43	-	-	PUNCT
iajs-3485	105	44	c	c	NOUN
iajs-3485	105	45	different	different	ADJ
iajs-3485	105	46	superscripts	superscript	NOUN
iajs-3485	105	47	indicate	indicate	VERB
iajs-3485	105	48	significant	significant	ADJ
iajs-3485	105	49	differences	difference	NOUN
iajs-3485	105	50	between	between	ADP
iajs-3485	105	51	designed	design	VERB
iajs-3485	105	52	groups	group	NOUN
iajs-3485	105	53	(	(	PUNCT
iajs-3485	105	54	p	p	X
iajs-3485	105	55	<	<	NOUN
iajs-3485	105	56	0.05	0.05	NUM
iajs-3485	105	57	)	)	PUNCT
iajs-3485	105	58	using	use	VERB
iajs-3485	105	59	the	the	DET
iajs-3485	105	60	unpaired	unpaired	ADJ
iajs-3485	105	61	student	student	NOUN
iajs-3485	105	62	t	t	NOUN
iajs-3485	105	63	-	-	PUNCT
iajs-3485	105	64	test	test	NOUN
iajs-3485	105	65	.	.	PUNCT
iajs-3485	106	1	ihjpas	ihjpas	PROPN
iajs-3485	106	2	.	.	PUNCT
iajs-3485	107	1	2024	2024	NUM
iajs-3485	107	2	,	,	PUNCT
iajs-3485	107	3	37	37	NUM
iajs-3485	107	4	(	(	PUNCT
iajs-3485	107	5	3	3	NUM
iajs-3485	107	6	)	)	PUNCT
iajs-3485	107	7	130	130	NUM
iajs-3485	107	8	figure	figure	NOUN
iajs-3485	107	9	1	1	NUM
iajs-3485	107	10	.	.	PUNCT
iajs-3485	108	1	a	a	X
iajs-3485	108	2	:	:	PUNCT
iajs-3485	108	3	(	(	PUNCT
iajs-3485	108	4	group	group	NOUN
iajs-3485	108	5	i	i	NOUN
iajs-3485	108	6	)	)	PUNCT
iajs-3485	108	7	negative	negative	ADJ
iajs-3485	108	8	control	control	VERB
iajs-3485	108	9	normal	normal	ADJ
iajs-3485	108	10	heart	heart	NOUN
iajs-3485	108	11	,	,	PUNCT
iajs-3485	108	12	b	b	X
iajs-3485	108	13	:	:	PUNCT
iajs-3485	108	14	group	group	PROPN
iajs-3485	108	15	ii	ii	PROPN
iajs-3485	108	16	take	take	VERB
iajs-3485	108	17	a.	a.	NOUN
iajs-3485	108	18	majus	maju	NOUN
iajs-3485	108	19	64	64	NUM
iajs-3485	108	20	mg	mg	NUM
iajs-3485	108	21	/	/	SYM
iajs-3485	108	22	kg	kg	NOUN
iajs-3485	108	23	with	with	ADP
iajs-3485	108	24	normal	normal	ADJ
iajs-3485	108	25	heart	heart	NOUN
iajs-3485	108	26	appearance	appearance	NOUN
iajs-3485	108	27	;	;	PUNCT
iajs-3485	108	28	c	c	X
iajs-3485	108	29	:	:	PUNCT
iajs-3485	108	30	group	group	NOUN
iajs-3485	108	31	iii	iii	PROPN
iajs-3485	108	32	take	take	VERB
iajs-3485	108	33	128	128	NUM
iajs-3485	108	34	mg	mg	NUM
iajs-3485	108	35	/	/	SYM
iajs-3485	108	36	kg	kg	NOUN
iajs-3485	108	37	a.	a.	NOUN
iajs-3485	108	38	majus	maju	NOUN
iajs-3485	108	39	with	with	ADP
iajs-3485	108	40	normal	normal	ADJ
iajs-3485	108	41	heart	heart	NOUN
iajs-3485	108	42	appearance	appearance	NOUN
iajs-3485	108	43	;	;	PUNCT
iajs-3485	108	44	group	group	NOUN
iajs-3485	108	45	iv	iv	NUM
iajs-3485	108	46	:	:	PUNCT
iajs-3485	108	47	take	take	VERB
iajs-3485	108	48	15	15	NUM
iajs-3485	108	49	mg	mg	PROPN
iajs-3485	108	50	/	/	SYM
iajs-3485	108	51	kg	kg	NOUN
iajs-3485	108	52	doxorubicin	doxorubicin	PROPN
iajs-3485	108	53	;	;	PUNCT
iajs-3485	108	54	it	it	PRON
iajs-3485	108	55	has	have	VERB
iajs-3485	108	56	inflammatory	inflammatory	ADJ
iajs-3485	108	57	cells	cell	NOUN
iajs-3485	108	58	and	and	CCONJ
iajs-3485	108	59	necrosis	necrosis	NOUN
iajs-3485	108	60	;	;	PUNCT
iajs-3485	108	61	group	group	NOUN
iajs-3485	108	62	v	v	NOUN
iajs-3485	108	63	:	:	PUNCT
iajs-3485	108	64	group	group	NOUN
iajs-3485	108	65	take	take	VERB
iajs-3485	108	66	64	64	NUM
iajs-3485	108	67	mg	mg	NOUN
iajs-3485	108	68	/	/	SYM
iajs-3485	108	69	kg	kg	PROPN
iajs-3485	108	70	of	of	ADP
iajs-3485	108	71	a.	a.	NOUN
iajs-3485	108	72	majus	maju	NOUN
iajs-3485	108	73	before	before	SCONJ
iajs-3485	108	74	doxorubicin	doxorubicin	PROPN
iajs-3485	108	75	looks	look	VERB
iajs-3485	108	76	normal	normal	ADJ
iajs-3485	108	77	;	;	PUNCT
iajs-3485	108	78	group	group	NOUN
iajs-3485	108	79	vi	vi	PROPN
iajs-3485	108	80	:	:	PUNCT
iajs-3485	108	81	take	take	VERB
iajs-3485	108	82	128	128	NUM
iajs-3485	108	83	mg	mg	NUM
iajs-3485	108	84	/	/	SYM
iajs-3485	108	85	kg	kg	NOUN
iajs-3485	108	86	a.	a.	NOUN
iajs-3485	108	87	majus	maju	NOUN
iajs-3485	108	88	before	before	SCONJ
iajs-3485	108	89	doxorubicin	doxorubicin	PROPN
iajs-3485	108	90	looks	look	VERB
iajs-3485	108	91	normal	normal	ADJ
iajs-3485	108	92	.	.	PUNCT
iajs-3485	109	1	4	4	X
iajs-3485	109	2	.	.	X
iajs-3485	109	3	discussion	discussion	NOUN
iajs-3485	109	4	:	:	PUNCT
iajs-3485	109	5	a.	a.	NOUN
iajs-3485	109	6	majus	maju	NOUN
iajs-3485	109	7	is	be	AUX
iajs-3485	109	8	one	one	NUM
iajs-3485	109	9	of	of	ADP
iajs-3485	109	10	the	the	DET
iajs-3485	109	11	plants	plant	NOUN
iajs-3485	109	12	that	that	PRON
iajs-3485	109	13	is	be	AUX
iajs-3485	109	14	particularly	particularly	ADV
iajs-3485	109	15	abundant	abundant	ADJ
iajs-3485	109	16	in	in	ADP
iajs-3485	109	17	active	active	ADJ
iajs-3485	109	18	components	component	NOUN
iajs-3485	109	19	with	with	ADP
iajs-3485	109	20	antioxidant	antioxidant	ADJ
iajs-3485	109	21	qualities	quality	NOUN
iajs-3485	109	22	,	,	PUNCT
iajs-3485	109	23	such	such	ADJ
iajs-3485	109	24	as	as	ADP
iajs-3485	109	25	flavonoids	flavonoid	NOUN
iajs-3485	109	26	like	like	ADP
iajs-3485	109	27	quercetin	quercetin	NOUN
iajs-3485	109	28	and	and	CCONJ
iajs-3485	109	29	kaempferol	kaempferol	NOUN
iajs-3485	109	30	,	,	PUNCT
iajs-3485	109	31	and	and	CCONJ
iajs-3485	109	32	coumarin	coumarin	NOUN
iajs-3485	109	33	[	[	X
iajs-3485	109	34	19	19	NUM
iajs-3485	109	35	]	]	X
iajs-3485	109	36	;	;	PUNCT
iajs-3485	109	37	and	and	CCONJ
iajs-3485	109	38	these	these	DET
iajs-3485	109	39	antioxidant	antioxidant	ADJ
iajs-3485	109	40	qualities	quality	NOUN
iajs-3485	109	41	of	of	ADP
iajs-3485	109	42	a.	a.	NOUN
iajs-3485	109	43	majus	maju	NOUN
iajs-3485	109	44	extract	extract	NOUN
iajs-3485	109	45	have	have	AUX
iajs-3485	109	46	been	be	AUX
iajs-3485	109	47	identified	identify	VERB
iajs-3485	109	48	when	when	SCONJ
iajs-3485	109	49	quercetin	quercetin	NOUN
iajs-3485	109	50	was	be	AUX
iajs-3485	109	51	used	use	VERB
iajs-3485	109	52	to	to	PART
iajs-3485	109	53	treat	treat	VERB
iajs-3485	109	54	diabetic	diabetic	ADJ
iajs-3485	109	55	nephropathy	nephropathy	NOUN
iajs-3485	109	56	in	in	ADP
iajs-3485	109	57	rats	rat	NOUN
iajs-3485	109	58	[	[	X
iajs-3485	109	59	29	29	NUM
iajs-3485	109	60	]	]	PUNCT
iajs-3485	109	61	.	.	PUNCT
iajs-3485	110	1	this	this	PRON
iajs-3485	110	2	is	be	AUX
iajs-3485	110	3	consistent	consistent	ADJ
iajs-3485	110	4	with	with	ADP
iajs-3485	110	5	the	the	DET
iajs-3485	110	6	finding	finding	NOUN
iajs-3485	110	7	that	that	SCONJ
iajs-3485	110	8	the	the	DET
iajs-3485	110	9	antioxidant	antioxidant	ADJ
iajs-3485	110	10	activities	activity	NOUN
iajs-3485	110	11	of	of	ADP
iajs-3485	110	12	a.	a.	NOUN
iajs-3485	110	13	majus	maju	VERB
iajs-3485	110	14	seed	seed	NOUN
iajs-3485	110	15	extract	extract	NOUN
iajs-3485	110	16	reduced	reduce	VERB
iajs-3485	110	17	the	the	DET
iajs-3485	110	18	generation	generation	NOUN
iajs-3485	110	19	of	of	ADP
iajs-3485	110	20	free	free	ADJ
iajs-3485	110	21	radicals	radical	NOUN
iajs-3485	110	22	by	by	ADP
iajs-3485	110	23	the	the	DET
iajs-3485	110	24	chemotherapy	chemotherapy	NOUN
iajs-3485	110	25	drug	drug	NOUN
iajs-3485	110	26	doxorubicin	doxorubicin	PROPN
iajs-3485	110	27	.	.	PUNCT
iajs-3485	111	1	one	one	NUM
iajs-3485	111	2	of	of	ADP
iajs-3485	111	3	the	the	DET
iajs-3485	111	4	byproducts	byproduct	NOUN
iajs-3485	111	5	of	of	ADP
iajs-3485	111	6	polyunsaturated	polyunsaturate	VERB
iajs-3485	111	7	fatty	fatty	NOUN
iajs-3485	111	8	acid	acid	NOUN
iajs-3485	111	9	peroxidation	peroxidation	NOUN
iajs-3485	111	10	in	in	ADP
iajs-3485	111	11	cells	cell	NOUN
iajs-3485	111	12	is	be	AUX
iajs-3485	111	13	malondialdehyde	malondialdehyde	NOUN
iajs-3485	111	14	(	(	PUNCT
iajs-3485	111	15	mda	mda	PROPN
iajs-3485	111	16	)	)	PUNCT
iajs-3485	111	17	.	.	PUNCT
iajs-3485	112	1	overproduction	overproduction	NOUN
iajs-3485	112	2	of	of	ADP
iajs-3485	112	3	mda	mda	PROPN
iajs-3485	112	4	is	be	AUX
iajs-3485	112	5	brought	bring	VERB
iajs-3485	112	6	on	on	ADP
iajs-3485	112	7	by	by	ADP
iajs-3485	112	8	an	an	DET
iajs-3485	112	9	increase	increase	NOUN
iajs-3485	112	10	in	in	ADP
iajs-3485	112	11	free	free	ADJ
iajs-3485	112	12	radicals	radical	NOUN
iajs-3485	112	13	.	.	PUNCT
iajs-3485	113	1	malondialdehyde	malondialdehyde	NOUN
iajs-3485	113	2	levels	level	NOUN
iajs-3485	113	3	are	be	AUX
iajs-3485	113	4	frequently	frequently	ADV
iajs-3485	113	5	used	use	VERB
iajs-3485	113	6	as	as	ADP
iajs-3485	113	7	indicators	indicator	NOUN
iajs-3485	113	8	of	of	ADP
iajs-3485	113	9	oxidative	oxidative	ADJ
iajs-3485	113	10	stress	stress	NOUN
iajs-3485	113	11	and	and	CCONJ
iajs-3485	113	12	the	the	DET
iajs-3485	113	13	antioxidant	antioxidant	ADJ
iajs-3485	113	14	state	state	NOUN
iajs-3485	113	15	in	in	ADP
iajs-3485	113	16	cancer	cancer	NOUN
iajs-3485	113	17	patients	patient	NOUN
iajs-3485	113	18	[	[	X
iajs-3485	113	19	30	30	NUM
iajs-3485	113	20	]	]	PUNCT
iajs-3485	113	21	,	,	PUNCT
iajs-3485	113	22	and	and	CCONJ
iajs-3485	113	23	one	one	NUM
iajs-3485	113	24	of	of	ADP
iajs-3485	113	25	the	the	DET
iajs-3485	113	26	main	main	ADJ
iajs-3485	113	27	mechanisms	mechanism	NOUN
iajs-3485	113	28	linked	link	VERB
iajs-3485	113	29	to	to	ADP
iajs-3485	113	30	the	the	DET
iajs-3485	113	31	toxicities	toxicity	NOUN
iajs-3485	113	32	of	of	ADP
iajs-3485	113	33	doxorganic	doxorganic	ADJ
iajs-3485	113	34	compounds	compound	NOUN
iajs-3485	113	35	is	be	AUX
iajs-3485	113	36	the	the	DET
iajs-3485	113	37	excessive	excessive	ADJ
iajs-3485	113	38	generation	generation	NOUN
iajs-3485	113	39	of	of	ADP
iajs-3485	113	40	reactive	reactive	ADJ
iajs-3485	113	41	oxygen	oxygen	NOUN
iajs-3485	113	42	species	specie	NOUN
iajs-3485	113	43	(	(	PUNCT
iajs-3485	113	44	ros	ros	PROPN
iajs-3485	113	45	)	)	PUNCT
iajs-3485	114	1	[	[	X
iajs-3485	114	2	31	31	NUM
iajs-3485	114	3	]	]	PUNCT
iajs-3485	114	4	.	.	PUNCT
iajs-3485	115	1	the	the	DET
iajs-3485	115	2	results	result	NOUN
iajs-3485	115	3	of	of	ADP
iajs-3485	115	4	the	the	DET
iajs-3485	115	5	current	current	ADJ
iajs-3485	115	6	study	study	NOUN
iajs-3485	115	7	exhibit	exhibit	VERB
iajs-3485	115	8	that	that	SCONJ
iajs-3485	115	9	the	the	DET
iajs-3485	115	10	cardiac	cardiac	ADJ
iajs-3485	115	11	tissue	tissue	NOUN
iajs-3485	115	12	mda	mda	NOUN
iajs-3485	115	13	contents	content	NOUN
iajs-3485	115	14	were	be	AUX
iajs-3485	115	15	significantly	significantly	ADV
iajs-3485	115	16	increased	increase	VERB
iajs-3485	115	17	(	(	PUNCT
iajs-3485	115	18	p<0.05	p<0.05	NOUN
iajs-3485	115	19	)	)	PUNCT
iajs-3485	115	20	in	in	ADP
iajs-3485	115	21	dox	dox	NOUN
iajs-3485	115	22	-	-	PUNCT
iajs-3485	115	23	treated	treat	VERB
iajs-3485	115	24	mice	mouse	NOUN
iajs-3485	115	25	(	(	PUNCT
iajs-3485	115	26	group	group	NOUN
iajs-3485	115	27	iv	iv	NUM
iajs-3485	115	28	)	)	PUNCT
iajs-3485	115	29	compared	compare	VERB
iajs-3485	115	30	with	with	ADP
iajs-3485	115	31	negative	negative	ADJ
iajs-3485	115	32	control	control	NOUN
iajs-3485	115	33	group	group	NOUN
iajs-3485	116	1	i	i	PRON
iajs-3485	117	1	[	[	X
iajs-3485	117	2	table	table	NOUN
iajs-3485	117	3	1	1	NUM
iajs-3485	117	4	]	]	PUNCT
iajs-3485	117	5	,	,	PUNCT
iajs-3485	117	6	and	and	CCONJ
iajs-3485	117	7	one	one	NUM
iajs-3485	117	8	of	of	ADP
iajs-3485	117	9	the	the	DET
iajs-3485	117	10	main	main	ADJ
iajs-3485	117	11	mechanisms	mechanism	NOUN
iajs-3485	117	12	linked	link	VERB
iajs-3485	117	13	to	to	ADP
iajs-3485	117	14	the	the	DET
iajs-3485	117	15	toxicities	toxicity	NOUN
iajs-3485	117	16	of	of	ADP
iajs-3485	117	17	dox	dox	NOUN
iajs-3485	117	18	-	-	PUNCT
iajs-3485	117	19	organic	organic	ADJ
iajs-3485	117	20	compounds	compound	NOUN
iajs-3485	117	21	is	be	AUX
iajs-3485	117	22	the	the	DET
iajs-3485	117	23	excessive	excessive	ADJ
iajs-3485	117	24	generation	generation	NOUN
iajs-3485	117	25	of	of	ADP
iajs-3485	117	26	reactive	reactive	ADJ
iajs-3485	117	27	oxygen	oxygen	NOUN
iajs-3485	117	28	species	specie	NOUN
iajs-3485	117	29	(	(	PUNCT
iajs-3485	117	30	ros	ros	PROPN
iajs-3485	117	31	)	)	PUNCT
iajs-3485	118	1	[	[	X
iajs-3485	118	2	31	31	NUM
iajs-3485	118	3	-	-	SYM
iajs-3485	118	4	33	33	NUM
iajs-3485	118	5	]	]	PUNCT
iajs-3485	118	6	.	.	PUNCT
iajs-3485	119	1	additionally	additionally	ADV
iajs-3485	119	2	,	,	PUNCT
iajs-3485	119	3	the	the	DET
iajs-3485	119	4	findings	finding	NOUN
iajs-3485	119	5	of	of	ADP
iajs-3485	119	6	this	this	DET
iajs-3485	119	7	study	study	NOUN
iajs-3485	119	8	demonstrated	demonstrate	VERB
iajs-3485	119	9	that	that	SCONJ
iajs-3485	119	10	64	64	NUM
iajs-3485	119	11	mg	mg	NUM
iajs-3485	119	12	/	/	SYM
iajs-3485	119	13	kg	kg	PROPN
iajs-3485	119	14	and	and	CCONJ
iajs-3485	119	15	128	128	NUM
iajs-3485	119	16	mg	mg	NUM
iajs-3485	119	17	/	/	SYM
iajs-3485	119	18	kg	kg	PROPN
iajs-3485	119	19	of	of	ADP
iajs-3485	119	20	a.	a.	NOUN
iajs-3485	119	21	majus	maju	NOUN
iajs-3485	119	22	(	(	PUNCT
iajs-3485	119	23	groups	group	NOUN
iajs-3485	119	24	v	v	ADP
iajs-3485	119	25	and	and	CCONJ
iajs-3485	119	26	vi	vi	NOUN
iajs-3485	119	27	,	,	PUNCT
iajs-3485	119	28	respectively	respectively	ADV
iajs-3485	119	29	)	)	PUNCT
iajs-3485	119	30	given	give	VERB
iajs-3485	119	31	before	before	ADP
iajs-3485	119	32	the	the	DET
iajs-3485	119	33	15	15	NUM
iajs-3485	119	34	mg	mg	PROPN
iajs-3485	119	35	/	/	SYM
iajs-3485	119	36	kg	kg	PROPN
iajs-3485	119	37	dox	dox	NOUN
iajs-3485	119	38	resulted	result	VERB
iajs-3485	119	39	in	in	ADP
iajs-3485	119	40	a	a	DET
iajs-3485	119	41	significant	significant	ADJ
iajs-3485	119	42	reduction	reduction	NOUN
iajs-3485	119	43	in	in	ADP
iajs-3485	119	44	mda	mda	PROPN
iajs-3485	119	45	levels	level	NOUN
iajs-3485	119	46	when	when	SCONJ
iajs-3485	119	47	compared	compare	VERB
iajs-3485	119	48	to	to	ADP
iajs-3485	119	49	the	the	DET
iajs-3485	119	50	positive	positive	ADJ
iajs-3485	119	51	controls	control	NOUN
iajs-3485	119	52	(	(	PUNCT
iajs-3485	119	53	group	group	NOUN
iajs-3485	119	54	iv	iv	NUM
iajs-3485	119	55	)	)	PUNCT
iajs-3485	119	56	,	,	PUNCT
iajs-3485	119	57	which	which	PRON
iajs-3485	119	58	is	be	AUX
iajs-3485	119	59	related	relate	VERB
iajs-3485	119	60	to	to	ADP
iajs-3485	119	61	its	its	PRON
iajs-3485	119	62	antioxidant	antioxidant	ADJ
iajs-3485	119	63	action	action	NOUN
iajs-3485	119	64	.	.	PUNCT
iajs-3485	120	1	in	in	ADP
iajs-3485	120	2	addition	addition	NOUN
iajs-3485	120	3	to	to	ADP
iajs-3485	120	4	quenching	quench	VERB
iajs-3485	120	5	alkyl	alkyl	NOUN
iajs-3485	120	6	radicals	radical	NOUN
iajs-3485	120	7	to	to	PART
iajs-3485	120	8	stop	stop	VERB
iajs-3485	120	9	chain	chain	NOUN
iajs-3485	120	10	reactions	reaction	NOUN
iajs-3485	120	11	,	,	PUNCT
iajs-3485	120	12	quercetin	quercetin	NOUN
iajs-3485	120	13	also	also	ADV
iajs-3485	120	14	has	have	VERB
iajs-3485	120	15	iron	iron	NOUN
iajs-3485	120	16	-	-	PUNCT
iajs-3485	120	17	chelating	chelate	VERB
iajs-3485	120	18	properties	property	NOUN
iajs-3485	120	19	similar	similar	ADJ
iajs-3485	120	20	to	to	ADP
iajs-3485	120	21	ferritin	ferritin	PROPN
iajs-3485	120	22	's	's	PART
iajs-3485	120	23	ability	ability	NOUN
iajs-3485	120	24	to	to	PART
iajs-3485	120	25	bind	bind	VERB
iajs-3485	120	26	iron	iron	NOUN
iajs-3485	120	27	during	during	ADP
iajs-3485	120	28	the	the	DET
iajs-3485	120	29	fenton	fenton	NOUN
iajs-3485	120	30	reaction	reaction	NOUN
iajs-3485	120	31	,	,	PUNCT
iajs-3485	120	32	which	which	PRON
iajs-3485	120	33	is	be	AUX
iajs-3485	120	34	another	another	DET
iajs-3485	120	35	anti	anti	ADJ
iajs-3485	120	36	-	-	ADJ
iajs-3485	120	37	oxidation	oxidation	ADJ
iajs-3485	120	38	mechanism[34	mechanism[34	NOUN
iajs-3485	120	39	]	]	PUNCT
iajs-3485	120	40	.	.	PUNCT
iajs-3485	121	1	it	it	PRON
iajs-3485	121	2	has	have	AUX
iajs-3485	121	3	been	be	AUX
iajs-3485	121	4	demonstrated	demonstrate	VERB
iajs-3485	121	5	that	that	SCONJ
iajs-3485	121	6	chronic	chronic	ADJ
iajs-3485	121	7	oral	oral	ADJ
iajs-3485	121	8	therapy	therapy	NOUN
iajs-3485	121	9	with	with	ADP
iajs-3485	121	10	quercetin	quercetin	NOUN
iajs-3485	121	11	(	(	PUNCT
iajs-3485	121	12	10	10	NUM
iajs-3485	121	13	mg	mg	PROPN
iajs-3485	121	14	/	/	SYM
iajs-3485	121	15	kg	kg	PROPN
iajs-3485	121	16	/	/	SYM
iajs-3485	121	17	day	day	NOUN
iajs-3485	121	18	)	)	PUNCT
iajs-3485	121	19	for	for	ADP
iajs-3485	121	20	five	five	NUM
iajs-3485	121	21	weeks	week	NOUN
iajs-3485	121	22	lowers	lower	VERB
iajs-3485	121	23	blood	blood	NOUN
iajs-3485	121	24	pressure	pressure	NOUN
iajs-3485	121	25	,	,	PUNCT
iajs-3485	121	26	boosts	boost	VERB
iajs-3485	121	27	glutathione	glutathione	NOUN
iajs-3485	121	28	production	production	NOUN
iajs-3485	121	29	,	,	PUNCT
iajs-3485	121	30	and	and	CCONJ
iajs-3485	121	31	lowers	lower	VERB
iajs-3485	121	32	levels	level	NOUN
iajs-3485	121	33	of	of	ADP
iajs-3485	121	34	both	both	DET
iajs-3485	121	35	plasma	plasma	NOUN
iajs-3485	121	36	and	and	CCONJ
iajs-3485	121	37	hepatic	hepatic	ADJ
iajs-3485	121	38	malondialdehyde	malondialdehyde	NOUN
iajs-3485	121	39	(	(	PUNCT
iajs-3485	121	40	mda	mda	PROPN
iajs-3485	121	41	)	)	PUNCT
iajs-3485	122	1	[	[	X
iajs-3485	122	2	35	35	NUM
iajs-3485	122	3	,	,	PUNCT
iajs-3485	122	4	36].the	36].the	DET
iajs-3485	122	5	biomarkers	biomarker	NOUN
iajs-3485	122	6	ck	ck	NOUN
iajs-3485	122	7	-	-	PUNCT
iajs-3485	122	8	mb	mb	NOUN
iajs-3485	122	9	and	and	CCONJ
iajs-3485	122	10	cpk	cpk	PROPN
iajs-3485	122	11	have	have	AUX
iajs-3485	122	12	been	be	AUX
iajs-3485	122	13	useful	useful	ADJ
iajs-3485	122	14	in	in	ADP
iajs-3485	122	15	the	the	DET
iajs-3485	122	16	diagnosis	diagnosis	NOUN
iajs-3485	122	17	of	of	ADP
iajs-3485	122	18	doxorubicin	doxorubicin	PROPN
iajs-3485	122	19	-	-	PUNCT
iajs-3485	122	20	induced	induce	VERB
iajs-3485	122	21	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	122	22	because	because	SCONJ
iajs-3485	122	23	they	they	PRON
iajs-3485	122	24	are	be	AUX
iajs-3485	122	25	sensitive	sensitive	ADJ
iajs-3485	122	26	and	and	CCONJ
iajs-3485	122	27	specific	specific	ADJ
iajs-3485	122	28	indicators	indicator	NOUN
iajs-3485	122	29	of	of	ADP
iajs-3485	122	30	myocardial	myocardial	ADJ
iajs-3485	122	31	injury	injury	NOUN
iajs-3485	123	1	[	[	X
iajs-3485	123	2	37	37	NUM
iajs-3485	123	3	]	]	PUNCT
iajs-3485	123	4	.	.	PUNCT
iajs-3485	124	1	a	a	DET
iajs-3485	124	2	prior	prior	ADJ
iajs-3485	124	3	study	study	NOUN
iajs-3485	124	4	found	find	VERB
iajs-3485	124	5	that	that	SCONJ
iajs-3485	124	6	after	after	SCONJ
iajs-3485	124	7	doxorubicin	doxorubicin	PROPN
iajs-3485	124	8	intraperitoneal	intraperitoneal	VERB
iajs-3485	124	9	15	15	NUM
iajs-3485	124	10	mg	mg	PROPN
iajs-3485	124	11	/	/	SYM
iajs-3485	124	12	kg	kg	PROPN
iajs-3485	124	13	(	(	PUNCT
iajs-3485	124	14	2.5	2.5	NUM
iajs-3485	124	15	mg	mg	PROPN
iajs-3485	124	16	/	/	SYM
iajs-3485	124	17	kg	kg	PROPN
iajs-3485	124	18	body	body	NOUN
iajs-3485	124	19	weight	weight	NOUN
iajs-3485	124	20	ip	ip	NOUN
iajs-3485	124	21	)	)	PUNCT
iajs-3485	124	22	in	in	ADP
iajs-3485	124	23	6	6	NUM
iajs-3485	124	24	equal	equal	ADJ
iajs-3485	124	25	injections	injection	NOUN
iajs-3485	124	26	alternatively	alternatively	ADV
iajs-3485	124	27	for	for	ADP
iajs-3485	124	28	2	2	NUM
iajs-3485	124	29	weeks	week	NOUN
iajs-3485	124	30	,	,	PUNCT
iajs-3485	124	31	a	a	DET
iajs-3485	124	32	total	total	ADJ
iajs-3485	124	33	cumulative	cumulative	ADJ
iajs-3485	124	34	dose	dose	NOUN
iajs-3485	124	35	of	of	ADP
iajs-3485	124	36	15	15	NUM
iajs-3485	124	37	mg	mg	PROPN
iajs-3485	124	38	/	/	SYM
iajs-3485	124	39	kg	kg	PROPN
iajs-3485	124	40	body	body	NOUN
iajs-3485	124	41	weight	weight	NOUN
iajs-3485	124	42	increased	increase	VERB
iajs-3485	124	43	the	the	DET
iajs-3485	124	44	serum	serum	NOUN
iajs-3485	124	45	ck	ck	NOUN
iajs-3485	124	46	-	-	PUNCT
iajs-3485	124	47	mb	mb	NOUN
iajs-3485	124	48	and	and	CCONJ
iajs-3485	124	49	cpk	cpk	PROPN
iajs-3485	125	1	[	[	X
iajs-3485	125	2	31	31	NUM
iajs-3485	125	3	,	,	PUNCT
iajs-3485	125	4	38	38	NUM
iajs-3485	125	5	–	–	PUNCT
iajs-3485	125	6	ihjpas	ihjpa	NOUN
iajs-3485	125	7	.	.	PUNCT
iajs-3485	126	1	2024	2024	NUM
iajs-3485	126	2	,	,	PUNCT
iajs-3485	126	3	37	37	NUM
iajs-3485	126	4	(	(	PUNCT
iajs-3485	126	5	3	3	NUM
iajs-3485	126	6	)	)	PUNCT
iajs-3485	126	7	131	131	NUM
iajs-3485	126	8	40	40	NUM
iajs-3485	126	9	]	]	PUNCT
iajs-3485	126	10	,	,	PUNCT
iajs-3485	126	11	and	and	CCONJ
iajs-3485	126	12	this	this	PRON
iajs-3485	126	13	is	be	AUX
iajs-3485	126	14	compatible	compatible	ADJ
iajs-3485	126	15	with	with	ADP
iajs-3485	126	16	our	our	PRON
iajs-3485	126	17	result	result	NOUN
iajs-3485	126	18	,	,	PUNCT
iajs-3485	126	19	which	which	PRON
iajs-3485	126	20	was	be	AUX
iajs-3485	126	21	characterized	characterize	VERB
iajs-3485	126	22	by	by	ADP
iajs-3485	126	23	a	a	DET
iajs-3485	126	24	significant	significant	ADJ
iajs-3485	126	25	elevation	elevation	NOUN
iajs-3485	126	26	(	(	PUNCT
iajs-3485	126	27	p<0.05	p<0.05	NOUN
iajs-3485	126	28	)	)	PUNCT
iajs-3485	126	29	in	in	ADP
iajs-3485	126	30	serum	serum	PROPN
iajs-3485	126	31	creatine	creatine	PROPN
iajs-3485	126	32	kinase	kinase	PROPN
iajs-3485	126	33	myocardial	myocardial	PROPN
iajs-3485	126	34	bound	bind	VERB
iajs-3485	126	35	ck	ck	PRON
iajs-3485	126	36	mb	mb	NOUN
iajs-3485	126	37	isoenzyme	isoenzyme	NOUN
iajs-3485	126	38	and	and	CCONJ
iajs-3485	126	39	creatine	creatine	PROPN
iajs-3485	126	40	phosphokinase	phosphokinase	PROPN
iajs-3485	126	41	cpk	cpk	PROPN
iajs-3485	126	42	levels	level	NOUN
iajs-3485	126	43	compared	compare	VERB
iajs-3485	126	44	to	to	ADP
iajs-3485	126	45	the	the	DET
iajs-3485	126	46	negative	negative	ADJ
iajs-3485	126	47	control	control	PROPN
iajs-3485	126	48	group	group	NOUN
iajs-3485	126	49	.	.	PUNCT
iajs-3485	127	1	it	it	PRON
iajs-3485	127	2	is	be	AUX
iajs-3485	127	3	well	well	ADV
iajs-3485	127	4	known	know	VERB
iajs-3485	127	5	that	that	SCONJ
iajs-3485	127	6	these	these	DET
iajs-3485	127	7	enzymes	enzyme	NOUN
iajs-3485	127	8	are	be	AUX
iajs-3485	127	9	released	release	VERB
iajs-3485	127	10	from	from	ADP
iajs-3485	127	11	damaged	damage	VERB
iajs-3485	127	12	heart	heart	NOUN
iajs-3485	127	13	muscle	muscle	NOUN
iajs-3485	127	14	cells	cell	NOUN
iajs-3485	127	15	and	and	CCONJ
iajs-3485	127	16	that	that	SCONJ
iajs-3485	127	17	,	,	PUNCT
iajs-3485	127	18	following	follow	VERB
iajs-3485	127	19	myocardial	myocardial	ADJ
iajs-3485	127	20	injury	injury	NOUN
iajs-3485	127	21	,	,	PUNCT
iajs-3485	127	22	blood	blood	NOUN
iajs-3485	127	23	levels	level	NOUN
iajs-3485	127	24	of	of	ADP
iajs-3485	127	25	these	these	DET
iajs-3485	127	26	enzymes	enzyme	NOUN
iajs-3485	127	27	serve	serve	VERB
iajs-3485	127	28	as	as	ADP
iajs-3485	127	29	a	a	DET
iajs-3485	127	30	measure	measure	NOUN
iajs-3485	127	31	of	of	ADP
iajs-3485	127	32	the	the	DET
iajs-3485	127	33	severity	severity	NOUN
iajs-3485	127	34	of	of	ADP
iajs-3485	127	35	cardiac	cardiac	ADJ
iajs-3485	127	36	muscular	muscular	ADJ
iajs-3485	127	37	damage	damage	NOUN
iajs-3485	127	38	.	.	PUNCT
iajs-3485	128	1	it	it	PRON
iajs-3485	128	2	was	be	AUX
iajs-3485	128	3	deemed	deem	VERB
iajs-3485	128	4	to	to	PART
iajs-3485	128	5	be	be	AUX
iajs-3485	128	6	a	a	DET
iajs-3485	128	7	sensitive	sensitive	ADJ
iajs-3485	128	8	predictor	predictor	NOUN
iajs-3485	128	9	with	with	ADP
iajs-3485	128	10	a	a	DET
iajs-3485	128	11	decent	decent	ADJ
iajs-3485	128	12	correlation	correlation	NOUN
iajs-3485	128	13	with	with	ADP
iajs-3485	128	14	the	the	DET
iajs-3485	128	15	left	left	ADJ
iajs-3485	128	16	ventricular	ventricular	ADJ
iajs-3485	128	17	systolic	systolic	ADJ
iajs-3485	128	18	and	and	CCONJ
iajs-3485	128	19	diastolic	diastolic	NOUN
iajs-3485	128	20	functions	function	NOUN
iajs-3485	128	21	.	.	PUNCT
iajs-3485	129	1	moreover	moreover	ADV
iajs-3485	129	2	,	,	PUNCT
iajs-3485	129	3	the	the	DET
iajs-3485	129	4	modification	modification	NOUN
iajs-3485	129	5	in	in	ADP
iajs-3485	129	6	the	the	DET
iajs-3485	129	7	structure	structure	NOUN
iajs-3485	129	8	and	and	CCONJ
iajs-3485	129	9	function	function	NOUN
iajs-3485	129	10	of	of	ADP
iajs-3485	129	11	the	the	DET
iajs-3485	129	12	cardiomyocyte	cardiomyocyte	NOUN
iajs-3485	129	13	membrane	membrane	NOUN
iajs-3485	129	14	caused	cause	VERB
iajs-3485	129	15	by	by	ADP
iajs-3485	129	16	the	the	DET
iajs-3485	129	17	binding	binding	NOUN
iajs-3485	129	18	of	of	ADP
iajs-3485	129	19	toxic	toxic	ADJ
iajs-3485	129	20	dox	dox	NOUN
iajs-3485	129	21	metabolites	metabolite	NOUN
iajs-3485	129	22	to	to	ADP
iajs-3485	129	23	the	the	DET
iajs-3485	129	24	lipid	lipid	NOUN
iajs-3485	129	25	and	and	CCONJ
iajs-3485	129	26	protein	protein	NOUN
iajs-3485	129	27	components	component	NOUN
iajs-3485	129	28	of	of	ADP
iajs-3485	129	29	the	the	DET
iajs-3485	129	30	membrane	membrane	NOUN
iajs-3485	129	31	may	may	AUX
iajs-3485	129	32	be	be	AUX
iajs-3485	129	33	the	the	DET
iajs-3485	129	34	cause	cause	NOUN
iajs-3485	129	35	of	of	ADP
iajs-3485	129	36	the	the	DET
iajs-3485	129	37	high	high	ADJ
iajs-3485	129	38	values	value	NOUN
iajs-3485	129	39	of	of	ADP
iajs-3485	129	40	serum	serum	NOUN
iajs-3485	129	41	activities	activity	NOUN
iajs-3485	129	42	of	of	ADP
iajs-3485	129	43	both	both	DET
iajs-3485	129	44	enzymes	enzyme	NOUN
iajs-3485	129	45	(	(	PUNCT
iajs-3485	129	46	ck	ck	NOUN
iajs-3485	129	47	-	-	PUNCT
iajs-3485	129	48	mb	mb	NOUN
iajs-3485	129	49	and	and	CCONJ
iajs-3485	129	50	cpk	cpk	NOUN
iajs-3485	129	51	)	)	PUNCT
iajs-3485	130	1	[	[	X
iajs-3485	130	2	41	41	NUM
iajs-3485	130	3	]	]	PUNCT
iajs-3485	130	4	.	.	PUNCT
iajs-3485	131	1	in	in	ADP
iajs-3485	131	2	a	a	DET
iajs-3485	131	3	model	model	NOUN
iajs-3485	131	4	of	of	ADP
iajs-3485	131	5	dox	dox	NOUN
iajs-3485	131	6	-	-	PUNCT
iajs-3485	131	7	induced	induce	VERB
iajs-3485	131	8	myocardial	myocardial	ADJ
iajs-3485	131	9	damage	damage	NOUN
iajs-3485	131	10	,	,	PUNCT
iajs-3485	131	11	pretreatment	pretreatment	NOUN
iajs-3485	131	12	with	with	ADP
iajs-3485	131	13	a.	a.	NOUN
iajs-3485	131	14	majus	maju	NOUN
iajs-3485	131	15	has	have	AUX
iajs-3485	131	16	been	be	AUX
iajs-3485	131	17	demonstrated	demonstrate	VERB
iajs-3485	131	18	to	to	PART
iajs-3485	131	19	enhance	enhance	VERB
iajs-3485	131	20	cardiac	cardiac	ADJ
iajs-3485	131	21	function	function	NOUN
iajs-3485	131	22	by	by	ADP
iajs-3485	131	23	lowering	lower	VERB
iajs-3485	131	24	cpk	cpk	PROPN
iajs-3485	131	25	and	and	CCONJ
iajs-3485	131	26	ck	ck	ADJ
iajs-3485	131	27	-	-	PUNCT
iajs-3485	131	28	mb	mb	NOUN
iajs-3485	131	29	expressions	expression	NOUN
iajs-3485	131	30	.	.	PUNCT
iajs-3485	132	1	moreover	moreover	ADV
iajs-3485	132	2	,	,	PUNCT
iajs-3485	132	3	bedouins	bedouin	NOUN
iajs-3485	132	4	advocate	advocate	VERB
iajs-3485	132	5	it	it	PRON
iajs-3485	132	6	as	as	ADP
iajs-3485	132	7	a	a	DET
iajs-3485	132	8	healer	healer	ADJ
iajs-3485	132	9	plant	plant	NOUN
iajs-3485	132	10	in	in	ADP
iajs-3485	132	11	traditional	traditional	ADJ
iajs-3485	132	12	medicine	medicine	NOUN
iajs-3485	132	13	,	,	PUNCT
iajs-3485	132	14	and	and	CCONJ
iajs-3485	132	15	bioactive	bioactive	ADJ
iajs-3485	132	16	components	component	NOUN
iajs-3485	132	17	like	like	ADP
iajs-3485	132	18	coumarin	coumarin	NOUN
iajs-3485	132	19	were	be	AUX
iajs-3485	132	20	studied	study	VERB
iajs-3485	132	21	.	.	PUNCT
iajs-3485	133	1	it	it	PRON
iajs-3485	133	2	was	be	AUX
iajs-3485	133	3	suggested	suggest	VERB
iajs-3485	133	4	that	that	SCONJ
iajs-3485	133	5	a.	a.	NOUN
iajs-3485	133	6	majus	maju	NOUN
iajs-3485	133	7	may	may	AUX
iajs-3485	133	8	have	have	VERB
iajs-3485	133	9	a	a	DET
iajs-3485	133	10	lipidlowering	lipidlowering	NOUN
iajs-3485	133	11	impact	impact	NOUN
iajs-3485	133	12	and/or	and/or	CCONJ
iajs-3485	133	13	an	an	DET
iajs-3485	133	14	increased	increase	VERB
iajs-3485	133	15	antioxidant	antioxidant	ADJ
iajs-3485	133	16	status	status	NOUN
iajs-3485	133	17	,	,	PUNCT
iajs-3485	133	18	which	which	PRON
iajs-3485	133	19	may	may	AUX
iajs-3485	133	20	have	have	AUX
iajs-3485	133	21	helped	help	VERB
iajs-3485	133	22	to	to	PART
iajs-3485	133	23	lessen	lessen	VERB
iajs-3485	133	24	the	the	DET
iajs-3485	133	25	doxorubicin	doxorubicin	PROPN
iajs-3485	133	26	tendency	tendency	NOUN
iajs-3485	133	27	to	to	PART
iajs-3485	133	28	elevate	elevate	VERB
iajs-3485	133	29	cardiac	cardiac	ADJ
iajs-3485	133	30	biomarkers	biomarker	NOUN
iajs-3485	133	31	.	.	PUNCT
iajs-3485	134	1	according	accord	VERB
iajs-3485	134	2	to	to	ADP
iajs-3485	134	3	the	the	DET
iajs-3485	134	4	data	datum	NOUN
iajs-3485	134	5	and	and	CCONJ
iajs-3485	134	6	results	result	NOUN
iajs-3485	134	7	mentioned	mention	VERB
iajs-3485	134	8	in	in	ADP
iajs-3485	134	9	tables	table	NOUN
iajs-3485	134	10	1	1	NUM
iajs-3485	134	11	and	and	CCONJ
iajs-3485	134	12	2	2	NUM
iajs-3485	134	13	,	,	PUNCT
iajs-3485	134	14	we	we	PRON
iajs-3485	134	15	notice	notice	VERB
iajs-3485	134	16	that	that	SCONJ
iajs-3485	134	17	animals	animal	NOUN
iajs-3485	134	18	treated	treat	VERB
iajs-3485	134	19	with	with	ADP
iajs-3485	134	20	a.	a.	NOUN
iajs-3485	134	21	majus	maju	NOUN
iajs-3485	134	22	restored	restore	VERB
iajs-3485	134	23	the	the	DET
iajs-3485	134	24	levels	level	NOUN
iajs-3485	134	25	of	of	ADP
iajs-3485	134	26	cpk	cpk	PROPN
iajs-3485	134	27	and	and	CCONJ
iajs-3485	134	28	ckmb	ckmb	PROPN
iajs-3485	134	29	(	(	PUNCT
iajs-3485	134	30	groups	group	NOUN
iajs-3485	134	31	v	v	ADP
iajs-3485	134	32	and	and	CCONJ
iajs-3485	134	33	vi	vi	PRON
iajs-3485	134	34	)	)	PUNCT
iajs-3485	134	35	compared	compare	VERB
iajs-3485	134	36	to	to	ADP
iajs-3485	134	37	a	a	DET
iajs-3485	134	38	positive	positive	ADJ
iajs-3485	134	39	control	control	NOUN
iajs-3485	134	40	(	(	PUNCT
iajs-3485	134	41	the	the	DET
iajs-3485	134	42	doxorubicin	doxorubicin	PROPN
iajs-3485	134	43	-	-	PUNCT
iajs-3485	134	44	treated	treat	VERB
iajs-3485	134	45	group	group	NOUN
iajs-3485	134	46	)	)	PUNCT
iajs-3485	134	47	,	,	PUNCT
iajs-3485	134	48	which	which	PRON
iajs-3485	134	49	indicates	indicate	VERB
iajs-3485	134	50	the	the	DET
iajs-3485	134	51	extract	extract	NOUN
iajs-3485	134	52	's	's	PART
iajs-3485	134	53	ability	ability	NOUN
iajs-3485	134	54	to	to	PART
iajs-3485	134	55	lessen	lessen	VERB
iajs-3485	134	56	leakages	leakage	NOUN
iajs-3485	134	57	of	of	ADP
iajs-3485	134	58	these	these	DET
iajs-3485	134	59	enzymes	enzyme	NOUN
iajs-3485	134	60	from	from	ADP
iajs-3485	134	61	cardiomyocytes	cardiomyocyte	NOUN
iajs-3485	134	62	.	.	PUNCT
iajs-3485	135	1	results	result	NOUN
iajs-3485	135	2	of	of	ADP
iajs-3485	135	3	the	the	DET
iajs-3485	135	4	current	current	ADJ
iajs-3485	135	5	study	study	NOUN
iajs-3485	135	6	showed	show	VERB
iajs-3485	135	7	that	that	SCONJ
iajs-3485	135	8	the	the	DET
iajs-3485	135	9	a.	a.	NOUN
iajs-3485	135	10	majus	maju	VERB
iajs-3485	135	11	doses	dose	NOUN
iajs-3485	135	12	alone	alone	ADV
iajs-3485	135	13	(	(	PUNCT
iajs-3485	135	14	64	64	NUM
iajs-3485	135	15	mg	mg	NOUN
iajs-3485	135	16	or	or	CCONJ
iajs-3485	135	17	128	128	NUM
iajs-3485	135	18	mg	mg	NUM
iajs-3485	135	19	/	/	SYM
iajs-3485	135	20	kg	kg	NOUN
iajs-3485	135	21	)	)	PUNCT
iajs-3485	135	22	each	each	DET
iajs-3485	135	23	produced	produce	VERB
iajs-3485	135	24	nonsignificant	nonsignificant	ADJ
iajs-3485	135	25	differences	difference	NOUN
iajs-3485	135	26	in	in	ADP
iajs-3485	135	27	the	the	DET
iajs-3485	135	28	cpk	cpk	PROPN
iajs-3485	135	29	and	and	CCONJ
iajs-3485	135	30	ck	ck	PROPN
iajs-3485	135	31	-	-	PUNCT
iajs-3485	135	32	mb	mb	VERB
iajs-3485	135	33	isozyme	isozyme	NOUN
iajs-3485	135	34	serum	serum	NOUN
iajs-3485	135	35	levels	level	NOUN
iajs-3485	135	36	compared	compare	VERB
iajs-3485	135	37	to	to	ADP
iajs-3485	135	38	the	the	DET
iajs-3485	135	39	negative	negative	ADJ
iajs-3485	135	40	control	control	NOUN
iajs-3485	135	41	(	(	PUNCT
iajs-3485	135	42	group	group	NOUN
iajs-3485	135	43	i	i	PROPN
iajs-3485	135	44	)	)	PUNCT
iajs-3485	135	45	.	.	PUNCT
iajs-3485	136	1	thus	thus	ADV
iajs-3485	136	2	,	,	PUNCT
iajs-3485	136	3	in	in	ADP
iajs-3485	136	4	the	the	DET
iajs-3485	136	5	current	current	ADJ
iajs-3485	136	6	study	study	NOUN
iajs-3485	136	7	,	,	PUNCT
iajs-3485	136	8	prior	prior	ADV
iajs-3485	136	9	to	to	ADP
iajs-3485	136	10	a	a	DET
iajs-3485	136	11	single	single	ADJ
iajs-3485	136	12	dose	dose	NOUN
iajs-3485	136	13	of	of	ADP
iajs-3485	136	14	doxorubicin	doxorubicin	PROPN
iajs-3485	136	15	,	,	PUNCT
iajs-3485	136	16	treatment	treatment	NOUN
iajs-3485	136	17	with	with	ADP
iajs-3485	136	18	ammi	ammi	PROPN
iajs-3485	136	19	majus	maju	NOUN
iajs-3485	136	20	reduced	reduce	VERB
iajs-3485	136	21	the	the	DET
iajs-3485	136	22	levels	level	NOUN
iajs-3485	136	23	of	of	ADP
iajs-3485	136	24	the	the	DET
iajs-3485	136	25	serum	serum	PROPN
iajs-3485	136	26	markers	markers	PROPN
iajs-3485	136	27	cpk	cpk	PROPN
iajs-3485	136	28	and	and	CCONJ
iajs-3485	136	29	ck	ck	PROPN
iajs-3485	136	30	-	-	PUNCT
iajs-3485	136	31	mb	mb	NOUN
iajs-3485	136	32	.	.	PUNCT
iajs-3485	137	1	this	this	PRON
iajs-3485	137	2	could	could	AUX
iajs-3485	137	3	be	be	AUX
iajs-3485	137	4	attributed	attribute	VERB
iajs-3485	137	5	to	to	ADP
iajs-3485	137	6	a.	a.	NOUN
iajs-3485	137	7	majus	maju	NOUN
iajs-3485	137	8	'	'	PUNCT
iajs-3485	137	9	protective	protective	ADJ
iajs-3485	137	10	effect	effect	NOUN
iajs-3485	137	11	on	on	ADP
iajs-3485	137	12	the	the	DET
iajs-3485	137	13	myocardium	myocardium	NOUN
iajs-3485	137	14	by	by	ADP
iajs-3485	137	15	reducing	reduce	VERB
iajs-3485	137	16	the	the	DET
iajs-3485	137	17	myocardial	myocardial	ADJ
iajs-3485	137	18	damage	damage	NOUN
iajs-3485	137	19	caused	cause	VERB
iajs-3485	137	20	by	by	ADP
iajs-3485	137	21	doxorubicin	doxorubicin	PROPN
iajs-3485	137	22	,	,	PUNCT
iajs-3485	137	23	which	which	PRON
iajs-3485	137	24	in	in	ADP
iajs-3485	137	25	turn	turn	NOUN
iajs-3485	137	26	limited	limit	VERB
iajs-3485	137	27	the	the	DET
iajs-3485	137	28	leakage	leakage	NOUN
iajs-3485	137	29	of	of	ADP
iajs-3485	137	30	the	the	DET
iajs-3485	137	31	intended	intend	VERB
iajs-3485	137	32	markers	marker	NOUN
iajs-3485	137	33	into	into	ADP
iajs-3485	137	34	the	the	DET
iajs-3485	137	35	serum	serum	NOUN
iajs-3485	137	36	,	,	PUNCT
iajs-3485	137	37	and	and	CCONJ
iajs-3485	137	38	this	this	DET
iajs-3485	137	39	protective	protective	ADJ
iajs-3485	137	40	effect	effect	NOUN
iajs-3485	137	41	is	be	AUX
iajs-3485	137	42	due	due	ADJ
iajs-3485	137	43	to	to	ADP
iajs-3485	137	44	its	its	PRON
iajs-3485	137	45	main	main	ADJ
iajs-3485	137	46	ingredient	ingredient	NOUN
iajs-3485	137	47	,	,	PUNCT
iajs-3485	137	48	quercetin	quercetin	NOUN
iajs-3485	137	49	,	,	PUNCT
iajs-3485	137	50	which	which	PRON
iajs-3485	137	51	,	,	PUNCT
iajs-3485	137	52	when	when	SCONJ
iajs-3485	137	53	administered	administer	VERB
iajs-3485	137	54	in	in	ADP
iajs-3485	137	55	a	a	DET
iajs-3485	137	56	doxorubicin	doxorubicin	PROPN
iajs-3485	137	57	-	-	PUNCT
iajs-3485	137	58	induced	induce	VERB
iajs-3485	137	59	heart	heart	NOUN
iajs-3485	137	60	injury	injury	NOUN
iajs-3485	137	61	model	model	NOUN
iajs-3485	137	62	,	,	PUNCT
iajs-3485	137	63	protects	protect	VERB
iajs-3485	137	64	the	the	DET
iajs-3485	137	65	cardiomyocytes	cardiomyocyte	NOUN
iajs-3485	137	66	.	.	PUNCT
iajs-3485	138	1	by	by	ADP
iajs-3485	138	2	preventing	prevent	VERB
iajs-3485	138	3	cell	cell	NOUN
iajs-3485	138	4	apoptosis	apoptosis	NOUN
iajs-3485	138	5	and	and	CCONJ
iajs-3485	138	6	maintaining	maintain	VERB
iajs-3485	138	7	cell	cell	NOUN
iajs-3485	138	8	shape	shape	NOUN
iajs-3485	138	9	by	by	ADP
iajs-3485	138	10	reorganizing	reorganize	VERB
iajs-3485	138	11	the	the	DET
iajs-3485	138	12	cytoskeleton	cytoskeleton	NOUN
iajs-3485	138	13	,	,	PUNCT
iajs-3485	138	14	quercetin	quercetin	NOUN
iajs-3485	138	15	dramatically	dramatically	ADV
iajs-3485	138	16	improves	improve	VERB
iajs-3485	138	17	cell	cell	NOUN
iajs-3485	138	18	survival	survival	NOUN
iajs-3485	138	19	[	[	X
iajs-3485	138	20	36	36	NUM
iajs-3485	138	21	]	]	PUNCT
iajs-3485	138	22	.	.	PUNCT
iajs-3485	139	1	moreover	moreover	ADV
iajs-3485	139	2	,	,	PUNCT
iajs-3485	139	3	there	there	PRON
iajs-3485	139	4	are	be	VERB
iajs-3485	139	5	other	other	ADJ
iajs-3485	139	6	active	active	ADJ
iajs-3485	139	7	ingredients	ingredient	NOUN
iajs-3485	139	8	with	with	ADP
iajs-3485	139	9	anti	anti	ADJ
iajs-3485	139	10	-	-	ADJ
iajs-3485	139	11	inflammatory	inflammatory	ADJ
iajs-3485	139	12	properties	property	NOUN
iajs-3485	139	13	,	,	PUNCT
iajs-3485	139	14	such	such	ADJ
iajs-3485	139	15	as	as	ADP
iajs-3485	139	16	the	the	DET
iajs-3485	139	17	phytochemical	phytochemical	ADJ
iajs-3485	139	18	coumarin	coumarin	NOUN
iajs-3485	139	19	[	[	X
iajs-3485	139	20	10	10	NUM
iajs-3485	139	21	]	]	PUNCT
iajs-3485	139	22	,	,	PUNCT
iajs-3485	139	23	an	an	DET
iajs-3485	139	24	antioxidant	antioxidant	NOUN
iajs-3485	139	25	;	;	PUNCT
iajs-3485	139	26	the	the	DET
iajs-3485	139	27	standard	standard	ADJ
iajs-3485	139	28	antioxidant	antioxidant	ADJ
iajs-3485	139	29	gallic	gallic	NOUN
iajs-3485	139	30	acid	acid	NOUN
iajs-3485	139	31	and	and	CCONJ
iajs-3485	139	32	the	the	DET
iajs-3485	139	33	dpph	dpph	NOUN
iajs-3485	139	34	-	-	PUNCT
iajs-3485	139	35	h	h	NOUN
iajs-3485	139	36	scavenging	scavenge	VERB
iajs-3485	139	37	activities	activity	NOUN
iajs-3485	139	38	of	of	ADP
iajs-3485	139	39	plant	plant	NOUN
iajs-3485	139	40	crude	crude	ADJ
iajs-3485	139	41	extracts	extract	NOUN
iajs-3485	139	42	were	be	AUX
iajs-3485	139	43	quite	quite	ADV
iajs-3485	139	44	similar	similar	ADJ
iajs-3485	139	45	;	;	PUNCT
iajs-3485	139	46	antioxidant	antioxidant	ADJ
iajs-3485	139	47	action	action	NOUN
iajs-3485	139	48	was	be	AUX
iajs-3485	139	49	attained	attain	VERB
iajs-3485	139	50	due	due	ADJ
iajs-3485	139	51	to	to	ADP
iajs-3485	139	52	the	the	DET
iajs-3485	139	53	presence	presence	NOUN
iajs-3485	139	54	of	of	ADP
iajs-3485	139	55	phenols	phenol	NOUN
iajs-3485	139	56	and	and	CCONJ
iajs-3485	139	57	flavonoids	flavonoid	NOUN
iajs-3485	139	58	,	,	PUNCT
iajs-3485	139	59	which	which	PRON
iajs-3485	139	60	are	be	AUX
iajs-3485	139	61	thought	think	VERB
iajs-3485	139	62	of	of	ADP
iajs-3485	139	63	as	as	ADP
iajs-3485	139	64	secondary	secondary	ADJ
iajs-3485	139	65	metabolites	metabolite	NOUN
iajs-3485	139	66	of	of	ADP
iajs-3485	139	67	plant	plant	NOUN
iajs-3485	139	68	origin	origin	NOUN
iajs-3485	139	69	[	[	X
iajs-3485	139	70	42	42	NUM
iajs-3485	139	71	]	]	PUNCT
iajs-3485	139	72	.	.	PUNCT
iajs-3485	140	1	another	another	DET
iajs-3485	140	2	study	study	NOUN
iajs-3485	140	3	demonstrates	demonstrate	VERB
iajs-3485	140	4	the	the	DET
iajs-3485	140	5	antioxidant	antioxidant	ADJ
iajs-3485	140	6	properties	property	NOUN
iajs-3485	140	7	and	and	CCONJ
iajs-3485	140	8	effects	effect	NOUN
iajs-3485	140	9	of	of	ADP
iajs-3485	140	10	the	the	DET
iajs-3485	140	11	linear	linear	PROPN
iajs-3485	140	12	furanocoumarin	furanocoumarin	PROPN
iajs-3485	140	13	marmesinin	marmesinin	NOUN
iajs-3485	140	14	(	(	PUNCT
iajs-3485	140	15	an	an	DET
iajs-3485	140	16	additional	additional	ADJ
iajs-3485	140	17	chemical	chemical	NOUN
iajs-3485	140	18	component	component	NOUN
iajs-3485	140	19	of	of	ADP
iajs-3485	140	20	a.	a.	NOUN
iajs-3485	140	21	majus	maju	NOUN
iajs-3485	140	22	on	on	ADP
iajs-3485	140	23	membranes	membrane	NOUN
iajs-3485	140	24	[	[	X
iajs-3485	140	25	19	19	NUM
iajs-3485	140	26	]	]	PUNCT
iajs-3485	140	27	.	.	PUNCT
iajs-3485	141	1	marmesinin	marmesinin	PROPN
iajs-3485	141	2	isolated	isolate	VERB
iajs-3485	141	3	from	from	ADP
iajs-3485	141	4	aegle	aegle	NOUN
iajs-3485	141	5	marmelose	marmelose	PROPN
iajs-3485	141	6	was	be	AUX
iajs-3485	141	7	evaluated	evaluate	VERB
iajs-3485	141	8	during	during	ADP
iajs-3485	141	9	an	an	DET
iajs-3485	141	10	experimental	experimental	ADJ
iajs-3485	141	11	myocardial	myocardial	ADJ
iajs-3485	141	12	injury	injury	NOUN
iajs-3485	141	13	.	.	PUNCT
iajs-3485	142	1	marmesinin	marmesinin	ADJ
iajs-3485	142	2	oral	oral	ADJ
iajs-3485	142	3	treatment	treatment	NOUN
iajs-3485	142	4	for	for	ADP
iajs-3485	142	5	2	2	NUM
iajs-3485	142	6	days	day	NOUN
iajs-3485	142	7	before	before	ADV
iajs-3485	142	8	and	and	CCONJ
iajs-3485	142	9	during	during	ADP
iajs-3485	142	10	isoproterenol	isoproterenol	NOUN
iajs-3485	142	11	administration	administration	NOUN
iajs-3485	142	12	decreased	decrease	VERB
iajs-3485	142	13	the	the	DET
iajs-3485	142	14	effect	effect	NOUN
iajs-3485	142	15	of	of	ADP
iajs-3485	142	16	lipid	lipid	NOUN
iajs-3485	142	17	peroxidation	peroxidation	NOUN
iajs-3485	142	18	.	.	PUNCT
iajs-3485	143	1	by	by	ADP
iajs-3485	143	2	preventing	prevent	VERB
iajs-3485	143	3	the	the	DET
iajs-3485	143	4	release	release	NOUN
iajs-3485	143	5	of	of	ADP
iajs-3485	143	6	beta	beta	NOUN
iajs-3485	143	7	-	-	PUNCT
iajs-3485	143	8	glucuronidase	glucuronidase	NOUN
iajs-3485	143	9	from	from	ADP
iajs-3485	143	10	the	the	DET
iajs-3485	143	11	subcellular	subcellular	ADJ
iajs-3485	143	12	fractions	fraction	NOUN
iajs-3485	143	13	,	,	PUNCT
iajs-3485	143	14	it	it	PRON
iajs-3485	143	15	was	be	AUX
iajs-3485	143	16	also	also	ADV
iajs-3485	143	17	demonstrated	demonstrate	VERB
iajs-3485	143	18	to	to	PART
iajs-3485	143	19	have	have	VERB
iajs-3485	143	20	a	a	DET
iajs-3485	143	21	membranestabilizing	membranestabilizing	NOUN
iajs-3485	143	22	effect	effect	NOUN
iajs-3485	143	23	.	.	PUNCT
iajs-3485	144	1	as	as	ADP
iajs-3485	144	2	a	a	DET
iajs-3485	144	3	result	result	NOUN
iajs-3485	144	4	,	,	PUNCT
iajs-3485	144	5	marmesinin	marmesinin	NOUN
iajs-3485	144	6	,	,	PUNCT
iajs-3485	144	7	a	a	DET
iajs-3485	144	8	linear	linear	ADJ
iajs-3485	144	9	furanocoumarin	furanocoumarin	NOUN
iajs-3485	144	10	,	,	PUNCT
iajs-3485	144	11	may	may	AUX
iajs-3485	144	12	offer	offer	VERB
iajs-3485	144	13	protection	protection	NOUN
iajs-3485	144	14	against	against	ADP
iajs-3485	144	15	the	the	DET
iajs-3485	144	16	harm	harm	NOUN
iajs-3485	144	17	brought	bring	VERB
iajs-3485	144	18	on	on	ADP
iajs-3485	144	19	by	by	ADP
iajs-3485	144	20	experimental	experimental	ADJ
iajs-3485	144	21	myocardial	myocardial	ADJ
iajs-3485	144	22	injury	injury	NOUN
iajs-3485	145	1	[	[	X
iajs-3485	145	2	43	43	NUM
iajs-3485	145	3	]	]	PUNCT
iajs-3485	145	4	.	.	PUNCT
iajs-3485	146	1	additionally	additionally	ADV
iajs-3485	146	2	,	,	PUNCT
iajs-3485	146	3	the	the	DET
iajs-3485	146	4	findings	finding	NOUN
iajs-3485	146	5	of	of	ADP
iajs-3485	146	6	a	a	DET
iajs-3485	146	7	histological	histological	ADJ
iajs-3485	146	8	examination	examination	NOUN
iajs-3485	146	9	of	of	ADP
iajs-3485	146	10	a	a	DET
iajs-3485	146	11	mouse	mouse	NOUN
iajs-3485	146	12	heart	heart	NOUN
iajs-3485	146	13	before	before	ADP
iajs-3485	146	14	and	and	CCONJ
iajs-3485	146	15	after	after	ADP
iajs-3485	146	16	a	a	DET
iajs-3485	146	17	doxorubicin	doxorubicin	PROPN
iajs-3485	146	18	toxicity	toxicity	NOUN
iajs-3485	146	19	test	test	NOUN
iajs-3485	146	20	,	,	PUNCT
iajs-3485	146	21	as	as	ADV
iajs-3485	146	22	well	well	ADV
iajs-3485	146	23	as	as	ADP
iajs-3485	146	24	preand	preand	VERB
iajs-3485	146	25	post	post	ADJ
iajs-3485	146	26	-	-	ADJ
iajs-3485	146	27	exposure	exposure	NOUN
iajs-3485	146	28	to	to	ADP
iajs-3485	146	29	a.	a.	NOUN
iajs-3485	146	30	majus	maju	NOUN
iajs-3485	146	31	during	during	ADP
iajs-3485	146	32	the	the	DET
iajs-3485	146	33	current	current	ADJ
iajs-3485	146	34	study	study	NOUN
iajs-3485	146	35	,	,	PUNCT
iajs-3485	146	36	are	be	AUX
iajs-3485	146	37	displayed	display	VERB
iajs-3485	146	38	in	in	ADP
iajs-3485	146	39	figure	figure	NOUN
iajs-3485	146	40	(	(	PUNCT
iajs-3485	146	41	1	1	NUM
iajs-3485	146	42	)	)	PUNCT
iajs-3485	146	43	,	,	PUNCT
iajs-3485	146	44	which	which	PRON
iajs-3485	146	45	shows	show	VERB
iajs-3485	146	46	a	a	DET
iajs-3485	146	47	normal	normal	ADJ
iajs-3485	146	48	heart	heart	NOUN
iajs-3485	146	49	in	in	ADP
iajs-3485	146	50	the	the	DET
iajs-3485	146	51	control	control	NOUN
iajs-3485	146	52	group	group	NOUN
iajs-3485	146	53	and	and	CCONJ
iajs-3485	146	54	in	in	ADP
iajs-3485	146	55	the	the	DET
iajs-3485	146	56	groups	group	NOUN
iajs-3485	146	57	that	that	PRON
iajs-3485	146	58	take	take	VERB
iajs-3485	146	59	a.	a.	NOUN
iajs-3485	146	60	majus	maju	NOUN
iajs-3485	146	61	extract	extract	VERB
iajs-3485	146	62	only	only	ADV
iajs-3485	146	63	.	.	PUNCT
iajs-3485	147	1	the	the	DET
iajs-3485	147	2	positive	positive	ADJ
iajs-3485	147	3	group	group	NOUN
iajs-3485	147	4	(	(	PUNCT
iajs-3485	147	5	the	the	DET
iajs-3485	147	6	doxorubicin	doxorubicin	PROPN
iajs-3485	147	7	group	group	NOUN
iajs-3485	147	8	)	)	PUNCT
iajs-3485	147	9	showed	show	VERB
iajs-3485	147	10	necrosis	necrosis	NOUN
iajs-3485	147	11	of	of	ADP
iajs-3485	147	12	cardiac	cardiac	ADJ
iajs-3485	147	13	myocytes	myocyte	NOUN
iajs-3485	147	14	,	,	PUNCT
iajs-3485	147	15	severe	severe	ADJ
iajs-3485	147	16	infiltration	infiltration	NOUN
iajs-3485	147	17	of	of	ADP
iajs-3485	147	18	inflammatory	inflammatory	ADJ
iajs-3485	147	19	cells	cell	NOUN
iajs-3485	147	20	,	,	PUNCT
iajs-3485	147	21	mainly	mainly	ADV
iajs-3485	147	22	neutrophils	neutrophil	NOUN
iajs-3485	147	23	,	,	PUNCT
iajs-3485	147	24	and	and	CCONJ
iajs-3485	147	25	severe	severe	ADJ
iajs-3485	147	26	vacuolation	vacuolation	NOUN
iajs-3485	147	27	in	in	ADP
iajs-3485	147	28	the	the	DET
iajs-3485	147	29	cytoplasm	cytoplasm	NOUN
iajs-3485	147	30	of	of	ADP
iajs-3485	147	31	the	the	DET
iajs-3485	147	32	cardiac	cardiac	ADJ
iajs-3485	147	33	ihjpas	ihjpa	NOUN
iajs-3485	147	34	.	.	PUNCT
iajs-3485	148	1	2024	2024	NUM
iajs-3485	148	2	,	,	PUNCT
iajs-3485	148	3	37	37	NUM
iajs-3485	148	4	(	(	PUNCT
iajs-3485	148	5	3	3	NUM
iajs-3485	148	6	)	)	PUNCT
iajs-3485	148	7	132	132	NUM
iajs-3485	148	8	muscles	muscle	NOUN
iajs-3485	148	9	(	(	PUNCT
iajs-3485	148	10	myocytolysis	myocytolysis	NOUN
iajs-3485	148	11	)	)	PUNCT
iajs-3485	148	12	,	,	PUNCT
iajs-3485	148	13	which	which	PRON
iajs-3485	148	14	returned	return	VERB
iajs-3485	148	15	to	to	ADP
iajs-3485	148	16	resembling	resemble	VERB
iajs-3485	148	17	normal	normal	ADJ
iajs-3485	148	18	cardiac	cardiac	ADJ
iajs-3485	148	19	architecture	architecture	NOUN
iajs-3485	148	20	in	in	ADP
iajs-3485	148	21	groups	group	NOUN
iajs-3485	148	22	receiving	receive	VERB
iajs-3485	148	23	a.	a.	NOUN
iajs-3485	148	24	majus	maju	NOUN
iajs-3485	148	25	seed	seed	NOUN
iajs-3485	148	26	extract	extract	NOUN
iajs-3485	148	27	prior	prior	ADV
iajs-3485	148	28	to	to	ADP
iajs-3485	148	29	doxorubicin	doxorubicin	PROPN
iajs-3485	148	30	(	(	PUNCT
iajs-3485	148	31	groups	group	NOUN
iajs-3485	148	32	v	v	ADP
iajs-3485	148	33	and	and	CCONJ
iajs-3485	148	34	vi	vi	NUM
iajs-3485	148	35	)	)	PUNCT
iajs-3485	148	36	.	.	PUNCT
iajs-3485	149	1	5	5	X
iajs-3485	149	2	.	.	X
iajs-3485	149	3	conclusion	conclusion	NOUN
iajs-3485	149	4	:	:	PUNCT
iajs-3485	149	5	we	we	PRON
iajs-3485	149	6	have	have	AUX
iajs-3485	149	7	concluded	conclude	VERB
iajs-3485	149	8	that	that	SCONJ
iajs-3485	149	9	a.	a.	NOUN
iajs-3485	149	10	majus	maju	NOUN
iajs-3485	149	11	seed	seed	VERB
iajs-3485	149	12	ethanolic	ethanolic	ADJ
iajs-3485	149	13	extract	extract	NOUN
iajs-3485	149	14	has	have	VERB
iajs-3485	149	15	a	a	DET
iajs-3485	149	16	cardioprotective	cardioprotective	ADJ
iajs-3485	149	17	effect	effect	NOUN
iajs-3485	149	18	against	against	ADP
iajs-3485	149	19	doxorubicin	doxorubicin	PROPN
iajs-3485	149	20	cardiotoxicity	cardiotoxicity	PROPN
iajs-3485	149	21	.	.	PUNCT
iajs-3485	150	1	acknowledgment	acknowledgment	NOUN
iajs-3485	150	2	we	we	PRON
iajs-3485	150	3	are	be	AUX
iajs-3485	150	4	very	very	ADV
iajs-3485	150	5	grateful	grateful	ADJ
iajs-3485	150	6	to	to	ADP
iajs-3485	150	7	the	the	DET
iajs-3485	150	8	staff	staff	NOUN
iajs-3485	150	9	of	of	ADP
iajs-3485	150	10	the	the	DET
iajs-3485	150	11	department	department	PROPN
iajs-3485	150	12	of	of	ADP
iajs-3485	150	13	pharmacology	pharmacology	PROPN
iajs-3485	150	14	&	&	CCONJ
iajs-3485	150	15	toxicology	toxicology	NOUN
iajs-3485	150	16	,	,	PUNCT
iajs-3485	150	17	college	college	NOUN
iajs-3485	150	18	of	of	ADP
iajs-3485	150	19	pharmacy	pharmacy	NOUN
iajs-3485	150	20	,	,	PUNCT
iajs-3485	150	21	university	university	NOUN
iajs-3485	150	22	of	of	ADP
iajs-3485	150	23	baghdad	baghdad	PROPN
iajs-3485	150	24	,	,	PUNCT
iajs-3485	150	25	for	for	ADP
iajs-3485	150	26	facilitating	facilitate	VERB
iajs-3485	150	27	the	the	DET
iajs-3485	150	28	work	work	NOUN
iajs-3485	150	29	of	of	ADP
iajs-3485	150	30	this	this	DET
iajs-3485	150	31	article	article	NOUN
iajs-3485	150	32	.	.	PUNCT
iajs-3485	151	1	conflict	conflict	NOUN
iajs-3485	151	2	of	of	ADP
iajs-3485	151	3	interest	interest	NOUN
iajs-3485	151	4	the	the	DET
iajs-3485	151	5	authors	author	NOUN
iajs-3485	151	6	declare	declare	VERB
iajs-3485	151	7	that	that	SCONJ
iajs-3485	151	8	they	they	PRON
iajs-3485	151	9	have	have	VERB
iajs-3485	151	10	no	no	DET
iajs-3485	151	11	conflicts	conflict	NOUN
iajs-3485	151	12	of	of	ADP
iajs-3485	151	13	interest	interest	NOUN
iajs-3485	151	14	.	.	PUNCT
iajs-3485	152	1	funding	funding	NOUN
iajs-3485	152	2	there	there	PRON
iajs-3485	152	3	is	be	VERB
iajs-3485	152	4	no	no	DET
iajs-3485	152	5	funding	funding	NOUN
iajs-3485	152	6	for	for	ADP
iajs-3485	152	7	the	the	DET
iajs-3485	152	8	article	article	NOUN
iajs-3485	152	9	.	.	PUNCT
iajs-3485	153	1	ethical	ethical	ADJ
iajs-3485	153	2	clearance	clearance	NOUN
iajs-3485	153	3	ethics	ethic	NOUN
iajs-3485	153	4	of	of	ADP
iajs-3485	153	5	scientific	scientific	ADJ
iajs-3485	153	6	research	research	NOUN
iajs-3485	153	7	were	be	AUX
iajs-3485	153	8	carried	carry	VERB
iajs-3485	153	9	out	out	ADP
iajs-3485	153	10	in	in	ADP
iajs-3485	153	11	accordance	accordance	NOUN
iajs-3485	153	12	with	with	ADP
iajs-3485	153	13	the	the	DET
iajs-3485	153	14	international	international	ADJ
iajs-3485	153	15	conditions	condition	NOUN
iajs-3485	153	16	followed	follow	VERB
iajs-3485	153	17	in	in	ADP
iajs-3485	153	18	dealing	deal	VERB
iajs-3485	153	19	with	with	ADP
iajs-3485	153	20	laboratory	laboratory	NOUN
iajs-3485	153	21	animals	animal	NOUN
iajs-3485	153	22	,	,	PUNCT
iajs-3485	153	23	and	and	CCONJ
iajs-3485	153	24	included	include	VERB
iajs-3485	153	25	animal	animal	NOUN
iajs-3485	153	26	health	health	NOUN
iajs-3485	153	27	,	,	PUNCT
iajs-3485	153	28	husbandry	husbandry	NOUN
iajs-3485	153	29	and	and	CCONJ
iajs-3485	153	30	care	care	VERB
iajs-3485	153	31	for	for	ADP
iajs-3485	153	32	it	it	PRON
iajs-3485	153	33	,	,	PUNCT
iajs-3485	153	34	and	and	CCONJ
iajs-3485	153	35	providing	provide	VERB
iajs-3485	153	36	appropriate	appropriate	ADJ
iajs-3485	153	37	conditions	condition	NOUN
iajs-3485	153	38	for	for	ADP
iajs-3485	153	39	it	it	PRON
iajs-3485	153	40	in	in	ADP
iajs-3485	153	41	terms	term	NOUN
iajs-3485	153	42	of	of	ADP
iajs-3485	153	43	food	food	NOUN
iajs-3485	153	44	,	,	PUNCT
iajs-3485	153	45	and	and	CCONJ
iajs-3485	153	46	appropriate	appropriate	ADJ
iajs-3485	153	47	methods	method	NOUN
iajs-3485	153	48	were	be	AUX
iajs-3485	153	49	adopted	adopt	VERB
iajs-3485	153	50	in	in	ADP
iajs-3485	153	51	dealing	deal	VERB
iajs-3485	153	52	with	with	ADP
iajs-3485	153	53	it	it	PRON
iajs-3485	153	54	when	when	SCONJ
iajs-3485	153	55	experimenting	experiment	VERB
iajs-3485	153	56	,	,	PUNCT
iajs-3485	153	57	and	and	CCONJ
iajs-3485	153	58	this	this	PRON
iajs-3485	153	59	is	be	AUX
iajs-3485	153	60	consistent	consistent	ADJ
iajs-3485	153	61	with	with	ADP
iajs-3485	153	62	the	the	DET
iajs-3485	153	63	instructions	instruction	NOUN
iajs-3485	153	64	of	of	ADP
iajs-3485	153	65	the	the	DET
iajs-3485	153	66	iraqi	iraqi	ADJ
iajs-3485	153	67	ministry	ministry	PROPN
iajs-3485	153	68	of	of	ADP
iajs-3485	153	69	health	health	PROPN
iajs-3485	153	70	and	and	CCONJ
iajs-3485	153	71	environment	environment	NOUN
iajs-3485	153	72	.	.	PUNCT
iajs-3485	154	1	references	reference	NOUN
iajs-3485	154	2	1	1	NUM
iajs-3485	154	3	.	.	PUNCT
iajs-3485	155	1	pharmacopeia	pharmacopeia	PROPN
iajs-3485	155	2	,	,	PUNCT
iajs-3485	155	3	u.s	u.s	PROPN
iajs-3485	155	4	.	.	PROPN
iajs-3485	155	5	national	national	PROPN
iajs-3485	155	6	formulary	formulary	PROPN
iajs-3485	155	7	usp	usp	PROPN
iajs-3485	155	8	38	38	NUM
iajs-3485	155	9	—	—	PUNCT
iajs-3485	155	10	nf	nf	NOUN
iajs-3485	155	11	33	33	NUM
iajs-3485	155	12	.	.	PUNCT
iajs-3485	156	1	in	in	ADP
iajs-3485	156	2	:	:	PUNCT
iajs-3485	156	3	proceedings	proceeding	NOUN
iajs-3485	156	4	of	of	ADP
iajs-3485	156	5	the	the	DET
iajs-3485	156	6	rockville	rockville	PROPN
iajs-3485	156	7	:	:	PUNCT
iajs-3485	156	8	the	the	DET
iajs-3485	156	9	united	united	PROPN
iajs-3485	156	10	states	states	PROPN
iajs-3485	156	11	pharmacopeial	pharmacopeial	ADJ
iajs-3485	156	12	convention	convention	NOUN
iajs-3485	156	13	,	,	PUNCT
iajs-3485	156	14	2015	2015	NUM
iajs-3485	156	15	.	.	PUNCT
iajs-3485	157	1	2	2	X
iajs-3485	157	2	.	.	X
iajs-3485	157	3	reddy	reddy	PROPN
iajs-3485	157	4	,	,	PUNCT
iajs-3485	157	5	l.h	l.h	PROPN
iajs-3485	157	6	.	.	PROPN
iajs-3485	157	7	;	;	PUNCT
iajs-3485	157	8	murthy	murthy	PROPN
iajs-3485	157	9	,	,	PUNCT
iajs-3485	157	10	r.s	r.s	PROPN
iajs-3485	157	11	.	.	PROPN
iajs-3485	157	12	pharmacokinetics	pharmacokinetic	NOUN
iajs-3485	157	13	and	and	CCONJ
iajs-3485	157	14	biodistribution	biodistribution	NOUN
iajs-3485	157	15	studies	study	NOUN
iajs-3485	157	16	of	of	ADP
iajs-3485	157	17	doxorubicin	doxorubicin	PROPN
iajs-3485	157	18	loaded	load	VERB
iajs-3485	157	19	poly	poly	NOUN
iajs-3485	157	20	(	(	PUNCT
iajs-3485	157	21	butyl	butyl	NOUN
iajs-3485	157	22	cyanoacrylate	cyanoacrylate	NOUN
iajs-3485	157	23	)	)	PUNCT
iajs-3485	157	24	nanoparticles	nanoparticle	NOUN
iajs-3485	157	25	synthesized	synthesize	VERB
iajs-3485	157	26	by	by	ADP
iajs-3485	157	27	two	two	NUM
iajs-3485	157	28	different	different	ADJ
iajs-3485	157	29	techniques	technique	NOUN
iajs-3485	157	30	.	.	PUNCT
iajs-3485	157	31	biomed	biome	VERB
iajs-3485	157	32	pap	pap	VERB
iajs-3485	157	33	med	med	PROPN
iajs-3485	157	34	fac	fac	PROPN
iajs-3485	157	35	univ	univ	PROPN
iajs-3485	157	36	palacky	palacky	PROPN
iajs-3485	157	37	olomouc	olomouc	PROPN
iajs-3485	157	38	czech	czech	PROPN
iajs-3485	157	39	repub	repub	PROPN
iajs-3485	157	40	2004	2004	NUM
iajs-3485	157	41	,	,	PUNCT
iajs-3485	157	42	148(2	148(2	NUM
iajs-3485	157	43	)	)	PUNCT
iajs-3485	157	44	,	,	PUNCT
iajs-3485	157	45	161–166	161–166	NUM
iajs-3485	157	46	.	.	PUNCT
iajs-3485	158	1	doi	doi	NOUN
iajs-3485	158	2	:	:	PUNCT
iajs-3485	158	3	https://doi.org/10.5507/bp.2004.029	https://doi.org/10.5507/bp.2004.029	NOUN
iajs-3485	158	4	.	.	PUNCT
iajs-3485	159	1	3	3	X
iajs-3485	159	2	.	.	X
iajs-3485	159	3	gharanei	gharanei	NOUN
iajs-3485	159	4	,	,	PUNCT
iajs-3485	159	5	m.	m.	NOUN
iajs-3485	159	6	;	;	PUNCT
iajs-3485	159	7	hussain	hussain	PROPN
iajs-3485	159	8	,	,	PUNCT
iajs-3485	159	9	a.	a.	NOUN
iajs-3485	159	10	;	;	PUNCT
iajs-3485	159	11	janneh	janneh	PROPN
iajs-3485	159	12	,	,	PUNCT
iajs-3485	159	13	o.	o.	PROPN
iajs-3485	159	14	;	;	PUNCT
iajs-3485	159	15	maddock	maddock	PROPN
iajs-3485	159	16	,	,	PUNCT
iajs-3485	159	17	h.l	h.l	PROPN
iajs-3485	159	18	.	.	PROPN
iajs-3485	159	19	doxorubicin	doxorubicin	PROPN
iajs-3485	159	20	induced	induce	VERB
iajs-3485	159	21	myocardial	myocardial	ADJ
iajs-3485	159	22	injury	injury	NOUN
iajs-3485	159	23	is	be	AUX
iajs-3485	159	24	exacerbated	exacerbate	VERB
iajs-3485	159	25	following	follow	VERB
iajs-3485	159	26	ischaemic	ischaemic	ADJ
iajs-3485	159	27	stress	stress	NOUN
iajs-3485	159	28	via	via	ADP
iajs-3485	159	29	opening	opening	NOUN
iajs-3485	159	30	of	of	ADP
iajs-3485	159	31	the	the	DET
iajs-3485	159	32	mitochondrial	mitochondrial	ADJ
iajs-3485	159	33	permeability	permeability	NOUN
iajs-3485	159	34	transition	transition	NOUN
iajs-3485	159	35	pore	pore	NOUN
iajs-3485	159	36	.	.	PUNCT
iajs-3485	160	1	toxicology	toxicology	NOUN
iajs-3485	160	2	and	and	CCONJ
iajs-3485	160	3	applied	apply	VERB
iajs-3485	160	4	.	.	PUNCT
iajs-3485	161	1	pharmacology	pharmacology	NOUN
iajs-3485	161	2	.	.	PUNCT
iajs-3485	162	1	2013	2013	NUM
iajs-3485	162	2	,	,	PUNCT
iajs-3485	162	3	268	268	NUM
iajs-3485	162	4	,	,	PUNCT
iajs-3485	162	5	149–156	149–156	NUM
iajs-3485	162	6	.	.	PUNCT
iajs-3485	163	1	doi	doi	NOUN
iajs-3485	163	2	:	:	PUNCT
iajs-3485	163	3	https://doi.org/10.1016/j.taap.2012.12.003	https://doi.org/10.1016/j.taap.2012.12.003	PROPN
iajs-3485	163	4	.	.	PROPN
iajs-3485	163	5	4	4	X
iajs-3485	163	6	.	.	X
iajs-3485	164	1	doroshow	doroshow	NOUN
iajs-3485	164	2	,	,	PUNCT
iajs-3485	164	3	j.h	j.h	PROPN
iajs-3485	164	4	.	.	PROPN
iajs-3485	164	5	role	role	NOUN
iajs-3485	164	6	of	of	ADP
iajs-3485	164	7	hydrogen	hydrogen	NOUN
iajs-3485	164	8	peroxide	peroxide	NOUN
iajs-3485	164	9	and	and	CCONJ
iajs-3485	164	10	hydroxyl	hydroxyl	NOUN
iajs-3485	164	11	radical	radical	ADJ
iajs-3485	164	12	formation	formation	NOUN
iajs-3485	164	13	in	in	ADP
iajs-3485	164	14	the	the	DET
iajs-3485	164	15	killing	killing	NOUN
iajs-3485	164	16	of	of	ADP
iajs-3485	164	17	ehrlich	ehrlich	NOUN
iajs-3485	164	18	tumor	tumor	NOUN
iajs-3485	164	19	cells	cell	NOUN
iajs-3485	164	20	by	by	ADP
iajs-3485	164	21	anticancer	anticancer	NOUN
iajs-3485	164	22	quinones	quinone	NOUN
iajs-3485	164	23	.	.	PUNCT
iajs-3485	165	1	proceedings	proceeding	NOUN
iajs-3485	165	2	of	of	ADP
iajs-3485	165	3	the	the	DET
iajs-3485	165	4	national	national	PROPN
iajs-3485	165	5	academy	academy	PROPN
iajs-3485	165	6	of	of	ADP
iajs-3485	165	7	sciences	sciences	PROPN
iajs-3485	165	8	.	.	PUNCT
iajs-3485	166	1	1986	1986	NUM
iajs-3485	166	2	,	,	PUNCT
iajs-3485	166	3	83(12	83(12	NUM
iajs-3485	166	4	)	)	PUNCT
iajs-3485	166	5	,	,	PUNCT
iajs-3485	166	6	4514–4518	4514–4518	NUM
iajs-3485	166	7	.	.	PUNCT
iajs-3485	166	8	doi	doi	NOUN
iajs-3485	166	9	:	:	PUNCT
iajs-3485	166	10	https://doi.org/10.1073/pnas.83.12.4514	https://doi.org/10.1073/pnas.83.12.4514	NOUN
iajs-3485	166	11	.	.	NOUN
iajs-3485	167	1	5	5	NUM
iajs-3485	167	2	.	.	X
iajs-3485	167	3	tewey	tewey	PROPN
iajs-3485	167	4	,	,	PUNCT
iajs-3485	167	5	k.m	k.m	PROPN
iajs-3485	167	6	.	.	PROPN
iajs-3485	167	7	;	;	PUNCT
iajs-3485	167	8	rowe	rowe	PROPN
iajs-3485	167	9	,	,	PUNCT
iajs-3485	167	10	t.c	t.c	PROPN
iajs-3485	167	11	.	.	PROPN
iajs-3485	167	12	;	;	PUNCT
iajs-3485	167	13	yang	yang	PROPN
iajs-3485	167	14	,	,	PUNCT
iajs-3485	167	15	l.	l.	PROPN
iajs-3485	167	16	;	;	PUNCT
iajs-3485	167	17	halligan	halligan	PROPN
iajs-3485	167	18	,	,	PUNCT
iajs-3485	167	19	b.d	b.d	PROPN
iajs-3485	167	20	.	.	PROPN
iajs-3485	167	21	;	;	PUNCT
iajs-3485	168	1	liu	liu	PROPN
iajs-3485	168	2	,	,	PUNCT
iajs-3485	168	3	l.-f	l.-f	NOUN
iajs-3485	168	4	.	.	PUNCT
iajs-3485	169	1	adriamycin	adriamycin	NOUN
iajs-3485	169	2	-	-	PUNCT
iajs-3485	169	3	induced	induce	VERB
iajs-3485	169	4	dna	dna	PROPN
iajs-3485	169	5	damage	damage	NOUN
iajs-3485	169	6	mediated	mediate	VERB
iajs-3485	169	7	by	by	ADP
iajs-3485	169	8	mammalian	mammalian	ADJ
iajs-3485	169	9	dna	dna	PROPN
iajs-3485	169	10	topoisomerase	topoisomerase	PROPN
iajs-3485	169	11	ii	ii	PROPN
iajs-3485	169	12	.	.	PUNCT
iajs-3485	170	1	science	science	PROPN
iajs-3485	170	2	.	.	PUNCT
iajs-3485	171	1	1984	1984	NUM
iajs-3485	171	2	,	,	PUNCT
iajs-3485	171	3	226	226	NUM
iajs-3485	171	4	,	,	PUNCT
iajs-3485	171	5	466–468	466–468	NUM
iajs-3485	171	6	.	.	PUNCT
iajs-3485	171	7	doi	doi	NOUN
iajs-3485	171	8	:	:	PUNCT
iajs-3485	171	9	https://doi.org/10.1126/science.6093249	https://doi.org/10.1126/science.6093249	NOUN
iajs-3485	171	10	.	.	PUNCT
iajs-3485	172	1	6	6	NUM
iajs-3485	172	2	.	.	X
iajs-3485	172	3	octavia	octavia	PROPN
iajs-3485	172	4	,	,	PUNCT
iajs-3485	172	5	y.	y.	PROPN
iajs-3485	172	6	,	,	PUNCT
iajs-3485	172	7	tocchetti	tocchetti	NOUN
iajs-3485	172	8	,	,	PUNCT
iajs-3485	172	9	c.g	c.g	PROPN
iajs-3485	172	10	.	.	PROPN
iajs-3485	172	11	,	,	PUNCT
iajs-3485	172	12	gabrielson	gabrielson	PROPN
iajs-3485	172	13	,	,	PUNCT
iajs-3485	172	14	k.l	k.l	PROPN
iajs-3485	172	15	.	.	PROPN
iajs-3485	172	16	,	,	PUNCT
iajs-3485	172	17	janssens	janssens	PROPN
iajs-3485	172	18	,	,	PUNCT
iajs-3485	172	19	s.	s.	PROPN
iajs-3485	172	20	,	,	PUNCT
iajs-3485	172	21	crijns	crijns	PROPN
iajs-3485	172	22	,	,	PUNCT
iajs-3485	172	23	h.j	h.j	PROPN
iajs-3485	172	24	.	.	PROPN
iajs-3485	172	25	and	and	CCONJ
iajs-3485	172	26	moens	moens	PROPN
iajs-3485	172	27	,	,	PUNCT
iajs-3485	172	28	a.l	a.l	PROPN
iajs-3485	172	29	.	.	PROPN
iajs-3485	172	30	doxorubicininduced	doxorubicininduce	VERB
iajs-3485	172	31	cardiomyopathy	cardiomyopathy	ADJ
iajs-3485	172	32	:	:	PUNCT
iajs-3485	172	33	from	from	ADP
iajs-3485	172	34	molecular	molecular	ADJ
iajs-3485	172	35	mechanisms	mechanism	NOUN
iajs-3485	172	36	to	to	ADP
iajs-3485	172	37	therapeutic	therapeutic	ADJ
iajs-3485	172	38	strategies	strategy	NOUN
iajs-3485	172	39	.	.	PUNCT
iajs-3485	173	1	journal	journal	NOUN
iajs-3485	173	2	of	of	ADP
iajs-3485	173	3	molecular	molecular	ADJ
iajs-3485	173	4	and	and	CCONJ
iajs-3485	173	5	cellular	cellular	ADJ
iajs-3485	173	6	cardiology	cardiology	NOUN
iajs-3485	173	7	2012	2012	NUM
iajs-3485	173	8	,	,	PUNCT
iajs-3485	173	9	52(6	52(6	NUM
iajs-3485	173	10	)	)	PUNCT
iajs-3485	173	11	,	,	PUNCT
iajs-3485	173	12	1213	1213	NUM
iajs-3485	173	13	-	-	SYM
iajs-3485	173	14	1225	1225	NUM
iajs-3485	173	15	.	.	PUNCT
iajs-3485	174	1	doi	doi	NOUN
iajs-3485	174	2	:	:	PUNCT
iajs-3485	174	3	https://doi.org/10.1016/j.yjmcc.2012.03.006	https://doi.org/10.1016/j.yjmcc.2012.03.006	NOUN
iajs-3485	174	4	.	.	PUNCT
iajs-3485	175	1	7	7	X
iajs-3485	175	2	.	.	X
iajs-3485	175	3	adımcılar	adımcılar	ADJ
iajs-3485	175	4	,	,	PUNCT
iajs-3485	175	5	v.	v.	PROPN
iajs-3485	175	6	;	;	PUNCT
iajs-3485	175	7	beyazit	beyazit	NOUN
iajs-3485	175	8	,	,	PUNCT
iajs-3485	175	9	n.	n.	NOUN
iajs-3485	175	10	;	;	PUNCT
iajs-3485	175	11	erim	erim	PROPN
iajs-3485	175	12	,	,	PUNCT
iajs-3485	175	13	f.b	f.b	PROPN
iajs-3485	175	14	.	.	PROPN
iajs-3485	175	15	khellin	khellin	PROPN
iajs-3485	175	16	and	and	CCONJ
iajs-3485	175	17	visnagin	visnagin	NOUN
iajs-3485	175	18	in	in	ADP
iajs-3485	175	19	different	different	ADJ
iajs-3485	175	20	organs	organ	NOUN
iajs-3485	175	21	of	of	ADP
iajs-3485	175	22	ammi	ammi	PROPN
iajs-3485	175	23	visnaga	visnaga	PROPN
iajs-3485	175	24	and	and	CCONJ
iajs-3485	175	25	ammi	ammi	PROPN
iajs-3485	175	26	majus	maju	NOUN
iajs-3485	175	27	.	.	PUNCT
iajs-3485	176	1	natural	natural	ADJ
iajs-3485	176	2	product	product	NOUN
iajs-3485	176	3	research	research	NOUN
iajs-3485	176	4	2023	2023	NUM
iajs-3485	176	5	,	,	PUNCT
iajs-3485	176	6	37(1	37(1	NUM
iajs-3485	176	7	)	)	PUNCT
iajs-3485	176	8	,	,	PUNCT
iajs-3485	176	9	164	164	NUM
iajs-3485	176	10	-	-	SYM
iajs-3485	176	11	166	166	NUM
iajs-3485	176	12	.	.	PUNCT
iajs-3485	177	1	doi	doi	NOUN
iajs-3485	177	2	:	:	PUNCT
iajs-3485	177	3	https://doi.org/10.1080/14786419.2021.1956924	https://doi.org/10.1080/14786419.2021.1956924	PROPN
iajs-3485	177	4	.	.	PROPN
iajs-3485	177	5	8	8	NUM
iajs-3485	177	6	.	.	X
iajs-3485	177	7	eisenreichoa	eisenreichoa	NOUN
iajs-3485	177	8	,	,	PUNCT
iajs-3485	177	9	e.	e.	PROPN
iajs-3485	177	10	;	;	PUNCT
iajs-3485	177	11	buckova	buckova	PROPN
iajs-3485	177	12	,	,	PUNCT
iajs-3485	177	13	l.	l.	PROPN
iajs-3485	177	14	;	;	PUNCT
iajs-3485	177	15	tomko	tomko	PROPN
iajs-3485	177	16	,	,	PUNCT
iajs-3485	177	17	j.	j.	PROPN
iajs-3485	177	18	contents	content	NOUN
iajs-3485	177	19	of	of	ADP
iajs-3485	177	20	ammi	ammi	PROPN
iajs-3485	177	21	majus	maju	NOUN
iajs-3485	177	22	l	l	PROPN
iajs-3485	177	23	substances	substance	NOUN
iajs-3485	177	24	.	.	PUNCT
iajs-3485	178	1	farm	farm	NOUN
iajs-3485	178	2	obz	obz	NOUN
iajs-3485	178	3	1980	1980	NUM
iajs-3485	178	4	,	,	PUNCT
iajs-3485	178	5	49	49	NUM
iajs-3485	178	6	.	.	PUNCT
iajs-3485	179	1	https://doi.org/10.5507/bp.2004.029	https://doi.org/10.5507/bp.2004.029	PROPN
iajs-3485	179	2	https://doi.org/10.1016/j.taap.2012.12.003	https://doi.org/10.1016/j.taap.2012.12.003	PROPN
iajs-3485	179	3	https://doi.org/10.1073/pnas.83.12.4514	https://doi.org/10.1073/pnas.83.12.4514	PART
iajs-3485	179	4	https://doi.org/10.1126/science.6093249	https://doi.org/10.1126/science.6093249	NOUN
iajs-3485	179	5	https://doi.org/10.1016/j.yjmcc.2012.03.006	https://doi.org/10.1016/j.yjmcc.2012.03.006	PROPN
iajs-3485	179	6	https://doi.org/10.1080/14786419.2021.1956924	https://doi.org/10.1080/14786419.2021.1956924	PROPN
iajs-3485	179	7	ihjpas	ihjpas	PROPN
iajs-3485	179	8	.	.	PUNCT
iajs-3485	180	1	2024	2024	NUM
iajs-3485	180	2	,	,	PUNCT
iajs-3485	180	3	37	37	NUM
iajs-3485	180	4	(	(	PUNCT
iajs-3485	180	5	3	3	NUM
iajs-3485	180	6	)	)	PUNCT
iajs-3485	180	7	133	133	NUM
iajs-3485	180	8	9	9	NUM
iajs-3485	180	9	.	.	PUNCT
iajs-3485	180	10	dar	dar	PROPN
iajs-3485	180	11	,	,	PUNCT
iajs-3485	180	12	a.a	a.a	PROPN
iajs-3485	180	13	.	.	PROPN
iajs-3485	180	14	;	;	PUNCT
iajs-3485	180	15	jamal	jamal	PROPN
iajs-3485	180	16	,	,	PUNCT
iajs-3485	180	17	k.	k.	PROPN
iajs-3485	180	18	evaluation	evaluation	NOUN
iajs-3485	180	19	of	of	ADP
iajs-3485	180	20	larvicidal	larvicidal	NOUN
iajs-3485	180	21	effects	effect	NOUN
iajs-3485	180	22	of	of	ADP
iajs-3485	180	23	aqueous	aqueous	ADJ
iajs-3485	180	24	leaf	leaf	NOUN
iajs-3485	180	25	and	and	CCONJ
iajs-3485	180	26	flower	flower	NOUN
iajs-3485	180	27	extracts	extract	NOUN
iajs-3485	180	28	of	of	ADP
iajs-3485	180	29	ammi	ammi	PROPN
iajs-3485	180	30	majus	maju	NOUN
iajs-3485	180	31	(	(	PUNCT
iajs-3485	180	32	linn	linn	PROPN
iajs-3485	180	33	.	.	PUNCT
iajs-3485	180	34	)	)	PUNCT
iajs-3485	181	1	on	on	ADP
iajs-3485	181	2	mosquito	mosquito	ADJ
iajs-3485	181	3	larvae	larvae	NOUN
iajs-3485	181	4	.	.	PUNCT
iajs-3485	182	1	munis	munis	PROPN
iajs-3485	182	2	entomol	entomol	PROPN
iajs-3485	182	3	.	.	PUNCT
iajs-3485	183	1	zoology	zoology	NOUN
iajs-3485	183	2	,	,	PUNCT
iajs-3485	183	3	2021	2021	NUM
iajs-3485	183	4	,	,	PUNCT
iajs-3485	183	5	16(2	16(2	NUM
iajs-3485	183	6	)	)	PUNCT
iajs-3485	183	7	,	,	PUNCT
iajs-3485	183	8	891–897	891–897	NUM
iajs-3485	183	9	.	.	PUNCT
iajs-3485	183	10	10	10	NUM
iajs-3485	183	11	.	.	PUNCT
iajs-3485	184	1	selim	selim	PROPN
iajs-3485	184	2	,	,	PUNCT
iajs-3485	184	3	y.a	y.a	PROPN
iajs-3485	184	4	.	.	PROPN
iajs-3485	184	5	;	;	PUNCT
iajs-3485	184	6	ouf	ouf	PROPN
iajs-3485	184	7	,	,	PUNCT
iajs-3485	184	8	n.h	n.h	PROPN
iajs-3485	184	9	.	.	PUNCT
iajs-3485	184	10	anti	anti	ADJ
iajs-3485	184	11	-	-	ADJ
iajs-3485	184	12	inflammatory	inflammatory	ADJ
iajs-3485	184	13	new	new	ADJ
iajs-3485	184	14	coumarin	coumarin	NOUN
iajs-3485	184	15	from	from	ADP
iajs-3485	184	16	the	the	DET
iajs-3485	184	17	ammi	ammi	PROPN
iajs-3485	184	18	majus	majus	PROPN
iajs-3485	184	19	l.	l.	PROPN
iajs-3485	184	20	org	org	PROPN
iajs-3485	184	21	.	.	PUNCT
iajs-3485	185	1	med	med	PROPN
iajs-3485	185	2	.	.	PROPN
iajs-3485	185	3	chem	chem	PROPN
iajs-3485	185	4	.	.	PUNCT
iajs-3485	186	1	lett	lett	PROPN
iajs-3485	186	2	.	.	PROPN
iajs-3485	186	3	2012	2012	NUM
iajs-3485	186	4	,	,	PUNCT
iajs-3485	186	5	2	2	NUM
iajs-3485	186	6	,	,	PUNCT
iajs-3485	186	7	1–4	1–4	PROPN
iajs-3485	186	8	.	.	PUNCT
iajs-3485	186	9	doi	doi	PROPN
iajs-3485	186	10	:	:	PUNCT
iajs-3485	186	11	https://doi.org/10.1186/2191-2858-2-1	https://doi.org/10.1186/2191-2858-2-1	PROPN
iajs-3485	186	12	.	.	PUNCT
iajs-3485	187	1	11	11	NUM
iajs-3485	187	2	.	.	X
iajs-3485	188	1	nayebi	nayebi	NOUN
iajs-3485	188	2	,	,	PUNCT
iajs-3485	188	3	s.	s.	PROPN
iajs-3485	188	4	;	;	PUNCT
iajs-3485	188	5	kakeshpour	kakeshpour	ADJ
iajs-3485	188	6	,	,	PUNCT
iajs-3485	188	7	t.	t.	PROPN
iajs-3485	188	8	;	;	PUNCT
iajs-3485	188	9	hasanvand	hasanvand	PROPN
iajs-3485	188	10	,	,	PUNCT
iajs-3485	188	11	a.	a.	NOUN
iajs-3485	188	12	;	;	PUNCT
iajs-3485	188	13	nadri	nadri	NOUN
iajs-3485	188	14	,	,	PUNCT
iajs-3485	188	15	m.	m.	NOUN
iajs-3485	188	16	;	;	PUNCT
iajs-3485	188	17	rashidi	rashidi	PROPN
iajs-3485	188	18	monfared	monfare	VERB
iajs-3485	188	19	,	,	PUNCT
iajs-3485	188	20	s.	s.	PROPN
iajs-3485	188	21	composition	composition	NOUN
iajs-3485	188	22	of	of	ADP
iajs-3485	188	23	volatile	volatile	ADJ
iajs-3485	188	24	compounds	compound	NOUN
iajs-3485	188	25	of	of	ADP
iajs-3485	188	26	extract	extract	NOUN
iajs-3485	188	27	of	of	ADP
iajs-3485	188	28	ammi	ammi	PROPN
iajs-3485	188	29	majus	maju	NOUN
iajs-3485	188	30	from	from	ADP
iajs-3485	188	31	iran	iran	PROPN
iajs-3485	188	32	by	by	ADP
iajs-3485	188	33	gc	gc	PROPN
iajs-3485	188	34	-	-	PUNCT
iajs-3485	188	35	ms	ms	PROPN
iajs-3485	188	36	.	.	PROPN
iajs-3485	188	37	journal	journal	PROPN
iajs-3485	188	38	of	of	ADP
iajs-3485	188	39	sciences	sciences	PROPN
iajs-3485	188	40	,	,	PUNCT
iajs-3485	188	41	islamic	islamic	PROPN
iajs-3485	188	42	republic	republic	NOUN
iajs-3485	188	43	of	of	ADP
iajs-3485	188	44	iran	iran	PROPN
iajs-3485	188	45	2013	2013	NUM
iajs-3485	188	46	,	,	PUNCT
iajs-3485	188	47	24(2	24(2	NUM
iajs-3485	188	48	)	)	PUNCT
iajs-3485	188	49	,	,	PUNCT
iajs-3485	188	50	335–338	335–338	NUM
iajs-3485	188	51	.	.	PUNCT
iajs-3485	189	1	12	12	NUM
iajs-3485	189	2	.	.	PUNCT
iajs-3485	190	1	hilal	hilal	PROPN
iajs-3485	190	2	,	,	PUNCT
iajs-3485	190	3	s.h	s.h	PROPN
iajs-3485	190	4	.	.	PROPN
iajs-3485	190	5	;	;	PUNCT
iajs-3485	190	6	haggag	haggag	PROPN
iajs-3485	190	7	,	,	PUNCT
iajs-3485	190	8	m.y	m.y	PROPN
iajs-3485	190	9	.	.	PROPN
iajs-3485	190	10	a	a	DET
iajs-3485	190	11	thin	thin	ADJ
iajs-3485	190	12	-	-	PUNCT
iajs-3485	190	13	layer	layer	NOUN
iajs-3485	190	14	chromatography	chromatography	NOUN
iajs-3485	190	15	(	(	PUNCT
iajs-3485	190	16	tlc	tlc	NOUN
iajs-3485	190	17	)	)	PUNCT
iajs-3485	190	18	colorimetric	colorimetric	ADJ
iajs-3485	190	19	assay	assay	NOUN
iajs-3485	190	20	of	of	ADP
iajs-3485	190	21	furocoumarins	furocoumarin	NOUN
iajs-3485	190	22	.	.	PUNCT
iajs-3485	191	1	egypt	egypt	PROPN
iajs-3485	191	2	j.	j.	PROPN
iajs-3485	191	3	pharm	pharm	PROPN
iajs-3485	191	4	sci	sci	PROPN
iajs-3485	191	5	.	.	PROPN
iajs-3485	191	6	1975	1975	NUM
iajs-3485	191	7	,	,	PUNCT
iajs-3485	191	8	16	16	NUM
iajs-3485	191	9	,	,	PUNCT
iajs-3485	191	10	495–499	495–499	NUM
iajs-3485	191	11	.	.	PUNCT
iajs-3485	192	1	doi	doi	NOUN
iajs-3485	192	2	:	:	PUNCT
iajs-3485	192	3	https://doi.org/10.1007/bf02268780	https://doi.org/10.1007/bf02268780	ADJ
iajs-3485	192	4	.	.	NOUN
iajs-3485	192	5	13	13	NUM
iajs-3485	192	6	.	.	X
iajs-3485	193	1	elgamal	elgamal	ADJ
iajs-3485	193	2	,	,	PUNCT
iajs-3485	193	3	m.h.a	m.h.a	NOUN
iajs-3485	193	4	.	.	PUNCT
iajs-3485	193	5	;	;	PUNCT
iajs-3485	193	6	shalaby	shalaby	NOUN
iajs-3485	193	7	,	,	PUNCT
iajs-3485	193	8	n.m.m	n.m.m	NOUN
iajs-3485	193	9	.	.	PROPN
iajs-3485	193	10	;	;	PUNCT
iajs-3485	194	1	duddeck	duddeck	PROPN
iajs-3485	194	2	,	,	PUNCT
iajs-3485	194	3	h.	h.	PROPN
iajs-3485	194	4	;	;	PUNCT
iajs-3485	194	5	hiegemann	hiegemann	PROPN
iajs-3485	194	6	,	,	PUNCT
iajs-3485	194	7	m.	m.	NOUN
iajs-3485	194	8	coumarins	coumarin	NOUN
iajs-3485	194	9	and	and	CCONJ
iajs-3485	194	10	coumarin	coumarin	NOUN
iajs-3485	194	11	glucosides	glucoside	VERB
iajs-3485	194	12	from	from	ADP
iajs-3485	194	13	the	the	DET
iajs-3485	194	14	fruits	fruit	NOUN
iajs-3485	194	15	of	of	ADP
iajs-3485	194	16	ammi	ammi	PROPN
iajs-3485	194	17	majus	maju	NOUN
iajs-3485	194	18	.	.	PUNCT
iajs-3485	195	1	phytochemistry	phytochemistry	NOUN
iajs-3485	195	2	1993	1993	NUM
iajs-3485	195	3	,	,	PUNCT
iajs-3485	195	4	34	34	NUM
iajs-3485	195	5	,	,	PUNCT
iajs-3485	195	6	819–823	819–823	NUM
iajs-3485	195	7	.	.	PUNCT
iajs-3485	195	8	doi	doi	NOUN
iajs-3485	195	9	:	:	PUNCT
iajs-3485	195	10	https://doi.org/10.1016/0031-9422(93)85365-x	https://doi.org/10.1016/0031-9422(93)85365-x	PROPN
iajs-3485	195	11	.	.	PUNCT
iajs-3485	196	1	14	14	NUM
iajs-3485	196	2	.	.	X
iajs-3485	197	1	arab	arab	PROPN
iajs-3485	197	2	,	,	PUNCT
iajs-3485	197	3	s.t	s.t	PROPN
iajs-3485	197	4	.	.	PROPN
iajs-3485	197	5	;	;	PUNCT
iajs-3485	197	6	al	al	PROPN
iajs-3485	197	7	-	-	PUNCT
iajs-3485	197	8	nami	nami	PROPN
iajs-3485	197	9	,	,	PUNCT
iajs-3485	197	10	s.y	s.y	PROPN
iajs-3485	197	11	.	.	PROPN
iajs-3485	197	12	;	;	PUNCT
iajs-3485	198	1	abu	abu	PROPN
iajs-3485	198	2	–	–	PUNCT
iajs-3485	198	3	mustafa	mustafa	PROPN
iajs-3485	198	4	,	,	PUNCT
iajs-3485	198	5	e.a	e.a	PROPN
iajs-3485	198	6	.	.	PROPN
iajs-3485	198	7	chemical	chemical	PROPN
iajs-3485	198	8	composition	composition	NOUN
iajs-3485	198	9	of	of	ADP
iajs-3485	198	10	ammi	ammi	PROPN
iajs-3485	198	11	majus	majus	PROPN
iajs-3485	198	12	l.	l.	PROPN
iajs-3485	198	13	and	and	CCONJ
iajs-3485	198	14	its	its	PRON
iajs-3485	198	15	inhibition	inhibition	NOUN
iajs-3485	198	16	activity	activity	NOUN
iajs-3485	198	17	against	against	ADP
iajs-3485	198	18	corrosion	corrosion	NOUN
iajs-3485	198	19	.	.	PUNCT
iajs-3485	199	1	egyptian	egyptian	ADJ
iajs-3485	199	2	journal	journal	PROPN
iajs-3485	199	3	of	of	ADP
iajs-3485	199	4	chemistry	chemistry	NOUN
iajs-3485	199	5	.	.	PUNCT
iajs-3485	200	1	2008	2008	NUM
iajs-3485	200	2	,	,	PUNCT
iajs-3485	200	3	51	51	NUM
iajs-3485	200	4	(	(	PUNCT
iajs-3485	200	5	special	special	ADJ
iajs-3485	200	6	issue	issue	NOUN
iajs-3485	200	7	)	)	PUNCT
iajs-3485	200	8	,	,	PUNCT
iajs-3485	200	9	115	115	NUM
iajs-3485	200	10	–	–	PUNCT
iajs-3485	200	11	128	128	NUM
iajs-3485	200	12	.	.	NOUN
iajs-3485	200	13	15	15	NUM
iajs-3485	200	14	.	.	PUNCT
iajs-3485	201	1	jain	jain	PROPN
iajs-3485	201	2	,	,	PUNCT
iajs-3485	201	3	p.k	p.k	PROPN
iajs-3485	201	4	.	.	PROPN
iajs-3485	201	5	;	;	PUNCT
iajs-3485	201	6	joshi	joshi	PROPN
iajs-3485	201	7	,	,	PUNCT
iajs-3485	201	8	h.	h.	PROPN
iajs-3485	201	9	coumarin	coumarin	PROPN
iajs-3485	201	10	:	:	PUNCT
iajs-3485	201	11	chemical	chemical	NOUN
iajs-3485	201	12	and	and	CCONJ
iajs-3485	201	13	pharmacological	pharmacological	ADJ
iajs-3485	201	14	profile	profile	NOUN
iajs-3485	201	15	.	.	PUNCT
iajs-3485	202	1	journal	journal	NOUN
iajs-3485	202	2	of	of	ADP
iajs-3485	202	3	applied	apply	VERB
iajs-3485	202	4	pharmaceutical	pharmaceutical	ADJ
iajs-3485	202	5	science	science	NOUN
iajs-3485	202	6	.	.	PUNCT
iajs-3485	203	1	2012	2012	NUM
iajs-3485	203	2	,	,	PUNCT
iajs-3485	203	3	236–240	236–240	NUM
iajs-3485	203	4	.	.	PUNCT
iajs-3485	204	1	doi	doi	NOUN
iajs-3485	204	2	:	:	PUNCT
iajs-3485	204	3	https://doi.org/10.7324/japs.2012.2643	https://doi.org/10.7324/japs.2012.2643	PROPN
iajs-3485	204	4	.	.	PROPN
iajs-3485	205	1	16	16	NUM
iajs-3485	205	2	.	.	PUNCT
iajs-3485	205	3	deng	deng	PROPN
iajs-3485	205	4	,	,	PUNCT
iajs-3485	205	5	m.	m.	NOUN
iajs-3485	205	6	;	;	PUNCT
iajs-3485	205	7	xie	xie	PROPN
iajs-3485	205	8	,	,	PUNCT
iajs-3485	205	9	l.	l.	PROPN
iajs-3485	205	10	;	;	PUNCT
iajs-3485	205	11	zhong	zhong	PROPN
iajs-3485	205	12	,	,	PUNCT
iajs-3485	205	13	l.	l.	PROPN
iajs-3485	205	14	;	;	PUNCT
iajs-3485	205	15	liao	liao	PROPN
iajs-3485	205	16	,	,	PUNCT
iajs-3485	205	17	y.	y.	PROPN
iajs-3485	205	18	;	;	PUNCT
iajs-3485	205	19	liu	liu	PROPN
iajs-3485	205	20	,	,	PUNCT
iajs-3485	205	21	l.	l.	PROPN
iajs-3485	205	22	;	;	PUNCT
iajs-3485	205	23	li	li	PROPN
iajs-3485	205	24	,	,	PUNCT
iajs-3485	205	25	x.	x.	PROPN
iajs-3485	205	26	imperatorin	imperatorin	PROPN
iajs-3485	205	27	:	:	PUNCT
iajs-3485	205	28	a	a	DET
iajs-3485	205	29	review	review	NOUN
iajs-3485	205	30	of	of	ADP
iajs-3485	205	31	its	its	PRON
iajs-3485	205	32	pharmacology	pharmacology	NOUN
iajs-3485	205	33	,	,	PUNCT
iajs-3485	205	34	toxicity	toxicity	NOUN
iajs-3485	205	35	and	and	CCONJ
iajs-3485	205	36	pharmacokinetics	pharmacokinetic	NOUN
iajs-3485	205	37	.	.	PUNCT
iajs-3485	206	1	european	european	ADJ
iajs-3485	206	2	journal	journal	PROPN
iajs-3485	206	3	of	of	ADP
iajs-3485	206	4	pharmacology	pharmacology	NOUN
iajs-3485	206	5	.	.	PUNCT
iajs-3485	207	1	2020	2020	NUM
iajs-3485	207	2	,	,	PUNCT
iajs-3485	207	3	879	879	NUM
iajs-3485	207	4	,	,	PUNCT
iajs-3485	207	5	173124	173124	NUM
iajs-3485	207	6	.	.	PUNCT
iajs-3485	208	1	doi	doi	NOUN
iajs-3485	208	2	:	:	PUNCT
iajs-3485	208	3	https://doi.org/10.1016/j.ejphar.2020.173124	https://doi.org/10.1016/j.ejphar.2020.173124	NOUN
iajs-3485	208	4	.	.	PUNCT
iajs-3485	209	1	17	17	NUM
iajs-3485	209	2	.	.	PUNCT
iajs-3485	210	1	chen	chen	PROPN
iajs-3485	210	2	,	,	PUNCT
iajs-3485	210	3	g.	g.	PROPN
iajs-3485	210	4	;	;	PUNCT
iajs-3485	210	5	liu	liu	PROPN
iajs-3485	210	6	,	,	PUNCT
iajs-3485	210	7	y.	y.	PROPN
iajs-3485	210	8	;	;	PUNCT
iajs-3485	210	9	xu	xu	INTJ
iajs-3485	210	10	,	,	PUNCT
iajs-3485	210	11	y.	y.	PROPN
iajs-3485	210	12	;	;	PUNCT
iajs-3485	210	13	zhang	zhang	PROPN
iajs-3485	210	14	,	,	PUNCT
iajs-3485	210	15	m.	m.	NOUN
iajs-3485	210	16	;	;	PUNCT
iajs-3485	210	17	guo	guo	PROPN
iajs-3485	210	18	,	,	PUNCT
iajs-3485	210	19	s.	s.	PROPN
iajs-3485	210	20	;	;	PUNCT
iajs-3485	210	21	zhang	zhang	PROPN
iajs-3485	210	22	,	,	PUNCT
iajs-3485	210	23	g.	g.	PROPN
iajs-3485	210	24	isoimperatorin	isoimperatorin	PROPN
iajs-3485	210	25	exerts	exert	VERB
iajs-3485	210	26	anti	anti	ADJ
iajs-3485	210	27	-	-	ADJ
iajs-3485	210	28	inflammatory	inflammatory	ADJ
iajs-3485	210	29	activity	activity	NOUN
iajs-3485	210	30	by	by	ADP
iajs-3485	210	31	targeting	target	VERB
iajs-3485	210	32	the	the	DET
iajs-3485	210	33	lps	lps	PROPN
iajs-3485	210	34	-	-	PUNCT
iajs-3485	210	35	tlr4	tlr4	NOUN
iajs-3485	210	36	/	/	SYM
iajs-3485	210	37	md-2	md-2	NOUN
iajs-3485	210	38	-	-	PUNCT
iajs-3485	210	39	nf	nf	NOUN
iajs-3485	210	40	-	-	PUNCT
iajs-3485	210	41	κb	κb	NOUN
iajs-3485	210	42	pathway	pathway	NOUN
iajs-3485	210	43	.	.	PUNCT
iajs-3485	211	1	european	european	ADJ
iajs-3485	211	2	journal	journal	PROPN
iajs-3485	211	3	of	of	ADP
iajs-3485	211	4	inflammation	inflammation	NOUN
iajs-3485	211	5	.	.	PUNCT
iajs-3485	212	1	2021	2021	NUM
iajs-3485	212	2	,	,	PUNCT
iajs-3485	212	3	19	19	NUM
iajs-3485	212	4	.	.	PUNCT
iajs-3485	213	1	https://doi.org/10.1177/20587392211000573	https://doi.org/10.1177/20587392211000573	NOUN
iajs-3485	213	2	.	.	PUNCT
iajs-3485	213	3	18	18	NUM
iajs-3485	213	4	.	.	PUNCT
iajs-3485	214	1	laing	laing	PROPN
iajs-3485	214	2	,	,	PUNCT
iajs-3485	214	3	t.j	t.j	PROPN
iajs-3485	214	4	.	.	PROPN
iajs-3485	214	5	;	;	PUNCT
iajs-3485	214	6	richardson	richardson	PROPN
iajs-3485	214	7	,	,	PUNCT
iajs-3485	214	8	b.c	b.c	PROPN
iajs-3485	214	9	.	.	PROPN
iajs-3485	214	10	;	;	PUNCT
iajs-3485	214	11	toth	toth	PROPN
iajs-3485	214	12	,	,	PUNCT
iajs-3485	214	13	m.b	m.b	PROPN
iajs-3485	214	14	.	.	PROPN
iajs-3485	214	15	;	;	PUNCT
iajs-3485	214	16	smith	smith	PROPN
iajs-3485	214	17	,	,	PUNCT
iajs-3485	214	18	e.m	e.m	PROPN
iajs-3485	214	19	.	.	PROPN
iajs-3485	214	20	;	;	PUNCT
iajs-3485	214	21	marks	mark	NOUN
iajs-3485	214	22	,	,	PUNCT
iajs-3485	214	23	r.m	r.m	PROPN
iajs-3485	214	24	.	.	PROPN
iajs-3485	214	25	ultraviolet	ultraviolet	PROPN
iajs-3485	214	26	light	light	NOUN
iajs-3485	214	27	and	and	CCONJ
iajs-3485	214	28	8methoxypsoralen	8methoxypsoralen	NUM
iajs-3485	214	29	inhibit	inhibit	NOUN
iajs-3485	214	30	expression	expression	NOUN
iajs-3485	214	31	of	of	ADP
iajs-3485	214	32	endothelial	endothelial	ADJ
iajs-3485	214	33	adhesion	adhesion	NOUN
iajs-3485	214	34	molecules	molecule	NOUN
iajs-3485	214	35	.	.	PUNCT
iajs-3485	215	1	the	the	DET
iajs-3485	215	2	journal	journal	NOUN
iajs-3485	215	3	of	of	ADP
iajs-3485	215	4	rheumatology	rheumatology	NOUN
iajs-3485	215	5	.	.	PUNCT
iajs-3485	216	1	1995	1995	NUM
iajs-3485	216	2	,	,	PUNCT
iajs-3485	216	3	22(11	22(11	NUM
iajs-3485	216	4	)	)	PUNCT
iajs-3485	216	5	,	,	PUNCT
iajs-3485	216	6	2126–2131	2126–2131	NUM
iajs-3485	216	7	.	.	PUNCT
iajs-3485	217	1	19	19	NUM
iajs-3485	217	2	.	.	PUNCT
iajs-3485	218	1	al	al	PROPN
iajs-3485	218	2	-	-	PUNCT
iajs-3485	218	3	snafi	snafi	PROPN
iajs-3485	218	4	,	,	PUNCT
iajs-3485	218	5	a.e	a.e	PROPN
iajs-3485	218	6	.	.	PROPN
iajs-3485	218	7	chemical	chemical	NOUN
iajs-3485	218	8	constituents	constituent	NOUN
iajs-3485	218	9	and	and	CCONJ
iajs-3485	218	10	pharmacological	pharmacological	ADJ
iajs-3485	218	11	activities	activity	NOUN
iajs-3485	218	12	of	of	ADP
iajs-3485	218	13	ammi	ammi	PROPN
iajs-3485	218	14	majus	maju	NOUN
iajs-3485	218	15	and	and	CCONJ
iajs-3485	218	16	ammi	ammi	PROPN
iajs-3485	218	17	visnaga	visnaga	PROPN
iajs-3485	218	18	.	.	PUNCT
iajs-3485	219	1	a	a	DET
iajs-3485	219	2	review	review	NOUN
iajs-3485	219	3	.	.	PUNCT
iajs-3485	220	1	international	international	ADJ
iajs-3485	220	2	journal	journal	PROPN
iajs-3485	220	3	of	of	ADP
iajs-3485	220	4	pharmacy	pharmacy	NOUN
iajs-3485	220	5	and	and	CCONJ
iajs-3485	220	6	industrial	industrial	ADJ
iajs-3485	220	7	research	research	NOUN
iajs-3485	220	8	.	.	PUNCT
iajs-3485	221	1	2013	2013	NUM
iajs-3485	221	2	,	,	PUNCT
iajs-3485	221	3	3(3	3(3	NUM
iajs-3485	221	4	)	)	PUNCT
iajs-3485	221	5	,	,	PUNCT
iajs-3485	221	6	257–265	257–265	NUM
iajs-3485	221	7	.	.	NOUN
iajs-3485	222	1	20	20	NUM
iajs-3485	222	2	.	.	PUNCT
iajs-3485	222	3	wu	wu	PROPN
iajs-3485	222	4	,	,	PUNCT
iajs-3485	222	5	c.	c.	PROPN
iajs-3485	222	6	;	;	PUNCT
iajs-3485	222	7	lan	lan	PROPN
iajs-3485	222	8	,	,	PUNCT
iajs-3485	222	9	c.	c.	PROPN
iajs-3485	222	10	;	;	PUNCT
iajs-3485	222	11	wang	wang	PROPN
iajs-3485	222	12	,	,	PUNCT
iajs-3485	222	13	l.	l.	PROPN
iajs-3485	222	14	;	;	PUNCT
iajs-3485	222	15	chen	chen	PROPN
iajs-3485	222	16	,	,	PUNCT
iajs-3485	222	17	g.	g.	PROPN
iajs-3485	222	18	;	;	PUNCT
iajs-3485	222	19	wu	wu	PROPN
iajs-3485	222	20	,	,	PUNCT
iajs-3485	222	21	c.	c.	PROPN
iajs-3485	222	22	;	;	PUNCT
iajs-3485	222	23	yu	yu	PROPN
iajs-3485	222	24	,	,	PUNCT
iajs-3485	222	25	h.	h.	PROPN
iajs-3485	222	26	effects	effect	NOUN
iajs-3485	222	27	of	of	ADP
iajs-3485	222	28	psoralen	psoralen	NOUN
iajs-3485	222	29	plus	plus	CCONJ
iajs-3485	222	30	ultraviolet	ultraviolet	ADJ
iajs-3485	222	31	a	a	DET
iajs-3485	222	32	irradiation	irradiation	NOUN
iajs-3485	222	33	on	on	ADP
iajs-3485	222	34	cultured	cultured	ADJ
iajs-3485	222	35	epidermal	epidermal	ADJ
iajs-3485	222	36	cells	cell	NOUN
iajs-3485	222	37	in	in	ADP
iajs-3485	222	38	vitro	vitro	X
iajs-3485	222	39	and	and	CCONJ
iajs-3485	222	40	patients	patient	NOUN
iajs-3485	222	41	with	with	ADP
iajs-3485	222	42	vitiligo	vitiligo	NOUN
iajs-3485	222	43	in	in	ADP
iajs-3485	222	44	vivo	vivo	NOUN
iajs-3485	222	45	.	.	PUNCT
iajs-3485	223	1	british	british	ADJ
iajs-3485	223	2	journal	journal	PROPN
iajs-3485	223	3	of	of	ADP
iajs-3485	223	4	dermatology	dermatology	NOUN
iajs-3485	223	5	.	.	PUNCT
iajs-3485	224	1	2007	2007	NUM
iajs-3485	224	2	,	,	PUNCT
iajs-3485	224	3	156(1	156(1	NUM
iajs-3485	224	4	)	)	PUNCT
iajs-3485	224	5	,	,	PUNCT
iajs-3485	224	6	122–129	122–129	NUM
iajs-3485	224	7	.	.	PUNCT
iajs-3485	225	1	doi	doi	NOUN
iajs-3485	225	2	:	:	PUNCT
iajs-3485	225	3	https://doi.org/10.1111/j.1365-2133.2006.07584.x	https://doi.org/10.1111/j.1365-2133.2006.07584.x	NOUN
iajs-3485	225	4	.	.	PUNCT
iajs-3485	226	1	21	21	NUM
iajs-3485	226	2	.	.	X
iajs-3485	226	3	mutlag	mutlag	PROPN
iajs-3485	226	4	,	,	PUNCT
iajs-3485	226	5	s.h	s.h	PROPN
iajs-3485	226	6	.	.	PROPN
iajs-3485	226	7	dose	dose	VERB
iajs-3485	226	8	dependent	dependent	ADJ
iajs-3485	226	9	anti	anti	ADJ
iajs-3485	226	10	-	-	ADJ
iajs-3485	226	11	inflammatory	inflammatory	ADJ
iajs-3485	226	12	effect	effect	NOUN
iajs-3485	226	13	of	of	ADP
iajs-3485	226	14	ammi	ammi	PROPN
iajs-3485	226	15	majus	majus	ADJ
iajs-3485	226	16	alcoholic	alcoholic	ADJ
iajs-3485	226	17	extract	extract	NOUN
iajs-3485	226	18	in	in	ADP
iajs-3485	226	19	rat	rat	NOUN
iajs-3485	226	20	:	:	PUNCT
iajs-3485	226	21	chronic	chronic	ADJ
iajs-3485	226	22	study	study	NOUN
iajs-3485	226	23	.	.	PUNCT
iajs-3485	227	1	iraqi	iraqi	ADJ
iajs-3485	227	2	journal	journal	PROPN
iajs-3485	227	3	of	of	ADP
iajs-3485	227	4	pharmaceutical	pharmaceutical	NOUN
iajs-3485	227	5	sciences	science	NOUN
iajs-3485	227	6	.	.	PUNCT
iajs-3485	227	7	2012	2012	NUM
iajs-3485	227	8	,	,	PUNCT
iajs-3485	227	9	21(1	21(1	NUM
iajs-3485	227	10	)	)	PUNCT
iajs-3485	227	11	,	,	PUNCT
iajs-3485	227	12	82–86.doi	82–86.doi	NUM
iajs-3485	227	13	:	:	PUNCT
iajs-3485	227	14	https://doi.org/10.31351/vol21iss1pp82-86	https://doi.org/10.31351/vol21iss1pp82-86	PROPN
iajs-3485	227	15	.	.	PROPN
iajs-3485	228	1	22	22	NUM
iajs-3485	228	2	.	.	PUNCT
iajs-3485	229	1	hussein	hussein	PROPN
iajs-3485	229	2	,	,	PUNCT
iajs-3485	229	3	h.m	h.m	PROPN
iajs-3485	229	4	.	.	PROPN
iajs-3485	229	5	;	;	PUNCT
iajs-3485	229	6	hameed	hameed	PROPN
iajs-3485	229	7	,	,	PUNCT
iajs-3485	229	8	i.h	i.h	PROPN
iajs-3485	229	9	.	.	PROPN
iajs-3485	229	10	;	;	PUNCT
iajs-3485	229	11	ubaid	ubaid	PROPN
iajs-3485	229	12	,	,	PUNCT
iajs-3485	229	13	j.m	j.m	PROPN
iajs-3485	229	14	.	.	NOUN
iajs-3485	229	15	analysis	analysis	NOUN
iajs-3485	229	16	of	of	ADP
iajs-3485	229	17	the	the	DET
iajs-3485	229	18	secondary	secondary	ADJ
iajs-3485	229	19	metabolite	metabolite	NOUN
iajs-3485	229	20	products	product	NOUN
iajs-3485	229	21	of	of	ADP
iajs-3485	229	22	ammi	ammi	PROPN
iajs-3485	229	23	majus	maju	NOUN
iajs-3485	229	24	and	and	CCONJ
iajs-3485	229	25	evaluation	evaluation	NOUN
iajs-3485	229	26	anti	anti	ADJ
iajs-3485	229	27	-	-	ADJ
iajs-3485	229	28	insect	insect	ADJ
iajs-3485	229	29	activity	activity	NOUN
iajs-3485	229	30	.	.	PUNCT
iajs-3485	230	1	international	international	ADJ
iajs-3485	230	2	journal	journal	PROPN
iajs-3485	230	3	of	of	ADP
iajs-3485	230	4	pharmacognosy	pharmacognosy	NOUN
iajs-3485	230	5	and	and	CCONJ
iajs-3485	230	6	phytochemical	phytochemical	ADJ
iajs-3485	230	7	research	research	NOUN
iajs-3485	230	8	2016	2016	NUM
iajs-3485	230	9	,	,	PUNCT
iajs-3485	230	10	8(8	8(8	NUM
iajs-3485	230	11	)	)	PUNCT
iajs-3485	230	12	,	,	PUNCT
iajs-3485	230	13	1403	1403	NUM
iajs-3485	230	14	-	-	SYM
iajs-3485	230	15	1411	1411	NUM
iajs-3485	230	16	.	.	PUNCT
iajs-3485	231	1	23	23	NUM
iajs-3485	231	2	.	.	X
iajs-3485	231	3	falabella	falabella	PROPN
iajs-3485	231	4	,	,	PUNCT
iajs-3485	231	5	r.	r.	PROPN
iajs-3485	231	6	;	;	PUNCT
iajs-3485	231	7	barona	barona	PROPN
iajs-3485	231	8	,	,	PUNCT
iajs-3485	231	9	m.i	m.i	PROPN
iajs-3485	231	10	.	.	PROPN
iajs-3485	231	11	update	update	NOUN
iajs-3485	231	12	on	on	ADP
iajs-3485	231	13	skin	skin	NOUN
iajs-3485	231	14	repigmentation	repigmentation	NOUN
iajs-3485	231	15	therapies	therapy	NOUN
iajs-3485	231	16	in	in	ADP
iajs-3485	231	17	vitiligo	vitiligo	PROPN
iajs-3485	231	18	.	.	PUNCT
iajs-3485	232	1	pigment	pigment	ADJ
iajs-3485	232	2	cell	cell	NOUN
iajs-3485	232	3	melanoma	melanoma	NOUN
iajs-3485	232	4	res	re	NOUN
iajs-3485	232	5	.	.	PUNCT
iajs-3485	232	6	2009	2009	NUM
iajs-3485	232	7	,	,	PUNCT
iajs-3485	232	8	22	22	NUM
iajs-3485	232	9	,	,	PUNCT
iajs-3485	232	10	42–65	42–65	NUM
iajs-3485	232	11	.	.	PUNCT
iajs-3485	233	1	doi	doi	NOUN
iajs-3485	233	2	:	:	PUNCT
iajs-3485	233	3	https://doi.org/10.1111/j.1755-148x.2008.00528.x	https://doi.org/10.1111/j.1755-148x.2008.00528.x	NOUN
iajs-3485	233	4	.	.	PUNCT
iajs-3485	234	1	24	24	NUM
iajs-3485	234	2	.	.	PUNCT
iajs-3485	235	1	el	el	PROPN
iajs-3485	235	2	mofty	mofty	PROPN
iajs-3485	235	3	,	,	PUNCT
iajs-3485	235	4	a.m.	a.m.	PROPN
iajs-3485	236	1	a	a	DET
iajs-3485	236	2	preliminary	preliminary	ADJ
iajs-3485	236	3	clinical	clinical	ADJ
iajs-3485	236	4	report	report	NOUN
iajs-3485	236	5	on	on	ADP
iajs-3485	236	6	the	the	DET
iajs-3485	236	7	treatment	treatment	NOUN
iajs-3485	236	8	of	of	ADP
iajs-3485	236	9	leucodermia	leucodermia	NOUN
iajs-3485	236	10	with	with	ADP
iajs-3485	236	11	ammi	ammi	PROPN
iajs-3485	236	12	majus	majus	PROPN
iajs-3485	236	13	linn	linn	PROPN
iajs-3485	236	14	.	.	PUNCT
iajs-3485	237	1	the	the	DET
iajs-3485	237	2	journal	journal	NOUN
iajs-3485	237	3	of	of	ADP
iajs-3485	237	4	the	the	DET
iajs-3485	237	5	egyptian	egyptian	PROPN
iajs-3485	237	6	medical	medical	PROPN
iajs-3485	237	7	association	association	PROPN
iajs-3485	237	8	.	.	PUNCT
iajs-3485	238	1	1948	1948	NUM
iajs-3485	238	2	,	,	PUNCT
iajs-3485	238	3	31(8	31(8	NUM
iajs-3485	238	4	)	)	PUNCT
iajs-3485	238	5	,	,	PUNCT
iajs-3485	238	6	651–665	651–665	NUM
iajs-3485	238	7	.	.	PUNCT
iajs-3485	239	1	25	25	NUM
iajs-3485	239	2	.	.	PUNCT
iajs-3485	240	1	al	al	PROPN
iajs-3485	240	2	akeel	akeel	PROPN
iajs-3485	240	3	,	,	PUNCT
iajs-3485	240	4	r.	r.	PROPN
iajs-3485	240	5	;	;	PUNCT
iajs-3485	240	6	al	al	PROPN
iajs-3485	240	7	-	-	PUNCT
iajs-3485	240	8	sheikh	sheikh	PROPN
iajs-3485	240	9	,	,	PUNCT
iajs-3485	240	10	y.	y.	PROPN
iajs-3485	240	11	;	;	PUNCT
iajs-3485	240	12	mateen	mateen	PROPN
iajs-3485	240	13	,	,	PUNCT
iajs-3485	240	14	a.	a.	NOUN
iajs-3485	240	15	;	;	PUNCT
iajs-3485	240	16	syed	sye	VERB
iajs-3485	240	17	,	,	PUNCT
iajs-3485	240	18	r.	r.	PROPN
iajs-3485	240	19	;	;	PUNCT
iajs-3485	240	20	janardhan	janardhan	PROPN
iajs-3485	240	21	,	,	PUNCT
iajs-3485	240	22	k.	k.	PROPN
iajs-3485	240	23	;	;	PUNCT
iajs-3485	240	24	gupta	gupta	PROPN
iajs-3485	240	25	,	,	PUNCT
iajs-3485	240	26	v.c	v.c	PROPN
iajs-3485	240	27	.	.	PROPN
iajs-3485	240	28	evaluation	evaluation	NOUN
iajs-3485	240	29	of	of	ADP
iajs-3485	240	30	antibacterial	antibacterial	ADJ
iajs-3485	240	31	activity	activity	NOUN
iajs-3485	240	32	of	of	ADP
iajs-3485	240	33	crude	crude	ADJ
iajs-3485	240	34	protein	protein	NOUN
iajs-3485	240	35	extracts	extract	NOUN
iajs-3485	240	36	from	from	ADP
iajs-3485	240	37	seeds	seed	NOUN
iajs-3485	240	38	of	of	ADP
iajs-3485	240	39	six	six	NUM
iajs-3485	240	40	different	different	ADJ
iajs-3485	240	41	medical	medical	ADJ
iajs-3485	240	42	plants	plant	NOUN
iajs-3485	240	43	against	against	ADP
iajs-3485	240	44	standard	standard	ADJ
iajs-3485	240	45	bacterial	bacterial	ADJ
iajs-3485	240	46	strains	strain	NOUN
iajs-3485	240	47	.	.	PUNCT
iajs-3485	241	1	saudi	saudi	ADJ
iajs-3485	241	2	journal	journal	NOUN
iajs-3485	241	3	of	of	ADP
iajs-3485	241	4	biological	biological	ADJ
iajs-3485	241	5	sciences	science	NOUN
iajs-3485	241	6	.	.	PUNCT
iajs-3485	241	7	2014	2014	NUM
iajs-3485	241	8	,	,	PUNCT
iajs-3485	241	9	21(2	21(2	NUM
iajs-3485	241	10	)	)	PUNCT
iajs-3485	241	11	,	,	PUNCT
iajs-3485	241	12	147–151	147–151	NUM
iajs-3485	241	13	.	.	PUNCT
iajs-3485	241	14	https://doi.org/10.1016/j.sjbs.2013.09.003	https://doi.org/10.1016/j.sjbs.2013.09.003	NUM
iajs-3485	241	15	.	.	NOUN
iajs-3485	241	16	26	26	NUM
iajs-3485	241	17	.	.	PUNCT
iajs-3485	242	1	odebiyi	odebiyi	PROPN
iajs-3485	242	2	,	,	PUNCT
iajs-3485	242	3	o.o	o.o	PROPN
iajs-3485	242	4	.	.	PROPN
iajs-3485	242	5	;	;	PUNCT
iajs-3485	242	6	sofowora	sofowora	PROPN
iajs-3485	242	7	,	,	PUNCT
iajs-3485	242	8	e.a	e.a	PROPN
iajs-3485	242	9	.	.	PROPN
iajs-3485	242	10	phytochemical	phytochemical	ADJ
iajs-3485	242	11	screening	screening	NOUN
iajs-3485	242	12	of	of	ADP
iajs-3485	242	13	nigerian	nigerian	ADJ
iajs-3485	242	14	medicinal	medicinal	PROPN
iajs-3485	242	15	plants	plants	PROPN
iajs-3485	242	16	ii	ii	PROPN
iajs-3485	242	17	.	.	PUNCT
iajs-3485	243	1	lloydia	lloydia	PROPN
iajs-3485	243	2	1978	1978	NUM
iajs-3485	243	3	,	,	PUNCT
iajs-3485	243	4	41	41	NUM
iajs-3485	243	5	,	,	PUNCT
iajs-3485	243	6	234–246	234–246	NUM
iajs-3485	243	7	.	.	PUNCT
iajs-3485	244	1	27	27	NUM
iajs-3485	244	2	.	.	PUNCT
iajs-3485	245	1	hussain	hussain	PROPN
iajs-3485	245	2	,	,	PUNCT
iajs-3485	245	3	i.	i.	PROPN
iajs-3485	245	4	;	;	PUNCT
iajs-3485	245	5	khan	khan	PROPN
iajs-3485	245	6	,	,	PUNCT
iajs-3485	245	7	s.	s.	PROPN
iajs-3485	245	8	;	;	PUNCT
iajs-3485	245	9	khan	khan	PROPN
iajs-3485	245	10	,	,	PUNCT
iajs-3485	245	11	m.i	m.i	PROPN
iajs-3485	245	12	.	.	PROPN
iajs-3485	245	13	;	;	PUNCT
iajs-3485	245	14	rehman	rehman	PROPN
iajs-3485	245	15	,	,	PUNCT
iajs-3485	245	16	i.u	i.u	PROPN
iajs-3485	245	17	.	.	PROPN
iajs-3485	245	18	;	;	PUNCT
iajs-3485	245	19	ahmed	ahmed	PROPN
iajs-3485	245	20	,	,	PUNCT
iajs-3485	245	21	m.	m.	NOUN
iajs-3485	245	22	investigation	investigation	NOUN
iajs-3485	245	23	of	of	ADP
iajs-3485	245	24	fatty	fatty	NOUN
iajs-3485	245	25	acid	acid	NOUN
iajs-3485	245	26	composition	composition	NOUN
iajs-3485	245	27	of	of	ADP
iajs-3485	245	28	ammi	ammi	PROPN
iajs-3485	245	29	majus	majus	ADJ
iajs-3485	245	30	seed	seed	NOUN
iajs-3485	245	31	oil	oil	NOUN
iajs-3485	245	32	by	by	ADP
iajs-3485	245	33	gas	gas	NOUN
iajs-3485	245	34	chromatography	chromatography	NOUN
iajs-3485	245	35	mass	mass	PROPN
iajs-3485	245	36	spectrometry	spectrometry	NOUN
iajs-3485	245	37	.	.	PUNCT
iajs-3485	246	1	journal	journal	PROPN
iajs-3485	246	2	of	of	ADP
iajs-3485	246	3	the	the	DET
iajs-3485	246	4	chinese	chinese	ADJ
iajs-3485	246	5	https://doi.org/10.1186/2191-2858-2-1	https://doi.org/10.1186/2191-2858-2-1	PROPN
iajs-3485	246	6	https://doi.org/10.1007/bf02268780	https://doi.org/10.1007/bf02268780	PROPN
iajs-3485	246	7	https://doi.org/10.1016/0031-9422(93)85365-x	https://doi.org/10.1016/0031-9422(93)85365-x	PROPN
iajs-3485	246	8	https://doi.org/10.7324/japs.2012.2643	https://doi.org/10.7324/japs.2012.2643	PROPN
iajs-3485	246	9	https://doi.org/10.1016/j.ejphar.2020.173124	https://doi.org/10.1016/j.ejphar.2020.173124	NOUN
iajs-3485	246	10	https://doi.org/10.1177/20587392211000573	https://doi.org/10.1177/20587392211000573	NOUN
iajs-3485	246	11	https://doi.org/10.1111/j.1365-2133.2006.07584.x	https://doi.org/10.1111/j.1365-2133.2006.07584.x	VERB
iajs-3485	246	12	https://doi.org/10.31351/vol21iss1pp82-86	https://doi.org/10.31351/vol21iss1pp82-86	PROPN
iajs-3485	246	13	https://doi.org/10.1111/j.1755-148x.2008.00528.x	https://doi.org/10.1111/j.1755-148x.2008.00528.x	NOUN
iajs-3485	246	14	https://doi.org/10.1016/j.sjbs.2013.09.003	https://doi.org/10.1016/j.sjbs.2013.09.003	NOUN
iajs-3485	246	15	ihjpas	ihjpa	NOUN
iajs-3485	246	16	.	.	PUNCT
iajs-3485	247	1	2024	2024	NUM
iajs-3485	247	2	,	,	PUNCT
iajs-3485	247	3	37	37	NUM
iajs-3485	247	4	(	(	PUNCT
iajs-3485	247	5	3	3	NUM
iajs-3485	247	6	)	)	PUNCT
iajs-3485	247	7	134	134	NUM
iajs-3485	247	8	chemical	chemical	NOUN
iajs-3485	247	9	society	society	NOUN
iajs-3485	247	10	.	.	PUNCT
iajs-3485	248	1	2012	2012	NUM
iajs-3485	248	2	,	,	PUNCT
iajs-3485	248	3	59	59	NUM
iajs-3485	248	4	,	,	PUNCT
iajs-3485	248	5	655–658	655–658	NUM
iajs-3485	248	6	.	.	PUNCT
iajs-3485	249	1	doi	doi	NOUN
iajs-3485	249	2	:	:	PUNCT
iajs-3485	249	3	https://doi.org/10.1002/jccs.201100477	https://doi.org/10.1002/jccs.201100477	NOUN
iajs-3485	249	4	.	.	PUNCT
iajs-3485	250	1	28	28	NUM
iajs-3485	250	2	.	.	PUNCT
iajs-3485	251	1	junqueira	junqueira	PROPN
iajs-3485	251	2	,	,	PUNCT
iajs-3485	251	3	l.c.u	l.c.u	PROPN
iajs-3485	251	4	.	.	PUNCT
iajs-3485	251	5	;	;	PUNCT
iajs-3485	251	6	carneiro	carneiro	PROPN
iajs-3485	251	7	,	,	PUNCT
iajs-3485	251	8	j.	j.	PROPN
iajs-3485	251	9	basic	basic	ADJ
iajs-3485	251	10	histology	histology	NOUN
iajs-3485	251	11	:	:	PUNCT
iajs-3485	251	12	text	text	NOUN
iajs-3485	251	13	\	\	PROPN
iajs-3485	251	14	&	&	CCONJ
iajs-3485	251	15	atlas	atlas	PROPN
iajs-3485	251	16	,	,	PUNCT
iajs-3485	251	17	new	new	PROPN
iajs-3485	251	18	york	york	PROPN
iajs-3485	251	19	mcgraw	mcgraw	PROPN
iajs-3485	251	20	-	-	PUNCT
iajs-3485	251	21	hill	hill	PROPN
iajs-3485	251	22	,	,	PUNCT
iajs-3485	251	23	2005	2005	NUM
iajs-3485	251	24	;	;	PUNCT
iajs-3485	251	25	isbn	isbn	PROPN
iajs-3485	251	26	9780071440912	9780071440912	NUM
iajs-3485	251	27	.	.	PUNCT
iajs-3485	252	1	29	29	NUM
iajs-3485	252	2	.	.	PUNCT
iajs-3485	253	1	anjaneyulu	anjaneyulu	VERB
iajs-3485	253	2	,	,	PUNCT
iajs-3485	253	3	m.	m.	NOUN
iajs-3485	253	4	;	;	PUNCT
iajs-3485	253	5	chopra	chopra	PROPN
iajs-3485	253	6	,	,	PUNCT
iajs-3485	253	7	k.	k.	PROPN
iajs-3485	253	8	quercetin	quercetin	PROPN
iajs-3485	253	9	,	,	PUNCT
iajs-3485	253	10	an	an	DET
iajs-3485	253	11	anti	anti	ADJ
iajs-3485	253	12	-	-	ADJ
iajs-3485	253	13	oxidant	oxidant	ADJ
iajs-3485	253	14	bioflavonoid	bioflavonoid	NOUN
iajs-3485	253	15	,	,	PUNCT
iajs-3485	253	16	attenuates	attenuate	VERB
iajs-3485	253	17	diabetic	diabetic	ADJ
iajs-3485	253	18	nephropathy	nephropathy	NOUN
iajs-3485	253	19	in	in	ADP
iajs-3485	253	20	rats	rat	NOUN
iajs-3485	253	21	.	.	PUNCT
iajs-3485	254	1	clinical	clinical	ADJ
iajs-3485	254	2	and	and	CCONJ
iajs-3485	254	3	experimental	experimental	ADJ
iajs-3485	254	4	pharmacology	pharmacology	NOUN
iajs-3485	254	5	and	and	CCONJ
iajs-3485	254	6	physiology	physiology	NOUN
iajs-3485	254	7	.	.	PUNCT
iajs-3485	255	1	2004	2004	NUM
iajs-3485	255	2	,	,	PUNCT
iajs-3485	255	3	31(4	31(4	NUM
iajs-3485	255	4	)	)	PUNCT
iajs-3485	255	5	,	,	PUNCT
iajs-3485	255	6	244–248	244–248	NUM
iajs-3485	255	7	.	.	PUNCT
iajs-3485	256	1	doi	doi	NOUN
iajs-3485	256	2	:	:	PUNCT
iajs-3485	256	3	https://doi.org/10.1111/j.1440-1681.2004.03982.x	https://doi.org/10.1111/j.1440-1681.2004.03982.x	NOUN
iajs-3485	256	4	.	.	PUNCT
iajs-3485	257	1	30	30	NUM
iajs-3485	257	2	.	.	X
iajs-3485	258	1	gaweł	gaweł	PROPN
iajs-3485	258	2	,	,	PUNCT
iajs-3485	258	3	s.	s.	PROPN
iajs-3485	258	4	;	;	PUNCT
iajs-3485	258	5	wardas	warda	NOUN
iajs-3485	258	6	,	,	PUNCT
iajs-3485	258	7	m.	m.	NOUN
iajs-3485	258	8	;	;	PUNCT
iajs-3485	258	9	niedworok	niedworok	PROPN
iajs-3485	258	10	,	,	PUNCT
iajs-3485	258	11	e.	e.	PROPN
iajs-3485	258	12	;	;	PUNCT
iajs-3485	258	13	wardas	warda	NOUN
iajs-3485	258	14	,	,	PUNCT
iajs-3485	259	1	p.	p.	NOUN
iajs-3485	260	1	[	[	X
iajs-3485	260	2	malondialdehyde	malondialdehyde	NOUN
iajs-3485	260	3	(	(	PUNCT
iajs-3485	260	4	mda	mda	PROPN
iajs-3485	260	5	)	)	PUNCT
iajs-3485	260	6	as	as	ADP
iajs-3485	260	7	a	a	DET
iajs-3485	260	8	lipid	lipid	NOUN
iajs-3485	260	9	peroxidation	peroxidation	NOUN
iajs-3485	260	10	marker	marker	NOUN
iajs-3485	260	11	]	]	PUNCT
iajs-3485	260	12	.	.	PUNCT
iajs-3485	261	1	wiadomosci	wiadomosci	PROPN
iajs-3485	261	2	lekarskie	lekarskie	PROPN
iajs-3485	261	3	.	.	PUNCT
iajs-3485	262	1	2004	2004	NUM
iajs-3485	262	2	,	,	PUNCT
iajs-3485	262	3	57	57	NUM
iajs-3485	262	4	,	,	PUNCT
iajs-3485	262	5	453–455	453–455	NUM
iajs-3485	262	6	.	.	PUNCT
iajs-3485	263	1	[	[	X
iajs-3485	263	2	article	article	NOUN
iajs-3485	263	3	in	in	ADP
iajs-3485	263	4	polish	polish	PROPN
iajs-3485	263	5	]	]	PUNCT
iajs-3485	263	6	.	.	PUNCT
iajs-3485	264	1	31	31	NUM
iajs-3485	264	2	.	.	PUNCT
iajs-3485	265	1	koti	koti	PROPN
iajs-3485	265	2	,	,	PUNCT
iajs-3485	265	3	b.c	b.c	PROPN
iajs-3485	265	4	.	.	PROPN
iajs-3485	265	5	;	;	PUNCT
iajs-3485	265	6	vishwanathswamy	vishwanathswamy	NOUN
iajs-3485	265	7	,	,	PUNCT
iajs-3485	265	8	a.h.m	a.h.m	NOUN
iajs-3485	265	9	.	.	PROPN
iajs-3485	265	10	;	;	PUNCT
iajs-3485	265	11	wagawade	wagawade	NOUN
iajs-3485	265	12	,	,	PUNCT
iajs-3485	265	13	j.	j.	PROPN
iajs-3485	265	14	;	;	PUNCT
iajs-3485	265	15	thippeswamy	thippeswamy	ADJ
iajs-3485	265	16	,	,	PUNCT
iajs-3485	265	17	a.h.m	a.h.m	ADJ
iajs-3485	265	18	.	.	PROPN
iajs-3485	265	19	cardioprotective	cardioprotective	ADJ
iajs-3485	265	20	effect	effect	NOUN
iajs-3485	265	21	of	of	ADP
iajs-3485	265	22	lipistat	lipistat	NOUN
iajs-3485	265	23	against	against	ADP
iajs-3485	265	24	doxorubicin	doxorubicin	PROPN
iajs-3485	265	25	induced	induce	VERB
iajs-3485	265	26	myocardial	myocardial	ADJ
iajs-3485	265	27	toxicity	toxicity	NOUN
iajs-3485	265	28	in	in	ADP
iajs-3485	265	29	albino	albino	NOUN
iajs-3485	265	30	rats	rat	NOUN
iajs-3485	265	31	.	.	PUNCT
iajs-3485	266	1	indian	indian	ADJ
iajs-3485	266	2	journal	journal	PROPN
iajs-3485	266	3	of	of	ADP
iajs-3485	266	4	experimental	experimental	ADJ
iajs-3485	266	5	biology	biology	NOUN
iajs-3485	266	6	.	.	PUNCT
iajs-3485	267	1	2009	2009	NUM
iajs-3485	267	2	,	,	PUNCT
iajs-3485	267	3	47	47	NUM
iajs-3485	267	4	,	,	PUNCT
iajs-3485	267	5	41–46	41–46	NUM
iajs-3485	267	6	.	.	NOUN
iajs-3485	267	7	32	32	NUM
iajs-3485	267	8	.	.	X
iajs-3485	268	1	ammar	ammar	PROPN
iajs-3485	268	2	,	,	PUNCT
iajs-3485	268	3	e.-s.m	e.-s.m	PROPN
iajs-3485	268	4	.	.	PUNCT
iajs-3485	268	5	;	;	PUNCT
iajs-3485	268	6	said	say	VERB
iajs-3485	268	7	,	,	PUNCT
iajs-3485	268	8	s.a	s.a	PROPN
iajs-3485	268	9	.	.	PROPN
iajs-3485	268	10	;	;	PUNCT
iajs-3485	269	1	suddek	suddek	PROPN
iajs-3485	269	2	,	,	PUNCT
iajs-3485	269	3	g.m	g.m	PROPN
iajs-3485	269	4	.	.	PROPN
iajs-3485	269	5	;	;	PUNCT
iajs-3485	269	6	el	el	PROPN
iajs-3485	269	7	-	-	PUNCT
iajs-3485	269	8	damarawy	damarawy	PROPN
iajs-3485	269	9	,	,	PUNCT
iajs-3485	269	10	s.l	s.l	PROPN
iajs-3485	269	11	.	.	NOUN
iajs-3485	269	12	amelioration	amelioration	NOUN
iajs-3485	269	13	of	of	ADP
iajs-3485	269	14	doxorubicin	doxorubicin	PROPN
iajs-3485	269	15	-	-	PUNCT
iajs-3485	269	16	induced	induce	VERB
iajs-3485	269	17	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	269	18	by	by	ADP
iajs-3485	269	19	deferiprone	deferiprone	NOUN
iajs-3485	269	20	in	in	ADP
iajs-3485	269	21	rats	rat	NOUN
iajs-3485	269	22	.	.	PUNCT
iajs-3485	270	1	canadian	canadian	ADJ
iajs-3485	270	2	journal	journal	PROPN
iajs-3485	270	3	of	of	ADP
iajs-3485	270	4	physiology	physiology	NOUN
iajs-3485	270	5	and	and	CCONJ
iajs-3485	270	6	pharmacology	pharmacology	NOUN
iajs-3485	270	7	.	.	PUNCT
iajs-3485	271	1	2011	2011	NUM
iajs-3485	271	2	,	,	PUNCT
iajs-3485	271	3	89(4	89(4	NOUN
iajs-3485	271	4	)	)	PUNCT
iajs-3485	271	5	,	,	PUNCT
iajs-3485	271	6	269–276	269–276	NUM
iajs-3485	271	7	,	,	PUNCT
iajs-3485	271	8	doi:10.1139	doi:10.1139	NOUN
iajs-3485	271	9	/	/	SYM
iajs-3485	271	10	y11	y11	NOUN
iajs-3485	271	11	-	-	PUNCT
iajs-3485	271	12	020	020	NUM
iajs-3485	271	13	.	.	PUNCT
iajs-3485	272	1	doi	doi	NOUN
iajs-3485	272	2	:	:	PUNCT
iajs-3485	272	3	https://doi.org/10.1139/y11-020	https://doi.org/10.1139/y11-020	NUM
iajs-3485	272	4	.	.	NOUN
iajs-3485	273	1	33	33	NUM
iajs-3485	273	2	.	.	PUNCT
iajs-3485	274	1	ahmed1	ahmed1	PROPN
iajs-3485	274	2	,	,	PUNCT
iajs-3485	274	3	i.a.;mohammed	i.a.;mohamme	VERB
iajs-3485	274	4	,	,	PUNCT
iajs-3485	274	5	a.i.a	a.i.a	NOUN
iajs-3485	274	6	.	.	PUNCT
iajs-3485	274	7	;	;	PUNCT
iajs-3485	274	8	khaleel	khaleel	PROPN
iajs-3485	274	9	,	,	PUNCT
iajs-3485	274	10	k.j	k.j	PROPN
iajs-3485	274	11	.	.	NOUN
iajs-3485	274	12	ameliorating	ameliorate	VERB
iajs-3485	274	13	the	the	DET
iajs-3485	274	14	anticancer	anticancer	NOUN
iajs-3485	274	15	drug	drug	NOUN
iajs-3485	274	16	”	"	PUNCT
iajs-3485	274	17	adriamycin	adriamycin	PROPN
iajs-3485	274	18	”	"	PUNCT
iajs-3485	274	19	acute	acute	NOUN
iajs-3485	274	20	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	274	21	by	by	ADP
iajs-3485	274	22	rosuvastatin	rosuvastatin	NOUN
iajs-3485	274	23	and	and	CCONJ
iajs-3485	274	24	telmisartan	telmisartan	NOUN
iajs-3485	274	25	in	in	ADP
iajs-3485	274	26	rats	rat	NOUN
iajs-3485	274	27	.	.	PUNCT
iajs-3485	275	1	iraqi	iraqi	ADJ
iajs-3485	275	2	journal	journal	PROPN
iajs-3485	275	3	of	of	ADP
iajs-3485	275	4	cancer	cancer	NOUN
iajs-3485	275	5	and	and	CCONJ
iajs-3485	275	6	medical	medical	ADJ
iajs-3485	275	7	genetics	genetic	NOUN
iajs-3485	275	8	.	.	PUNCT
iajs-3485	276	1	2014	2014	NUM
iajs-3485	276	2	,	,	PUNCT
iajs-3485	276	3	7(2	7(2	NUM
iajs-3485	276	4	)	)	PUNCT
iajs-3485	276	5	.	.	PUNCT
iajs-3485	277	1	https://doi.org/10.29409/ijcmg.v7i2.138	https://doi.org/10.29409/ijcmg.v7i2.138	PROPN
iajs-3485	277	2	.	.	PUNCT
iajs-3485	278	1	34	34	NUM
iajs-3485	278	2	.	.	PUNCT
iajs-3485	278	3	mutlag	mutlag	PROPN
iajs-3485	278	4	,	,	PUNCT
iajs-3485	278	5	s.h	s.h	PROPN
iajs-3485	278	6	.	.	PROPN
iajs-3485	278	7	;	;	PUNCT
iajs-3485	278	8	ismael	ismael	PROPN
iajs-3485	278	9	,	,	PUNCT
iajs-3485	278	10	d.k	d.k	PROPN
iajs-3485	278	11	.	.	PROPN
iajs-3485	278	12	;	;	PUNCT
iajs-3485	278	13	al	al	PROPN
iajs-3485	278	14	-	-	PUNCT
iajs-3485	278	15	shawi	shawi	PROPN
iajs-3485	278	16	,	,	PUNCT
iajs-3485	278	17	n.n	n.n	PROPN
iajs-3485	278	18	.	.	PROPN
iajs-3485	278	19	study	study	VERB
iajs-3485	278	20	the	the	DET
iajs-3485	278	21	possible	possible	ADJ
iajs-3485	278	22	hepatoprotective	hepatoprotective	ADJ
iajs-3485	278	23	effect	effect	NOUN
iajs-3485	278	24	of	of	ADP
iajs-3485	278	25	different	different	ADJ
iajs-3485	278	26	doses	dose	NOUN
iajs-3485	278	27	of	of	ADP
iajs-3485	278	28	ammi	ammi	PROPN
iajs-3485	278	29	majus	majus	ADJ
iajs-3485	278	30	seeds	seed	NOUN
iajs-3485	278	31	’	'	PUNCT
iajs-3485	278	32	extract	extract	NOUN
iajs-3485	278	33	against	against	ADP
iajs-3485	278	34	ccl4	ccl4	PROPN
iajs-3485	278	35	induced	induce	VERB
iajs-3485	278	36	liver	liver	NOUN
iajs-3485	278	37	damage	damage	NOUN
iajs-3485	278	38	in	in	ADP
iajs-3485	278	39	rats	rat	NOUN
iajs-3485	278	40	.	.	PUNCT
iajs-3485	279	1	pharm	pharm	PROPN
iajs-3485	279	2	glob(ijcp	glob(ijcp	PROPN
iajs-3485	279	3	)	)	PUNCT
iajs-3485	279	4	2011	2011	NUM
iajs-3485	279	5	,	,	PUNCT
iajs-3485	279	6	9	9	NUM
iajs-3485	279	7	,	,	PUNCT
iajs-3485	279	8	1–5	1–5	NUM
iajs-3485	279	9	.	.	NOUN
iajs-3485	279	10	35	35	NUM
iajs-3485	279	11	.	.	PUNCT
iajs-3485	280	1	yagmurca	yagmurca	PROPN
iajs-3485	280	2	,	,	PUNCT
iajs-3485	280	3	m.	m.	NOUN
iajs-3485	280	4	;	;	PUNCT
iajs-3485	280	5	yasar	yasar	PROPN
iajs-3485	280	6	,	,	PUNCT
iajs-3485	280	7	z.	z.	PROPN
iajs-3485	280	8	;	;	PUNCT
iajs-3485	280	9	bas	bas	PROPN
iajs-3485	280	10	,	,	PUNCT
iajs-3485	280	11	o.	o.	ADJ
iajs-3485	280	12	effects	effect	NOUN
iajs-3485	280	13	of	of	ADP
iajs-3485	280	14	quercetin	quercetin	NOUN
iajs-3485	280	15	on	on	ADP
iajs-3485	280	16	kidney	kidney	NOUN
iajs-3485	280	17	injury	injury	NOUN
iajs-3485	280	18	induced	induce	VERB
iajs-3485	280	19	by	by	ADP
iajs-3485	280	20	doxorubicin	doxorubicin	PROPN
iajs-3485	280	21	.	.	PUNCT
iajs-3485	281	1	bratislavske	bratislavske	PROPN
iajs-3485	281	2	lekarske	lekarske	PROPN
iajs-3485	281	3	listy	listy	PROPN
iajs-3485	281	4	,	,	PUNCT
iajs-3485	281	5	2015	2015	NUM
iajs-3485	281	6	,	,	PUNCT
iajs-3485	281	7	116(8	116(8	NUM
iajs-3485	281	8	)	)	PUNCT
iajs-3485	281	9	,	,	PUNCT
iajs-3485	281	10	486–489	486–489	NUM
iajs-3485	281	11	.	.	PUNCT
iajs-3485	282	1	doi	doi	PROPN
iajs-3485	282	2	:	:	PUNCT
iajs-3485	282	3	https://doi.org/10.4149/bll_2015_092	https://doi.org/10.4149/bll_2015_092	PROPN
iajs-3485	282	4	.	.	PROPN
iajs-3485	283	1	36	36	NUM
iajs-3485	283	2	.	.	PUNCT
iajs-3485	284	1	chen	chen	PROPN
iajs-3485	284	2	,	,	PUNCT
iajs-3485	284	3	j.-y	j.-y	PROPN
iajs-3485	284	4	.	.	PUNCT
iajs-3485	284	5	;	;	PUNCT
iajs-3485	284	6	hu	hu	PROPN
iajs-3485	284	7	,	,	PUNCT
iajs-3485	284	8	r.-y	r.-y	NOUN
iajs-3485	284	9	.	.	PUNCT
iajs-3485	284	10	;	;	PUNCT
iajs-3485	284	11	chou	chou	NOUN
iajs-3485	284	12	,	,	PUNCT
iajs-3485	284	13	h.-c	h.-c	PROPN
iajs-3485	284	14	.	.	PUNCT
iajs-3485	285	1	quercetin	quercetin	NOUN
iajs-3485	285	2	-	-	PUNCT
iajs-3485	285	3	induced	induce	VERB
iajs-3485	285	4	cardioprotection	cardioprotection	NOUN
iajs-3485	285	5	against	against	ADP
iajs-3485	285	6	doxorubicin	doxorubicin	PROPN
iajs-3485	285	7	cytotoxicity	cytotoxicity	NOUN
iajs-3485	285	8	.	.	PUNCT
iajs-3485	286	1	journal	journal	PROPN
iajs-3485	286	2	of	of	ADP
iajs-3485	286	3	biomedical	biomedical	ADJ
iajs-3485	286	4	science	science	NOUN
iajs-3485	286	5	.	.	PUNCT
iajs-3485	287	1	2013	2013	NUM
iajs-3485	287	2	,	,	PUNCT
iajs-3485	287	3	20	20	NUM
iajs-3485	287	4	,	,	PUNCT
iajs-3485	287	5	1–11	1–11	PROPN
iajs-3485	287	6	.	.	PUNCT
iajs-3485	288	1	doi	doi	PROPN
iajs-3485	288	2	:	:	PUNCT
iajs-3485	288	3	https://doi.org/10.1186/1423-012720-95	https://doi.org/10.1186/1423-012720-95	NUM
iajs-3485	288	4	.	.	PUNCT
iajs-3485	289	1	37	37	NUM
iajs-3485	289	2	.	.	X
iajs-3485	290	1	wakade	wakade	PROPN
iajs-3485	290	2	,	,	PUNCT
iajs-3485	290	3	a.s	a.s	PROPN
iajs-3485	290	4	.	.	PROPN
iajs-3485	290	5	;	;	PUNCT
iajs-3485	290	6	shah	shah	PROPN
iajs-3485	290	7	,	,	PUNCT
iajs-3485	290	8	a.s	a.s	PROPN
iajs-3485	290	9	.	.	PROPN
iajs-3485	290	10	;	;	PUNCT
iajs-3485	290	11	kulkarni	kulkarni	PROPN
iajs-3485	290	12	,	,	PUNCT
iajs-3485	290	13	m.p	m.p	PROPN
iajs-3485	290	14	.	.	PROPN
iajs-3485	290	15	;	;	PUNCT
iajs-3485	290	16	juvekar	juvekar	PROPN
iajs-3485	290	17	,	,	PUNCT
iajs-3485	290	18	a.r	a.r	PROPN
iajs-3485	290	19	.	.	PROPN
iajs-3485	290	20	protective	protective	ADJ
iajs-3485	290	21	effect	effect	NOUN
iajs-3485	290	22	of	of	ADP
iajs-3485	290	23	piper	piper	NOUN
iajs-3485	290	24	longum	longum	NOUN
iajs-3485	290	25	l.	l.	NOUN
iajs-3485	290	26	on	on	ADP
iajs-3485	290	27	oxidative	oxidative	ADJ
iajs-3485	290	28	stress	stress	NOUN
iajs-3485	290	29	induced	induce	VERB
iajs-3485	290	30	injury	injury	NOUN
iajs-3485	290	31	and	and	CCONJ
iajs-3485	290	32	cellular	cellular	ADJ
iajs-3485	290	33	abnormality	abnormality	NOUN
iajs-3485	290	34	in	in	ADP
iajs-3485	290	35	adriamycin	adriamycin	NOUN
iajs-3485	290	36	induced	induce	VERB
iajs-3485	290	37	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	290	38	in	in	ADP
iajs-3485	290	39	rats	rat	NOUN
iajs-3485	290	40	.	.	PUNCT
iajs-3485	291	1	indian	indian	ADJ
iajs-3485	291	2	journal	journal	PROPN
iajs-3485	291	3	of	of	ADP
iajs-3485	291	4	experimental	experimental	ADJ
iajs-3485	291	5	biology	biology	NOUN
iajs-3485	291	6	.	.	PUNCT
iajs-3485	292	1	2008	2008	NUM
iajs-3485	292	2	,	,	PUNCT
iajs-3485	292	3	46(7	46(7	NUM
iajs-3485	292	4	)	)	PUNCT
iajs-3485	292	5	,	,	PUNCT
iajs-3485	292	6	528–533	528–533	NUM
iajs-3485	292	7	.	.	PUNCT
iajs-3485	293	1	38	38	NUM
iajs-3485	293	2	.	.	PUNCT
iajs-3485	294	1	kaithwas	kaithwas	PROPN
iajs-3485	294	2	,	,	PUNCT
iajs-3485	294	3	g.	g.	PROPN
iajs-3485	294	4	;	;	PUNCT
iajs-3485	294	5	dubey	dubey	PROPN
iajs-3485	294	6	,	,	PUNCT
iajs-3485	294	7	k.	k.	PROPN
iajs-3485	294	8	;	;	PUNCT
iajs-3485	294	9	pillai	pillai	PROPN
iajs-3485	294	10	,	,	PUNCT
iajs-3485	294	11	k.k	k.k	PROPN
iajs-3485	294	12	.	.	PROPN
iajs-3485	294	13	effect	effect	NOUN
iajs-3485	294	14	of	of	ADP
iajs-3485	294	15	aloe	aloe	PROPN
iajs-3485	294	16	vera	vera	NOUN
iajs-3485	294	17	(	(	PUNCT
iajs-3485	294	18	aloe	aloe	PROPN
iajs-3485	294	19	barbadensis	barbadensis	PROPN
iajs-3485	294	20	miller	miller	PROPN
iajs-3485	294	21	)	)	PUNCT
iajs-3485	294	22	gel	gel	NOUN
iajs-3485	294	23	on	on	ADP
iajs-3485	294	24	doxorubicin	doxorubicin	PROPN
iajs-3485	294	25	-	-	PUNCT
iajs-3485	294	26	induced	induce	VERB
iajs-3485	294	27	myocardial	myocardial	ADJ
iajs-3485	294	28	oxidative	oxidative	ADJ
iajs-3485	294	29	stress	stress	NOUN
iajs-3485	294	30	and	and	CCONJ
iajs-3485	294	31	calcium	calcium	NOUN
iajs-3485	294	32	overload	overload	NOUN
iajs-3485	294	33	in	in	ADP
iajs-3485	294	34	albino	albino	NOUN
iajs-3485	294	35	rats	rat	NOUN
iajs-3485	294	36	.	.	PUNCT
iajs-3485	294	37	.	.	PUNCT
iajs-3485	295	1	indian	indian	PROPN
iajs-3485	295	2	journal	journal	PROPN
iajs-3485	295	3	of	of	ADP
iajs-3485	295	4	experimental	experimental	ADJ
iajs-3485	295	5	biology	biology	NOUN
iajs-3485	295	6	.	.	PUNCT
iajs-3485	296	1	2011	2011	NUM
iajs-3485	296	2	,	,	PUNCT
iajs-3485	296	3	49	49	NUM
iajs-3485	296	4	,	,	PUNCT
iajs-3485	296	5	260–268	260–268	NUM
iajs-3485	296	6	.	.	PUNCT
iajs-3485	297	1	39	39	NUM
iajs-3485	297	2	.	.	PUNCT
iajs-3485	298	1	zilinyi	zilinyi	PROPN
iajs-3485	298	2	,	,	PUNCT
iajs-3485	298	3	r.	r.	PROPN
iajs-3485	298	4	;	;	PUNCT
iajs-3485	298	5	czompa	czompa	PROPN
iajs-3485	298	6	,	,	PUNCT
iajs-3485	298	7	a.	a.	NOUN
iajs-3485	298	8	;	;	PUNCT
iajs-3485	298	9	czegledi	czegledi	PROPN
iajs-3485	298	10	,	,	PUNCT
iajs-3485	298	11	a.	a.	NOUN
iajs-3485	298	12	;	;	PUNCT
iajs-3485	298	13	gajtko	gajtko	PROPN
iajs-3485	298	14	,	,	PUNCT
iajs-3485	298	15	a.	a.	NOUN
iajs-3485	298	16	;	;	PUNCT
iajs-3485	298	17	pituk	pituk	PROPN
iajs-3485	298	18	,	,	PUNCT
iajs-3485	298	19	d.	d.	PROPN
iajs-3485	298	20	;	;	PUNCT
iajs-3485	298	21	lekli	lekli	PROPN
iajs-3485	298	22	,	,	PUNCT
iajs-3485	298	23	i.	i.	NOUN
iajs-3485	298	24	;	;	PUNCT
iajs-3485	298	25	tosaki	tosaki	NOUN
iajs-3485	298	26	,	,	PUNCT
iajs-3485	298	27	a.	a.	NOUN
iajs-3485	298	28	the	the	DET
iajs-3485	298	29	cardioprotective	cardioprotective	ADJ
iajs-3485	298	30	effect	effect	NOUN
iajs-3485	298	31	of	of	ADP
iajs-3485	298	32	metformin	metformin	NOUN
iajs-3485	298	33	in	in	ADP
iajs-3485	298	34	doxorubicin	doxorubicin	PROPN
iajs-3485	298	35	-	-	PUNCT
iajs-3485	298	36	induced	induce	VERB
iajs-3485	298	37	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	298	38	:	:	PUNCT
iajs-3485	298	39	the	the	DET
iajs-3485	298	40	role	role	NOUN
iajs-3485	298	41	of	of	ADP
iajs-3485	298	42	autophagy	autophagy	NOUN
iajs-3485	298	43	.	.	PUNCT
iajs-3485	299	1	molecules	molecule	NOUN
iajs-3485	299	2	2018	2018	NUM
iajs-3485	299	3	,	,	PUNCT
iajs-3485	299	4	23(5	23(5	NUM
iajs-3485	299	5	)	)	PUNCT
iajs-3485	299	6	,	,	PUNCT
iajs-3485	299	7	1184	1184	NUM
iajs-3485	299	8	.	.	PUNCT
iajs-3485	300	1	https://doi.org/10.3390%2fmolecules23051184	https://doi.org/10.3390%2fmolecules23051184	VERB
iajs-3485	300	2	.	.	PROPN
iajs-3485	300	3	40	40	NUM
iajs-3485	300	4	.	.	PUNCT
iajs-3485	301	1	koti	koti	PROPN
iajs-3485	301	2	,	,	PUNCT
iajs-3485	301	3	b.c	b.c	PROPN
iajs-3485	301	4	.	.	PROPN
iajs-3485	301	5	;	;	PUNCT
iajs-3485	301	6	vishwanathswamy	vishwanathswamy	NOUN
iajs-3485	301	7	,	,	PUNCT
iajs-3485	301	8	a.h.m	a.h.m	NOUN
iajs-3485	301	9	.	.	PROPN
iajs-3485	301	10	;	;	PUNCT
iajs-3485	301	11	wagawade	wagawade	NOUN
iajs-3485	301	12	,	,	PUNCT
iajs-3485	301	13	j.	j.	PROPN
iajs-3485	301	14	;	;	PUNCT
iajs-3485	301	15	thippeswamy	thippeswamy	ADJ
iajs-3485	301	16	,	,	PUNCT
iajs-3485	301	17	a.h.m	a.h.m	ADJ
iajs-3485	301	18	.	.	PROPN
iajs-3485	301	19	cardioprotective	cardioprotective	ADJ
iajs-3485	301	20	effect	effect	NOUN
iajs-3485	301	21	of	of	ADP
iajs-3485	301	22	lipistat	lipistat	NOUN
iajs-3485	301	23	against	against	ADP
iajs-3485	301	24	doxorubicin	doxorubicin	PROPN
iajs-3485	301	25	induced	induce	VERB
iajs-3485	301	26	myocardial	myocardial	ADJ
iajs-3485	301	27	toxicity	toxicity	NOUN
iajs-3485	301	28	in	in	ADP
iajs-3485	301	29	albino	albino	NOUN
iajs-3485	301	30	rats	rat	NOUN
iajs-3485	301	31	.	.	PUNCT
iajs-3485	302	1	indian	indian	ADJ
iajs-3485	302	2	journal	journal	PROPN
iajs-3485	302	3	of	of	ADP
iajs-3485	302	4	experimental	experimental	ADJ
iajs-3485	302	5	biology	biology	NOUN
iajs-3485	302	6	.	.	PUNCT
iajs-3485	303	1	2009	2009	NUM
iajs-3485	303	2	,	,	PUNCT
iajs-3485	303	3	47	47	NUM
iajs-3485	303	4	,	,	PUNCT
iajs-3485	303	5	41–46	41–46	NUM
iajs-3485	303	6	.	.	NOUN
iajs-3485	303	7	41	41	NUM
iajs-3485	303	8	.	.	PUNCT
iajs-3485	304	1	shirinbayan	shirinbayan	PROPN
iajs-3485	304	2	,	,	PUNCT
iajs-3485	304	3	v.	v.	PROPN
iajs-3485	304	4	;	;	PUNCT
iajs-3485	304	5	roshan	roshan	PROPN
iajs-3485	304	6	,	,	PUNCT
iajs-3485	304	7	v.d	v.d	PROPN
iajs-3485	304	8	.	.	PROPN
iajs-3485	304	9	pretreatment	pretreatment	NOUN
iajs-3485	304	10	effect	effect	NOUN
iajs-3485	304	11	of	of	ADP
iajs-3485	304	12	running	run	VERB
iajs-3485	304	13	exercise	exercise	NOUN
iajs-3485	304	14	on	on	ADP
iajs-3485	304	15	hsp	hsp	X
iajs-3485	304	16	70	70	NUM
iajs-3485	304	17	and	and	CCONJ
iajs-3485	304	18	dox	dox	NOUN
iajs-3485	304	19	-	-	PUNCT
iajs-3485	304	20	induced	induce	VERB
iajs-3485	304	21	cardiotoxicity	cardiotoxicity	NOUN
iajs-3485	304	22	.	.	PUNCT
iajs-3485	305	1	asian	asian	PROPN
iajs-3485	305	2	pacific	pacific	PROPN
iajs-3485	305	3	journal	journal	PROPN
iajs-3485	305	4	cancer	cancer	NOUN
iajs-3485	305	5	prev	prev	NOUN
iajs-3485	305	6	.	.	PROPN
iajs-3485	305	7	2012	2012	NUM
iajs-3485	305	8	,	,	PUNCT
iajs-3485	305	9	13	13	NUM
iajs-3485	305	10	,	,	PUNCT
iajs-3485	305	11	5849–5855	5849–5855	NUM
iajs-3485	305	12	.	.	PUNCT
iajs-3485	306	1	doi	doi	NOUN
iajs-3485	306	2	:	:	PUNCT
iajs-3485	306	3	https://doi.org/10.7314/apjcp.2012.13.11.5849	https://doi.org/10.7314/apjcp.2012.13.11.5849	X
iajs-3485	306	4	.	.	NOUN
iajs-3485	306	5	42	42	NUM
iajs-3485	306	6	.	.	PUNCT
iajs-3485	307	1	al	al	PROPN
iajs-3485	307	2	-	-	PUNCT
iajs-3485	307	3	hadhrami	hadhrami	PROPN
iajs-3485	307	4	,	,	PUNCT
iajs-3485	307	5	r.m.s	r.m.	NOUN
iajs-3485	307	6	.	.	PUNCT
iajs-3485	307	7	;	;	PUNCT
iajs-3485	307	8	hossain	hossain	PROPN
iajs-3485	307	9	,	,	PUNCT
iajs-3485	307	10	m.a	m.a	PROPN
iajs-3485	307	11	.	.	PROPN
iajs-3485	307	12	evaluation	evaluation	NOUN
iajs-3485	307	13	of	of	ADP
iajs-3485	307	14	antioxidant	antioxidant	ADJ
iajs-3485	307	15	,	,	PUNCT
iajs-3485	307	16	antimicrobial	antimicrobial	ADJ
iajs-3485	307	17	and	and	CCONJ
iajs-3485	307	18	cytotoxic	cytotoxic	ADJ
iajs-3485	307	19	activities	activity	NOUN
iajs-3485	307	20	of	of	ADP
iajs-3485	307	21	seed	seed	NOUN
iajs-3485	307	22	crude	crude	ADJ
iajs-3485	307	23	extracts	extract	NOUN
iajs-3485	307	24	of	of	ADP
iajs-3485	307	25	ammi	ammi	PROPN
iajs-3485	307	26	majus	maju	NOUN
iajs-3485	307	27	grown	grow	VERB
iajs-3485	307	28	in	in	ADP
iajs-3485	307	29	oman	oman	NOUN
iajs-3485	307	30	.	.	PUNCT
iajs-3485	308	1	egyptian	egyptian	PROPN
iajs-3485	308	2	journal	journal	PROPN
iajs-3485	308	3	of	of	ADP
iajs-3485	308	4	basic	basic	ADJ
iajs-3485	308	5	and	and	CCONJ
iajs-3485	308	6	applied	applied	ADJ
iajs-3485	308	7	sciences	science	NOUN
iajs-3485	308	8	.	.	PUNCT
iajs-3485	308	9	2016	2016	NUM
iajs-3485	308	10	,	,	PUNCT
iajs-3485	308	11	3(4	3(4	NUM
iajs-3485	308	12	)	)	PUNCT
iajs-3485	308	13	,	,	PUNCT
iajs-3485	308	14	329–334	329–334	NUM
iajs-3485	308	15	.	.	PUNCT
iajs-3485	309	1	doi	doi	NOUN
iajs-3485	309	2	:	:	PUNCT
iajs-3485	309	3	https://doi.org/10.1016/j.ejbas.2016.08.001	https://doi.org/10.1016/j.ejbas.2016.08.001	PROPN
iajs-3485	309	4	.	.	PROPN
iajs-3485	310	1	43	43	NUM
iajs-3485	310	2	.	.	PUNCT
iajs-3485	311	1	vimal	vimal	PROPN
iajs-3485	311	2	,	,	PUNCT
iajs-3485	311	3	v.	v.	ADV
iajs-3485	311	4	;	;	PUNCT
iajs-3485	311	5	devaki	devaki	PROPN
iajs-3485	311	6	,	,	PUNCT
iajs-3485	311	7	t.	t.	PROPN
iajs-3485	311	8	linear	linear	PROPN
iajs-3485	311	9	furanocoumarin	furanocoumarin	PROPN
iajs-3485	311	10	protects	protect	VERB
iajs-3485	311	11	rat	rat	PRON
iajs-3485	311	12	myocardium	myocardium	NOUN
iajs-3485	311	13	against	against	ADP
iajs-3485	311	14	lipidperoxidation	lipidperoxidation	NOUN
iajs-3485	311	15	and	and	CCONJ
iajs-3485	311	16	membrane	membrane	NOUN
iajs-3485	311	17	damage	damage	NOUN
iajs-3485	311	18	during	during	ADP
iajs-3485	311	19	experimental	experimental	ADJ
iajs-3485	311	20	myocardial	myocardial	ADJ
iajs-3485	311	21	injury	injury	NOUN
iajs-3485	311	22	.	.	PUNCT
iajs-3485	312	1	biomedicine	biomedicine	NOUN
iajs-3485	312	2	&	&	CCONJ
iajs-3485	312	3	pharmacotherapy	pharmacotherapy	NOUN
iajs-3485	312	4	.	.	PUNCT
iajs-3485	313	1	2004	2004	NUM
iajs-3485	313	2	,	,	PUNCT
iajs-3485	313	3	58(6	58(6	NUM
iajs-3485	313	4	-	-	SYM
iajs-3485	313	5	7	7	NUM
iajs-3485	313	6	)	)	PUNCT
iajs-3485	313	7	,	,	PUNCT
iajs-3485	313	8	393–400	393–400	NUM
iajs-3485	313	9	.	.	PUNCT
iajs-3485	314	1	doi	doi	NOUN
iajs-3485	314	2	:	:	PUNCT
iajs-3485	314	3	https://doi.org/10.1016/j.biopha.2003.12.007	https://doi.org/10.1016/j.biopha.2003.12.007	ADJ
iajs-3485	314	4	.	.	PUNCT
iajs-3485	315	1	https://doi.org/10.1002/jccs.201100477	https://doi.org/10.1002/jccs.201100477	NOUN
iajs-3485	315	2	https://doi.org/10.1111/j.1440-1681.2004.03982.x	https://doi.org/10.1111/j.1440-1681.2004.03982.x	NOUN
iajs-3485	315	3	https://doi.org/10.1139/y11-020	https://doi.org/10.1139/y11-020	NUM
iajs-3485	315	4	https://doi.org/10.29409/ijcmg.v7i2.138	https://doi.org/10.29409/ijcmg.v7i2.138	NOUN
iajs-3485	315	5	https://doi.org/10.4149/bll_2015_092	https://doi.org/10.4149/bll_2015_092	PUNCT
iajs-3485	316	1	https://doi.org/10.1186/1423-0127-20-95	https://doi.org/10.1186/1423-0127-20-95	PROPN
iajs-3485	316	2	https://doi.org/10.1186/1423-0127-20-95	https://doi.org/10.1186/1423-0127-20-95	PROPN
iajs-3485	316	3	https://doi.org/10.3390%2fmolecules23051184	https://doi.org/10.3390%2fmolecules23051184	PROPN
iajs-3485	316	4	https://doi.org/10.7314/apjcp.2012.13.11.5849	https://doi.org/10.7314/apjcp.2012.13.11.5849	NUM
iajs-3485	316	5	https://doi.org/10.1016/j.ejbas.2016.08.001	https://doi.org/10.1016/j.ejbas.2016.08.001	ADJ
iajs-3485	316	6	https://doi.org/10.1016/j.biopha.2003.12.007	https://doi.org/10.1016/j.biopha.2003.12.007	NOUN